Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemokine activity (GO:0008009),0.7820414380285471,2.061825854003934,0.0,0.0009312653782575243,0.001,8/31,8.47%,CCL11;CCL7;CXCL5;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,chemokine receptor binding (GO:0042379),0.7547811026675467,2.024194025509532,0.0,0.0023281634456438108,0.004,8/35,8.47%,CCL11;CCL7;CXCL5;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,platelet-derived growth factor binding (GO:0048407),0.9505365023442389,1.985353742627659,0.0,0.004656326891287622,0.012,7/11,3.16%,COL4A1;COL1A2;COL1A1;COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5934554754203487,-1.9688618402022853,0.0,0.133929647756588,0.092,15/29,19.28%,GABRB1;GRID2;GRIK4;GLRA3;GABRA2;GABRA5;GABRG3;GRIN2D;GABRB2;GLRA2;CHRNB1;GABRG1;GRIA2;GABRE;GABRA4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5870501318284359,-1.9189937213795774,0.0,0.12540685199025967,0.168,13/26,17.03%,ABCG2;SLC6A6;SLC16A11;SLC16A1;SLC5A6;SLC6A1;SLC16A9;SLC16A4;MPC2;MPC1;SLC16A13;SLC6A12;SLC26A6
prerank,glutamate receptor activity (GO:0008066),-0.6380892044672983,-1.91688702128357,0.0,0.08603965249817168,0.172,7/19,7.83%,GRM7;GRM1;GRID2;GRIK4;GRM3;GRM8;GRIN2D
prerank,monocarboxylic acid binding (GO:0033293),0.8142392497504789,1.8902934470931347,0.0,0.027239512314032585,0.093,3/18,7.04%,NR1H4;NR2F2;PYGL
prerank,metalloendopeptidase activity (GO:0004222),0.6404052274327126,1.8804950077834222,0.0,0.02756545519642272,0.116,25/76,12.39%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;MMP11;ADAMTS2;ADAMTSL2;ADAMTS5;ADAMTS7;MMP12;ADAMTS1;ADAMTS6;ADAMTS12;MMP17;ADAMTS15;MMP16;OMA1;ADAMTS4;ADAMTS9;ADAMTS14;ADAMTS18;ADAMTS10;NLN
prerank,semaphorin receptor binding (GO:0030215),-0.5891789980713905,-1.866888288210078,0.00392156862745098,0.11901475516551341,0.29,17/23,26.64%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;RIT2;SEMA3D;SEMA4D;SEMA5A;SEMA5B;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SEMA4A;SEMA4G;SEMA3F
prerank,serine-type endopeptidase activity (GO:0004252),0.6260790768359163,1.8278213362278892,0.0,0.06410210020339292,0.287,9/80,8.76%,FAP;HP;HPR;MMP2;MASP1;PRTN3;PLAT;KLK2;RHBDL3
prerank,lipoprotein particle receptor binding (GO:0070325),0.7158795448670571,1.8061631394686164,0.0013192612137203166,0.07849236759599135,0.384,5/27,3.63%,CLTC;LRP1;HSPG2;CRP;APOE
prerank,CXCR chemokine receptor binding (GO:0045236),0.8474709073203779,1.8052333880263423,0.0,0.07019412788616089,0.388,5/11,8.47%,CXCL5;CXCL1;CXCL12;YARS1;CXCL10
prerank,cytokine activity (GO:0005125),0.5834995601554114,1.7715394380288723,0.0,0.10554340953585276,0.56,22/131,9.37%,CCL11;IL34;CCL7;CXCL5;ADIPOQ;WNT2;CXCL1;CXCL12;TNFSF11;IL16;WNT5A;TIMP1;XCL1;TSLP;WNT2B;WNT9A;BMP5;CCL5;CXCL10;IL33;INHBB;TGFB3
prerank,endopeptidase activity (GO:0004175),0.5605912703785564,1.7638569307066123,0.0,0.10700239196178955,0.597,53/257,12.50%,PSMA7;MMP3;MMP13;FAP;MMP27;CASP4;HP;HPR;MMP2;MMP14;ADAM19;MMP11;MASP1;SFRP1;ADAMTS2;PDIA3;PRTN3;USP9X;ADAMTSL2;ADAMTS5;HTRA3;CASP1;ADAMTS7;PLAT;USP24;USP42;USP38;MMP12;ADAMTS1;CTSS;KLK2;ADAMTS6;ADAMTS12;USP40;MMP17;ADAMTS15;MMP16;CASP7;OMA1;RHBDL3;CTSB;ADAMTS4;CTSK;USP14;ADAMTS9;ADAMTS14;ADAMTS18;ADAMTS10;PSMB8;HTRA4;CTSL;NLN;PCSK5
prerank,triglyceride lipase activity (GO:0004806),0.7334337147837825,1.755063543202839,0.0,0.11141320343517291,0.653,3/20,3.05%,CEL;LIPC;LPL
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6378186933917445,-1.7526649784976818,0.009900990099009901,0.3043855630831545,0.677,8/15,22.34%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC4A3;SLC26A6;CFTR;SLC26A8
prerank,serine-type peptidase activity (GO:0008236),0.5844995201917094,1.7383631052560646,0.0,0.12882504399229086,0.733,10/96,8.76%,FAP;HP;HPR;MMP2;MASP1;PRTN3;HTRA3;PLAT;KLK2;RHBDL3
prerank,anion transmembrane transporter activity (GO:0008509),-0.6453387879919109,-1.7359443023270438,0.01818181818181818,0.29139844572493995,0.728,3/12,3.69%,ABCG2;SLC22A6;SLC39A8
prerank,CCR chemokine receptor binding (GO:0048020),0.6745854974872142,1.7314765762618372,0.0,0.13202477631758597,0.771,7/28,15.90%,CCL11;CCL7;XCL1;CCL5;CCL2;NARS1;CX3CL1
prerank,metallopeptidase activity (GO:0008237),0.5682637151716238,1.7311873380338798,0.0,0.12332614366353216,0.775,33/113,13.42%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAM12;MMP11;ANPEP;ADAMTS2;ADAMTSL2;ADAMTS5;ADAMTS7;BMP1;MMP12;ADAMTS1;ADAMTS6;ADAMTS12;MMP17;EIF3H;ADAMTS15;MMP16;OMA1;ADAMTS4;ADAMTS9;ADAMTS14;LAP3;ADAMTS18;ADAMTS10;NLN;METAP1;PAPPA2;PMPCB
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.7052157179869489,1.7272109179063126,0.005277044854881266,0.1218715958346347,0.798,6/22,5.96%,RBMS3;ZFP36L1;CPEB1;ZFP36L2;ILF3;KHSRP
prerank,poly(U) RNA binding (GO:0008266),0.7190482571182728,1.717073112570441,0.0026490066225165563,0.13084278564518217,0.836,5/20,5.61%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.6996493433233345,1.7051862756698886,0.004070556309362279,0.14478437616086098,0.876,4/22,3.63%,CLTC;HSPG2;CRP;APOE
prerank,steroid hydroxylase activity (GO:0008395),0.7275348950282543,1.6864911479038358,0.012640449438202247,0.17311188642498204,0.921,2/16,0.21%,CYP7B1;CYP1B1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5605908592621478,-1.6838013354375714,0.017482517482517484,0.38683056702682034,0.864,12/19,27.63%,GRID2;GRIK4;GABRA2;GABRA5;GABRG3;CHRNB1;GABRG1;GABRE;GABRA4;GABRG2;GRIK2;GRIK3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.7624382880621279,1.6756796217329346,0.016566265060240965,0.18728236896431583,0.949,3/13,5.46%,SLC7A2;SLC38A3;SLC7A7
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5047197930059775,-1.6597440867459778,0.004608294930875576,0.4033108710851797,0.912,13/28,27.63%,GRID2;GRIK4;GABRA2;GABRA5;GABRG3;CHRNB1;GABRG1;GABRE;GABRA4;GABRG2;CHRNA4;GRIK2;GRIK3
prerank,cytokine receptor binding (GO:0005126),0.5596596989194944,1.6482285900495608,0.0,0.2433396433386911,0.988,14/83,7.35%,IL34;IL23R;OSMR;CXCL12;JAK1;TNFSF11;JAK2;XCL1;SMAD2;TSLP;SPRED1;SPRED2;PXDN;CCL5
prerank,I-SMAD binding (GO:0070411),0.7442140123482981,1.6482225413788267,0.017133956386292833,0.23179638724533713,0.988,6/13,13.71%,SMAD2;TGFB1I1;TGFBR1;SMAD5;SMURF1;SMAD3
prerank,aminopeptidase activity (GO:0004177),0.6529376705135007,1.6479652573795054,0.011568123393316195,0.22202213222548706,0.988,15/26,19.31%,MMP14;XPNPEP2;ANPEP;XPNPEP3;XPNPEP1;MMP17;MMP16;LAP3;METAP1;ENPEP;NPEPPS;LVRN;MMP15;METAP1D;CTSH
prerank,E-box binding (GO:0070888),0.6229823904243905,1.6454360357785973,0.01371571072319202,0.21783511891415133,0.988,12/34,15.18%,ZEB1;TCF4;SNAI1;MITF;SNAI2;PPARG;BHLHE40;AHR;TCF3;CLOCK;PRMT5;CIART
prerank,poly-pyrimidine tract binding (GO:0008187),0.6713468994662408,1.6372695320543258,0.016774193548387096,0.22901367760316288,0.992,5/23,5.61%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5735502421048111,-1.6292817386028464,0.024922118380062305,0.4514376106704385,0.956,9/15,12.60%,HS3ST3A1;HS3ST1;NDST3;HS6ST3;HS6ST1;HS3ST3B1;HS3ST2;NDST1;HS6ST2
prerank,neuropeptide receptor binding (GO:0071855),0.7103087220167442,1.617218820261329,0.025222551928783383,0.27271175336893344,0.997,2/14,4.04%,QRFP;APLN
prerank,vinculin binding (GO:0017166),-0.6400897413793106,-1.6140350577713445,0.026239067055393587,0.45670009884996504,0.972,4/11,14.94%,DMD;SORBS3;RTCB;CORO2B
prerank,diacylglycerol kinase activity (GO:0004143),-0.6307546538092548,-1.6104728086643152,0.03333333333333333,0.42569704567920447,0.973,6/11,14.70%,DGKB;DGKI;DGKG;DGKQ;DGKA;DGKZ
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6158722330503106,-1.6073133104628103,0.0345821325648415,0.39935385876509877,0.974,6/11,27.14%,KCNJ3;KCND3;KCNQ1;KCNE4;KCNJ8;KCNH2
prerank,cholesterol transfer activity (GO:0120020),0.6910854009085238,1.6015089633973674,0.02877697841726619,0.30746084642163807,0.998,5/16,9.82%,ABCA1;ABCG1;PLTP;NPC2;GRAMD1A
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.599227414920739,1.599293142974854,0.012468827930174564,0.3018334564863554,0.998,6/38,7.24%,SERPING1;TFPI2;SERPINE2;SERPINH1;SERPINA2;SERPINF1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5714651449938826,-1.5972277813402551,0.03514376996805112,0.3941090613704351,0.981,7/16,22.34%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR;SLC26A8
prerank,chloride channel activity (GO:0005254),-0.41305078302060233,-1.59663617871954,0.007751937984496124,0.36743685829323647,0.981,24/59,24.36%,SLC26A7;GABRB1;GLRA3;GABRA2;ANO4;GABRA5;CLCN3;ANO3;CLCC1;GABRG3;GABRB2;ANO1;GLRA2;FXYD1;GABRG1;GABRE;GABRA4;ANO2;CFTR;SLC26A8;CLIC4;ANO5;GLRA1;GABRG2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7469136502071765,1.5959568511107816,0.02197802197802198,0.3002665655324618,0.999,5/11,8.55%,CASP4;CASP1;CFLAR;CASP12;CASP7
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6178287783243771,-1.5959076132011858,0.03197674418604651,0.3456196606954859,0.981,8/12,19.28%,GABRB1;GABRA2;GABRA5;GABRG3;GABRB2;GABRG1;GABRE;GABRA4
prerank,ligand-gated anion channel activity (GO:0099095),-0.5471562456080616,-1.5924200791469767,0.02631578947368421,0.3322368421052631,0.982,13/17,24.36%,GABRB1;GLRA3;GABRA2;GABRA5;GABRG3;GABRB2;GLRA2;GABRG1;GABRE;GABRA4;CFTR;GLRA1;GABRG2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7544252776502558,1.582121207326116,0.0282574568288854,0.33130568646492686,0.999,5/10,8.55%,CASP4;CASP1;CFLAR;CASP12;CASP7
prerank,frizzled binding (GO:0005109),0.6019115929366988,1.578174565307883,0.016560509554140127,0.33345508977474425,1.0,9/34,13.84%,WNT2;SFRP1;WNT5A;WNT2B;WNT9A;DVL2;FZD1;LRP6;SDCBP
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6309775000897692,-1.5742248301560373,0.03296703296703297,0.35537909741614415,0.988,4/10,4.50%,SLCO1C1;SLCO3A1;SLC22A6;SLCO2A1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.742879802472158,1.5675742787433469,0.02635658914728682,0.35514255812130496,1.0,1/11,0.03%,ROR2
prerank,AMP binding (GO:0016208),-0.6156148797766787,-1.563218124049607,0.04594594594594595,0.36133948399782484,0.989,6/11,18.74%,PRKAG2;MPPED2;PFKM;PRKAG3;ACSS2;APRT
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5378728988099852,1.5608925493234111,0.006578947368421052,0.3649687221477379,1.0,29/78,19.91%,CASP4;SFRP1;PDIA3;USP9X;CAPN5;CASP1;CFLAR;USP24;USP42;CAPN2;USP38;CASP12;CTSS;CAPN15;USP40;CASP7;CTSB;CTSK;USP14;CTSL;USP47;CASP8;PIGK;CTSW;CTSC;USP12;CTSH;UCHL1;CAPNS1
prerank,GABA receptor activity (GO:0016917),-0.5255216039552035,-1.5590012711620178,0.04081632653061224,0.3511648180411972,0.991,9/21,19.28%,GABRB1;GABRA2;GABRA5;GPR156;GABRG3;GABRB2;GABRG1;GABRE;GABRA4
prerank,neurexin family protein binding (GO:0042043),0.7303144536563623,1.557769320953712,0.042879019908116385,0.36404010240975954,1.0,1/10,0.07%,CEL
prerank,phosphatase inhibitor activity (GO:0019212),0.6410675115233644,1.5550277316208798,0.035326086956521736,0.3613035766057354,1.0,4/20,7.65%,MGAT5;PPP1R9B;PTN;PPP1R2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5457591540727909,-1.551385192283267,0.03426791277258567,0.3522349735998264,0.995,8/15,21.28%,COX5A;COX8A;COX4I1;COX6A1;COX5B;COX6B1;COX10;CYB5A
prerank,anion:anion antiporter activity (GO:0015301),-0.5370928147095284,-1.5506630354140711,0.048109965635738834,0.3363895308587548,0.995,4/17,7.75%,SLC26A7;SLC26A2;SLC25A4;SLC4A3
prerank,GABA-A receptor activity (GO:0004890),-0.5476115315308534,-1.550222043742437,0.035483870967741936,0.3220399257419775,0.995,8/18,19.28%,GABRB1;GABRA2;GABRA5;GABRG3;GABRB2;GABRG1;GABRE;GABRA4
prerank,metalloaminopeptidase activity (GO:0070006),0.6738177527332481,1.5501623196943106,0.025495750708215296,0.36683873628675684,1.0,10/16,17.70%,MMP14;ANPEP;XPNPEP3;XPNPEP1;MMP17;MMP16;ENPEP;NPEPPS;LVRN;MMP15
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6790534989823084,1.5485496771875722,0.029914529914529916,0.36146030917756633,1.0,8/15,21.63%,SH3PXD2B;SESTD1;PLEKHF1;PLEKHA5;PLA2G4A;SAP30L;RUBCNL;PLA2G4E
prerank,MHC class II protein complex binding (GO:0023026),-0.5927632853339051,-1.5454386300456704,0.03508771929824561,0.31740797152114686,0.996,4/11,9.80%,ATP1B1;ANXA11;CD81;HSP90AB1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4305359600558432,-1.5392325176722073,0.026737967914438502,0.31793072064035494,0.996,16/37,21.28%,SLCO1C1;SLCO3A1;COX5A;COX8A;SLC22A6;SLC22A8;COX4I1;SLCO2A1;COX6A1;COX5B;COX6B1;COX10;UQCRFS1;UQCR10;UQCR11;CYB5A
prerank,anion channel activity (GO:0005253),-0.38635355462114895,-1.5380503530497225,0.022900763358778626,0.30784338307977915,0.996,28/61,24.36%,SLC26A7;LRRC8D;GABRB1;GLRA3;GABRA2;GPR89B;GPR89A;ANO4;GABRA5;CLCN3;ANO3;CLCC1;GABRG3;GABRB2;ANO1;GLRA2;LRRC8B;FXYD1;GABRG1;GABRE;GABRA4;ANO2;CFTR;SLC26A8;CLIC4;ANO5;GLRA1;GABRG2
prerank,calcium-release channel activity (GO:0015278),0.6595898361604717,1.5237489446930008,0.037396121883656507,0.4351022863226439,1.0,4/17,4.71%,MCOLN2;RASA3;ITPR1;PKD2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6178744671565917,-1.504786953935329,0.06868131868131869,0.36582461827778506,0.999,7/10,24.36%,GABRA2;GABRA5;GABRG3;GABRG1;GABRE;GABRA4;GABRG2
prerank,sterol transfer activity (GO:0120015),0.6434999468649661,1.5039309999073525,0.05300859598853868,0.49428135300200027,1.0,5/17,9.82%,ABCA1;ABCG1;PLTP;NPC2;GRAMD1A
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5948120032050447,1.5036644158978028,0.04365079365079365,0.48249098033516763,1.0,5/26,7.65%,MGAT5;PPP1R9B;PTN;PABIR1;PPP1R2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.7243951714481186,1.498556672093698,0.05221518987341772,0.48898416848856957,1.0,4/10,7.56%,APOBEC1;LACC1;CDADC1;GDA
prerank,SH2 domain binding (GO:0042169),0.5825036695978463,1.4971208966736502,0.03359173126614987,0.4826907452036744,1.0,11/31,15.79%,DLC1;SH3PXD2B;JAK2;IRS1;KHDRBS1;SQSTM1;SH2B2;LAT2;PTK2;RUFY1;ABL1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5339177263499602,-1.4829817247762642,0.058823529411764705,0.38535212286327364,1.0,7/16,11.68%,PTPRB;PTPRT;PTPRG;PTPRO;PTPRK;PTPRN2;PTPRU
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5339177263499602,-1.4829817247762642,0.058823529411764705,0.38535212286327364,1.0,7/16,11.68%,PTPRB;PTPRT;PTPRG;PTPRO;PTPRK;PTPRN2;PTPRU
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6624510111030749,1.4822386159377154,0.06599713055954089,0.5281161614128027,1.0,4/15,6.73%,KMT2A;CXXC1;KMT2B;RBBP5
prerank,sterol binding (GO:0032934),0.5182122684934919,1.4790927660072513,0.04033214709371293,0.5287421615064931,1.0,10/56,9.82%,RORA;ABCA1;APOD;OSBPL11;VDAC2;ABCG1;INSIG2;SOAT1;NPC2;GRAMD1A
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.418399751708478,-1.4789505444808444,0.022935779816513763,0.38058691439293735,1.0,13/33,24.02%,ERCC5;WDR43;CTR9;URI1;HNRNPU;RPRD1A;WAC;UVSSA;SUPT4H1;MAF1;SCAF8;SMYD2;ELOF1
prerank,Toll-like receptor binding (GO:0035325),0.6907476098242868,1.4758894287141509,0.07418856259659969,0.5295301931505682,1.0,3/11,7.23%,TLR2;TIRAP;CD36
prerank,growth factor receptor binding (GO:0070851),0.4926950714948178,1.4757150036586135,0.019417475728155338,0.5183009199657711,1.0,13/95,6.55%,GLMN;IL23R;PDGFRA;FGF20;JAK2;ATXN2;PDGFRB;FGF7;IL1R1;EGF;TSLP;FGF9;FRS2
prerank,protease binding (GO:0002020),0.48965924187107196,1.475184673186718,0.022604951560818085,0.5093009374092291,1.0,25/99,16.72%,FAP;COL1A2;COL1A1;COL3A1;CLTC;CCBE1;TNFAIP3;TIMP1;SLC2A13;BCL2;CFLAR;PTEN;ADAMTS4;BIN1;PZP;BAG6;RAD23A;SELENOS;LCOR;GSK3B;ITGA3;TNF;SYVN1;CHMP3;TIMP2
prerank,poly-purine tract binding (GO:0070717),0.5763684947678702,1.473120962469603,0.04292929292929293,0.5060535693765357,1.0,5/27,5.61%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,PDZ domain binding (GO:0030165),-0.366518190672352,-1.472834816216719,0.02127659574468085,0.382592360424653,1.0,24/61,17.06%,CRIM1;KIDINS220;CADM1;GRID2;PRKN;TGFBR3;USHBP1;CLCN3;FZD4;DOCK4;ATP2B2;CRIPT;ARHGAP29;CXADR;RAPGEF2;ERC1;SNTG2;ATP2B4;CCDC88C;NLGN1;PLEKHA1;FZD8;SLC26A6;F11R
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6094178133404086,1.4713251582092524,0.05198358413132695,0.50270869200064,1.0,7/21,20.19%,FGF20;FGF7;FGF9;FRS2;FGF2;NPTN;FGF18
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6794331644210145,1.4712881785700902,0.08211143695014662,0.4926013742664648,1.0,3/12,7.08%,STAT1;POU2F1;HDAC1
prerank,cation:chloride symporter activity (GO:0015377),-0.5935013925567735,-1.4711267801075967,0.09424083769633508,0.3747280848227584,1.0,4/10,6.18%,SLC12A7;SLC12A2;SLC12A6;SLC6A1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.42301041223692515,-1.4650103910070755,0.05714285714285714,0.37660103792463295,1.0,10/33,13.88%,ERCC5;WDR43;CTR9;URI1;HNRNPU;RPRD1A;LLPH;WAC;UVSSA;SUPT4H1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6760776260285942,1.464482547071755,0.08125,0.508061139762175,1.0,5/12,11.05%,GAB2;IRS1;FRS2;PIK3R1;SH2B2
prerank,hormone activity (GO:0005179),0.5169262482954655,1.46445282053431,0.022067363530778164,0.4982087172623195,1.0,4/54,4.04%,QRFP;ADIPOQ;EDN3;APLN
prerank,phospholipid transfer activity (GO:0120014),-0.47317142372921556,-1.4618648763365947,0.04580152671755725,0.37253103399401344,1.0,7/21,13.07%,PITPNC1;CERT1;PITPNA;TNFAIP8L3;PITPNM2;ABCA3;OSBPL2
prerank,potassium ion leak channel activity (GO:0022841),-0.5274974007088284,-1.4610305958534435,0.07119741100323625,0.36300664152634554,1.0,6/15,22.46%,KCNK5;TMEM175;KCNK10;KCNK6;KCNK13;KCNK12
prerank,cysteine-type peptidase activity (GO:0008234),0.5100597825209396,1.457372501754487,0.022271714922048998,0.5124825012349484,1.0,26/73,19.58%,CASP4;OTULINL;SFRP1;PDIA3;USP9X;CASP1;USP24;USP42;CAPN2;USP38;CTSS;USP40;CASP7;CTSB;CTSK;USP14;ATG4A;GGH;CTSL;USP47;CASP8;CTSW;CTSC;USP12;CTSH;UCHL1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6623109169551653,1.4525940418502234,0.06432748538011696,0.5195757968882075,1.0,3/14,6.87%,RDH10;RDH12;AKR1A1
prerank,myosin II binding (GO:0045159),-0.5850277645483231,-1.4419623028591628,0.058333333333333334,0.39375316440436875,1.0,6/10,15.77%,SHROOM4;TRIOBP;STXBP5L;GSN;SHROOM1;STXBP5
prerank,receptor antagonist activity (GO:0048019),0.620171511285568,1.440880684801049,0.09141274238227147,0.5527577389612995,1.0,5/17,12.35%,PXDN;CCL5;DKK3;WFIKKN1;DKK2
prerank,poly(A) binding (GO:0008143),0.5891408068244546,1.4363848130054329,0.07142857142857142,0.5591486652036042,1.0,4/21,5.61%,RBMS3;RBMS1;KHDRBS1;PABPC4
prerank,neuropeptide receptor activity (GO:0008188),-0.4237210768404104,-1.4273090571718519,0.06866952789699571,0.415486293608506,1.0,17/29,45.41%,SORCS1;SORCS2;SORCS3;OPRM1;NPSR1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,lipase activity (GO:0016298),0.5258414924071325,1.4200823023168527,0.05012224938875306,0.6136207355772213,1.0,4/43,3.05%,CEL;PLA1A;LIPC;LPL
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6931138617713659,1.4167439774498698,0.10903426791277258,0.6163016245373742,1.0,2/10,3.27%,DPYSL4;DPYSL3
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.49436063675123587,1.415540699940253,0.05408515535097814,0.611038538533937,1.0,16/60,12.47%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;DDR2;EPHB3;FGFR1;EGFR;ACVR1B;EPHA1;ACVR1;DDR1;MERTK;ACVR2A;EPHB2
prerank,transcription coactivator binding (GO:0001223),0.5858163183254568,1.4146716084912798,0.0821917808219178,0.6042965255354122,1.0,5/20,13.71%,RORA;CDK9;AHR;TERT;SMAD3
prerank,cytokine receptor activity (GO:0004896),0.4826808140710986,1.411426988264747,0.04008667388949079,0.6064865775902127,1.0,8/83,5.52%,IL23R;IL1RL2;OSMR;GHR;CMKLR1;IL10RA;IL1R1;CCR1
prerank,alpha-actinin binding (GO:0051393),0.581392747674093,1.4100091427338213,0.06976744186046512,0.6020249004296264,1.0,8/24,12.92%,PALLD;PKD2;CACNA1C;PDLIM7;KCNA5;PPARG;PDLIM2;PDLIM4
prerank,estrogen receptor binding (GO:0030331),0.549139213928728,1.4085997323617445,0.07875,0.5981727810278654,1.0,12/32,14.01%,WIPI1;NRIP1;DNAAF4;TACC1;PADI2;PPID;ARID5A;STRN;MMS19;RERG;LCOR;NSD1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6518125435079265,1.4085742164519532,0.08558558558558559,0.5888405768712458,1.0,3/14,7.33%,CAPN5;CAPN2;CAPN15
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5540706376597107,-1.4078458141202708,0.10644257703081232,0.4484175208793672,1.0,3/11,2.10%,ATP10A;ATP8A1;ABCA4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5272577380111917,-1.4048055085817885,0.1130952380952381,0.44235232462379276,1.0,10/13,24.36%,GLRA3;GABRA2;GABRA5;GABRG3;GLRA2;GABRG1;GABRE;GABRA4;GLRA1;GABRG2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5129980148876948,-1.4023018687950217,0.11180124223602485,0.4357240311745218,1.0,6/14,24.24%,SLC26A7;SLC26A2;SLC26A6;SLC25A14;SLC26A8;SLC25A30
prerank,mRNA 3'-UTR binding (GO:0003730),0.47791380900733865,1.3995613407027372,0.045951859956236324,0.6143004761546548,1.0,11/79,5.96%,RBMS3;IGF2BP1;RBMS1;ZFP36L1;IGF2BP2;CPEB1;ZFP36L2;CELF1;ILF3;PABPC4;KHSRP
prerank,carboxylic acid binding (GO:0031406),-0.39754723206790055,-1.3981985191704391,0.046875,0.4337798659498035,1.0,12/38,16.54%,GRM7;NOS3;GLRA3;GLUD1;SESN2;GRIN3A;PHYH;SESN3;GLRA2;GRIN2B;MAG;GCLC
prerank,thyroid hormone receptor binding (GO:0046966),0.5619151513302242,1.3971699235075479,0.08040201005025126,0.6138614830280291,1.0,13/28,24.91%,TACC1;ARID5A;MED13;TAF7;MED12;OASL;NSD1;GTF2H1;THRAP3;MED24;TRIP12;BRD8;HMGN3
prerank,retinoic acid receptor binding (GO:0042974),0.6064391798093761,1.3970480851107627,0.09274193548387097,0.6049979639931495,1.0,6/17,14.01%,NRIP1;ASXL1;TACC1;ARID5A;PPARG;NSD1
prerank,mRNA 5'-UTR binding (GO:0048027),0.5610660715025231,1.3921169717189392,0.08661417322834646,0.6156220129612539,1.0,4/24,4.47%,IGF2BP1;IGF2BP2;SYNCRIP;GNL3
prerank,protein tyrosine kinase activity (GO:0004713),0.45974955605774287,1.387074995840604,0.0288153681963714,0.6258514194263325,1.0,21/108,10.32%,ROR2;ROR1;EPHA7;PDGFRA;TEC;AATK;JAK1;PEAK1;JAK2;PDGFRB;DDR2;BLK;EPHB3;FGFR1;EGFR;EPHA1;DDR1;MERTK;STYK1;HIPK4;FRK
prerank,receptor ligand activity (GO:0048018),0.44189194086778855,1.385915030277885,0.008072653884964682,0.6212754766949329,1.0,33/245,9.37%,CCL11;EPHA7;IL34;ADIPOQ;WNT2;EDN3;CXCL1;FGF20;TNFSF11;IL16;PTN;SFRP2;WNT5A;TIMP1;FGF7;JAG1;APLN;EGF;TSLP;WNT2B;WNT9A;FGF9;SHH;MDK;BMP5;CCL5;TAFA2;CXCL10;IL33;SEMA3E;INHBB;GREM2;TGFB3
prerank,lipoprotein particle binding (GO:0071813),0.5928100353097685,1.3843779207994213,0.11015736766809728,0.6180276163850471,1.0,7/20,7.23%,LIPC;COLEC12;CRP;LPL;TREM2;PLTP;CD36
prerank,retinoic acid binding (GO:0001972),0.645181142814757,1.37991627909305,0.11940298507462686,0.6260070803957305,1.0,1/12,2.50%,NR2F2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.37178568296484826,-1.3784353003279999,0.052941176470588235,0.46833802101311506,1.0,13/42,9.79%,LRRC4C;BSG;STXBP6;BAIAP2L1;ESAM;NTNG1;CNTN4;PDLIM5;CD200;TMOD3;DSCAML1;CD47;ROBO4
prerank,endopeptidase inhibitor activity (GO:0004866),0.46446352087819875,1.377251486910006,0.054626532887402456,0.6272072322564427,1.0,13/82,10.39%,KNG1;SERPING1;TFPI2;FETUB;SERPINE2;PROS1;TIMP1;SERPINH1;SERPINA2;SERPINF1;BIN1;PZP;USP14
prerank,transcription cis-regulatory region binding (GO:0000976),0.4309156449096403,1.3717283524283883,0.001,0.6403788966817975,1.0,90/406,18.09%,RORA;RUNX1;NR1H4;TRPS1;CREB3L1;RUNX3;POU5F1;ETV6;TCF7L2;SNAI1;YAP1;DEAF1;SOX5;GLI3;TBX18;CREB3L3;SATB2;ZBTB48;SNAI2;MLXIP;SMAD2;GATA6;NPAS4;IRF1;ARNT;ARID5B;ZBTB10;ZBTB5;E2F1;ARID5A;MMP12;ZNF25;TEAD1;RBBP5;PRDM2;STAT3;HDAC1;TAF4;HSF2;CARM1;TAF7;CREB3L2;PRDM5;SNAPC3;NONO;FOXM1;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;MXI1;ENO1;ETV5;TCF12;NFKB1;AHR;HDAC5;XBP1;AHRR;CALCOCO1;TFDP1;CREB3;SETX;CTCF;TCF3;STAT6;SMAD3;TBL1X;PRDX5;HMGB2;NFXL1;FOXN2;NR2C2;YY1;GABPB1;TNF;ZNF35;KLF10;ATF2;ARID4B;TAF2;NFE2L2;SPI1;KMT2D;EGR2;GABPA;TFAP2C;BBX
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4432230586932026,1.371653872571859,0.022540983606557378,0.6320019904877416,1.0,33/173,13.40%,ZEB2;TRPS1;CREB3L1;POU5F1;ZEB1;ETV6;SNAI1;DEAF1;BCL6;BACH1;TBX18;MITF;SNAI2;TBX2;ZBTB5;ZNF25;PRDM2;PRDM5;FOXK2;ZBTB20;PPARG;E2F8;BHLHE40;MXI1;ENO1;ZBTB12;NFKB1;FOXP4;NR2F1;HEYL;PRDM1;CTCF;TCF3
prerank,metalloexopeptidase activity (GO:0008235),0.4907889315017442,1.3701123963877309,0.09639953542392567,0.6293988101132754,1.0,19/51,18.25%,MMP14;CPXM1;ANPEP;XPNPEP3;CPQ;XPNPEP1;MMP17;MMP16;AGTPBP1;LAP3;CPA6;METAP1;ENPEP;NPEPPS;AGBL3;PEPD;LVRN;MMP15;METAP1D
prerank,protein kinase inhibitor activity (GO:0004860),0.4968750434488275,1.3647680228136638,0.09349112426035502,0.6422790271940315,1.0,13/42,11.23%,GSKIP;SPRED1;SPRED2;HEXIM1;NCK1;PARVA;SH3BP5L;MAPK8IP1;RPTOR;SH3BP5;SPRY2;IBTK;TAOK3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5049379849750534,-1.3612336096700577,0.11965811965811966,0.4978878139003028,1.0,3/13,4.10%,BMP6;BMP4;CDH5
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4759173467939555,1.361157770297489,0.08685714285714285,0.6473624758001592,1.0,13/60,10.07%,ROR2;ROR1;EPHA7;PDGFRA;NRP1;PDGFRB;DDR2;EPHB3;FGFR1;EGFR;EPHA1;DDR1;MERTK
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4237522681290986,1.361019084376788,0.0,0.639624103966543,1.0,143/731,15.18%,RORA;RUNX1;NR1H4;RUNX2;ZEB2;SOHLH2;CREB3L1;RUNX3;POU5F1;ZEB1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;TEAD3;PRRX1;SOX5;BCL6;NKX6-1;NRIP1;MEIS2;GLI3;BACH1;PKNOX2;TBX18;USF1;CREB3L3;NR2F2;EGR3;CCAR1;SATB2;ZBTB48;IRF7;NFIX;GLIS1;STAT1;MITF;RARB;SNAI2;MLXIP;SMAD2;ZIC4;GATA6;MAFB;NPAS4;REL;PRRX2;BATF;RXRG;IRF1;ARNT;HOXB3;LITAF;BHLHE22;POU2F1;ZNF496;SOX21;ZKSCAN1;UBP1;TBX2;ZNF260;ZBTB5;ZBTB38;MEIS1;E2F1;NFKB2;TEAD1;ZSCAN12;MYBL1;CEBPD;STAT3;HDAC1;ELF4;HSF2;CC2D1B;CREB3L2;PRDM5;SNAPC3;ZNF250;PBX3;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;STAT5A;BHLHE40;NR1D2;MXI1;FOXE1;ZNF418;ZBTB12;TCF12;BCL11B;NFKB1;CHD2;FOXJ3;AHR;HDAC5;SALL1;HOXA1;FOXP4;NFE2L3;XBP1;CALCOCO1;CREB3L4;CREB3;NR2F1;ZNF367;MAFG;ZIC1;BACH2;ZNF445;GLIS3;HEYL;ZNF182;RBPJ;PGBD1;HIVEP2;PRDM1;SMAD5;HIVEP1;CTCF;TCF3;TCF7L1;NEUROD6;STAT6;SMAD3;CLOCK;TGIF2;JUNB;NSD1;RELB;ZSCAN22;ELK4;THRAP3;NR2C2;YY1;SP7;PRMT5;CIART
prerank,muscle alpha-actinin binding (GO:0051371),0.5981697270470544,1.3550480174562636,0.12696148359486448,0.6543612803427238,1.0,5/15,12.92%,PALLD;PKD2;PDLIM7;PDLIM2;PDLIM4
prerank,BMP receptor binding (GO:0070700),-0.504940542620903,-1.353139341472448,0.136986301369863,0.5078566939032055,1.0,3/12,4.10%,BMP6;BMP4;CDH5
prerank,four-way junction DNA binding (GO:0000400),0.5784867547518554,1.3526880275223416,0.13031161473087818,0.6556224671105254,1.0,7/17,17.73%,RAD51B;XRCC3;HMGB2;YY1;ABL1;HMGB3;XRCC2
prerank,MAP-kinase scaffold activity (GO:0005078),0.6354714765020659,1.3515041430481,0.14029850746268657,0.6523226547108077,1.0,9/11,28.38%,MAPK8IP1;MAP2K1;AKAP13;SH3RF1;MAPK8IP3;MAP2K2;KSR1;IQGAP1;MAPK8IP2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3944291237065638,-1.35105478274233,0.08629441624365482,0.5012123367386525,1.0,7/31,6.67%,SLC12A7;SLC12A2;KCNK5;TMEM175;ABCC9;SLC12A6;KCNK10
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5488886341172825,-1.3510066547396686,0.1349862258953168,0.49023662377810456,1.0,6/10,22.44%,ANKRD13A;IDE;DNAJC2;FAAP20;DNAJB2;ANKRD13D
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.41976469060182586,1.3477276549979338,0.0,0.6593245309114705,1.0,141/732,15.01%,RORA;RUNX1;NR1H4;RUNX2;ZEB2;SOHLH2;RUNX3;POU5F1;ZEB1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;TEAD3;PRRX1;SOX5;BCL6;NKX6-1;NRIP1;MEIS2;GLI3;BACH1;PKNOX2;TBX18;USF1;CREB3L3;NR2F2;EGR3;CCAR1;SATB2;ZBTB48;IRF7;NFIX;GLIS1;STAT1;MITF;RARB;SNAI2;MLXIP;SMAD2;ZIC4;GATA6;MAFB;NPAS4;REL;PRRX2;BATF;RXRG;IRF1;ARNT;HOXB3;LITAF;BHLHE22;POU2F1;ZNF496;SOX21;ZKSCAN1;UBP1;TBX2;ZNF260;ZBTB5;ZBTB38;MEIS1;E2F1;NFKB2;TEAD1;ZSCAN12;MYBL1;CEBPD;STAT3;HDAC1;ELF4;HSF2;CC2D1B;PRDM5;SNAPC3;ZNF250;PBX3;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;STAT5A;BHLHE40;NR1D2;MXI1;FOXE1;ZNF418;ZBTB12;TCF12;BCL11B;NFKB1;CHD2;FOXJ3;AHR;HDAC5;SALL1;HOXA1;FOXP4;NFE2L3;XBP1;CALCOCO1;CREB3L4;CREB3;NR2F1;ZNF367;MAFG;ZIC1;BACH2;ZNF445;GLIS3;HEYL;ZNF182;RBPJ;PGBD1;HIVEP2;PRDM1;SMAD5;HIVEP1;CTCF;TCF3;TCF7L1;NEUROD6;STAT6;SMAD3;CLOCK;TGIF2;JUNB;NSD1;RELB;HMGB2;FOXN2;ZSCAN22;ELK4;THRAP3;NR2C2;YY1;SP7
prerank,ferrous iron binding (GO:0008198),0.5622438031183494,1.3451745314679642,0.11543810848400557,0.661030117590868,1.0,4/21,9.74%,HEPH;FXN;FTO;ALKBH1
prerank,gated channel activity (GO:0022836),0.5922249876907233,1.3416840134347103,0.13649851632047477,0.6672294705363196,1.0,4/14,10.42%,TMC3;PIEZO2;TMC5;TMEM266
prerank,acylglycerol lipase activity (GO:0047372),-0.542478354508439,-1.3390093436709187,0.14168937329700274,0.508323890348868,1.0,5/11,20.86%,MGLL;ABHD6;LIPE;ABHD3;FAAH
prerank,transforming growth factor beta binding (GO:0050431),0.5453077429718607,1.3369711567626084,0.12365591397849462,0.6770847103095884,1.0,7/23,10.95%,LTBP3;LTBP1;CD36;TGFBR1;ACVR1;TGFB3;WFIKKN1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.42719925551424226,1.3367436337057754,0.030456852791878174,0.6701428976609902,1.0,52/188,20.62%,RUNX1;CREB3L1;POU5F1;TCF7L2;YAP1;SOX5;TBX18;CREB3L3;ZBTB48;GATA6;IRF1;ARID5B;ARID5A;RBBP5;STAT3;CARM1;TAF7;CREB3L2;PRDM5;NONO;FOXK2;ZBTB20;PPARG;TCF7;ETV5;TCF12;NFKB1;AHR;HDAC5;AHRR;CALCOCO1;CTCF;SMAD3;TBL1X;HMGB2;YY1;GABPB1;TNF;ARID4B;TAF2;NFE2L2;SPI1;KMT2D;EGR2;GABPA;FOXO3;LIN54;ELK1;MTERF3;ATMIN;MAFK;ETS1
prerank,nuclear receptor binding (GO:0016922),0.45176334100112736,1.333086487667132,0.05561497326203209,0.6769335921954694,1.0,27/111,14.82%,NR1H4;TCF7L2;NCOR2;WIPI1;NRIP1;ASXL1;DNAAF4;TACC1;STAT1;PADI2;PPID;TGFB1I1;ARID5A;MED13;TAF7;SMARCD3;MED12;STRN;MED14;MMS19;OASL;RERG;LCOR;SMAD3;NSD1;GTF2H1;THRAP3
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6176455886926063,1.3310608646016806,0.14508580343213728,0.6765642973040914,1.0,6/12,18.02%,SULF1;ARSG;GALNS;GNS;IDS;ARSB
prerank,Wnt-activated receptor activity (GO:0042813),0.5859011602339707,1.3289087336834957,0.14866760168302945,0.6769776117135428,1.0,4/15,10.47%,ROR1;FZD1;FZD3;FZD9
prerank,low-density lipoprotein particle binding (GO:0030169),0.588985096147446,1.3267289139593508,0.1424287856071964,0.6775990366132666,1.0,6/16,7.23%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36
prerank,transcription corepressor binding (GO:0001222),0.5312582930528876,1.3251267756401228,0.1378413524057217,0.6759860940747339,1.0,4/27,6.71%,RORA;NEK6;EHMT1;PHF1
prerank,nuclear receptor coactivator activity (GO:0030374),0.4744016784358405,1.324258253817533,0.11622554660529344,0.6715739295706028,1.0,19/52,21.05%,ZMIZ1;CCAR1;TACC1;PPRC1;MED13;CARM1;MED12;MED14;SLC30A9;CALCOCO1;FGF2;CCAR2;USP22;THRAP3;PSMC3IP;ELK1;MED24;ETS1;PKN1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5033862465050962,1.3221012058909873,0.13975903614457832,0.6721733309775761,1.0,13/35,22.81%,STAT1;POU2F1;MMP12;HDAC1;TAF4;SNAPC3;KLF10;BAZ2A;SMARCB1;SMARCA4;DRAP1;PARK7;TBP
prerank,insulin-like growth factor I binding (GO:0031994),-0.49546377044197715,-1.321855120933661,0.1466275659824047,0.5414177249734408,1.0,5/13,6.94%,IGF1R;ITGA6;IGFBP2;INSR;ITGB4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.43002405885340306,-1.3199903092106582,0.12393162393162394,0.5353888399996786,1.0,5/21,25.52%,GRM1;CHRNB1;GRM5;GRIA1;CHRNA4
prerank,mechanosensitive ion channel activity (GO:0008381),0.6027488111613337,1.3184463614217354,0.1559633027522936,0.6784565492960829,1.0,3/12,5.91%,TMC3;PIEZO2;TMC5
prerank,calcium ion binding (GO:0005509),0.41597111350525307,1.3166184446013995,0.011022044088176353,0.6778925758172905,1.0,59/323,13.98%,MMP13;SCUBE1;ENPP1;FBLN1;LRP1;SPARC;CDH11;THBS4;PCDHB6;PAM;SLIT3;SLIT1;MASP1;CRP;LPL;LCP1;NUCB2;ITPR1;PLA2G5;CALR3;FBN1;AIF1L;ANXA1;ADGRL3;PKD2;ATP2A2;CALML4;GALNT3;ASTN2;SHH;CALU;PADI2;MMP12;ITSN1;SYT10;AIF1;TNNC1;RCN3;DCHS1;RCN2;MAN1C1;CANX;SYT2;CEMIP2;THBS3;CALM3;CLEC3B;MICU2;ADGRV1;MCTP2;CDH6;S100A6;PPP3CA;SYT3;NDUFAB1;TPM4;CALM2;FKBP9;TKT
prerank,NAD binding (GO:0051287),-0.3975169166247968,-1.3151213180277024,0.11336032388663968,0.5366628074669364,1.0,15/26,28.11%,ALDH1A1;GLUD1;UXS1;NUDT6;ME1;HPGD;HADH;ALDH2;CRYL1;SIRT1;NNT;CRYZ;PARP9;GRHPR;SIRT5
prerank,hyaluronic acid binding (GO:0005540),0.6201560470099656,1.3122522642818086,0.1752411575562701,0.6860321619830431,1.0,1/10,0.38%,CEMIP
prerank,hormone receptor binding (GO:0051427),0.5929810975261629,1.3115783009292217,0.14804063860667635,0.6813502332944149,1.0,2/14,3.03%,JAK1;JAK2
prerank,insulin-like growth factor binding (GO:0005520),-0.4788152838879999,-1.308287649988561,0.1266233766233766,0.5437787207367939,1.0,5/15,6.94%,IGF1R;ITGA6;IGFBP2;INSR;ITGB4
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5035512408178154,1.3041143337561865,0.12978986402966625,0.702069565418818,1.0,15/34,20.26%,TAOK1;CKS1B;FAM20A;INCENP;MAP2K1;CALM3;RICTOR;SPRY2;ALS2;CCNT1;CALM2;DBF4;STK4;MAP2K2;DDX3X
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5995012912671183,1.3012081874501433,0.1761194029850746,0.7056545819733985,1.0,7/12,19.89%,TNFSF11;STAT1;BABAM2;TRAF2;TNF;TRAP1;TRAF5
prerank,peptidoglycan binding (GO:0042834),0.6276920751200862,1.2989443696069223,0.1858678955453149,0.7074171192857632,1.0,3/10,9.05%,TLR2;RNASE7;NOD1
prerank,solute:anion antiporter activity (GO:0140323),-0.4759892986730086,-1.2959554227431311,0.15337423312883436,0.5651305921023085,1.0,3/14,7.75%,SLC26A7;SLC26A2;SLC4A3
prerank,ubiquitin-specific protease binding (GO:1990381),0.551719220458327,1.2954406384362775,0.174931129476584,0.7137273181661404,1.0,10/19,22.31%,CLTC;PTEN;BAG6;RAD23A;SELENOS;LCOR;SYVN1;CHMP3;RHBDD2;PARK7
prerank,copper ion binding (GO:0005507),0.4812434422098543,1.2949539823705545,0.1437125748502994,0.7089394642776325,1.0,3/42,2.31%,HEPH;LACC1;PAM
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5153738199876211,1.2927172021508795,0.16049382716049382,0.7098954605754154,1.0,9/25,23.89%,PARP8;PARP3;PARP11;SIRT2;PARP14;TNKS2;PARP1;SIRT3;PARP4
prerank,vitamin D receptor binding (GO:0042809),0.5939302638467802,1.2925093792670124,0.18220338983050846,0.7038396275172879,1.0,6/14,19.84%,MED13;TAF7;MED12;MED14;THRAP3;MED24
prerank,signal sequence binding (GO:0005048),0.49202190078538555,1.2919553769188674,0.15099009900990099,0.6991319616371987,1.0,14/35,20.93%,CEMIP;KDELR3;KPNA3;BRAP;BABAM2;SEC61A2;TNPO1;NUP153;KPNB1;KDELR2;NUP214;PEX5;SEC61A1;KCNIP2
prerank,histone methyltransferase activity (GO:0042054),0.504245356727713,1.2918347685466507,0.1417624521072797,0.6929053690357801,1.0,14/32,22.83%,KMT5A;EHMT1;CARM1;NSD3;SETDB1;SETD7;PRMT5;EZH2;NTMT1;FBL;KMT2E;PRMT6;SETD2;KMT5B
prerank,solute:proton symporter activity (GO:0015295),0.5698905318403634,1.2915607997192595,0.18672199170124482,0.6874218072048042,1.0,5/16,12.85%,SLC11A2;SLC2A13;SLC36A2;SLC17A5;SLC15A1
prerank,bHLH transcription factor binding (GO:0043425),0.5476646806650409,1.2886937725940655,0.1752873563218391,0.6913869379080236,1.0,7/19,13.71%,USF1;FHL2;CREBBP;BHLHE40;TCF12;TCF3;SMAD3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.40117279950995094,1.2866943507173996,0.001,0.6919728946406735,1.0,149/831,15.01%,RORA;RUNX1;NR1H4;RUNX2;ZEB2;TRPS1;SOHLH2;RUNX3;POU5F1;ZEB1;PAX1;GLI2;ETV6;TCF7L2;TCF4;SNAI1;DEAF1;TEAD3;PRRX1;SOX5;BCL6;NKX6-1;NRIP1;MEIS2;GLI3;BACH1;PKNOX2;TBX18;USF1;CREB3L3;NR2F2;EGR3;CCAR1;SATB2;ZBTB48;IRF7;NFIX;GLIS1;STAT1;MITF;RARB;SNAI2;MLXIP;SMAD2;ZIC4;GATA6;MAFB;NPAS4;REL;PRRX2;BATF;RXRG;IRF1;ARNT;HOXB3;LITAF;BHLHE22;POU2F1;ZNF496;SOX21;ZKSCAN1;ZBTB10;UBP1;TBX2;ZNF260;ZBTB5;ZBTB38;MEIS1;E2F1;NFKB2;ZNF25;TEAD1;ZSCAN12;MYBL1;CEBPD;PRDM2;STAT3;HDAC1;ELF4;HSF2;CC2D1B;PRDM5;SNAPC3;ZNF250;FOXM1;PBX3;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;STAT5A;BHLHE40;NR1D2;MXI1;ENO1;FOXE1;ZNF418;ZBTB12;ETV5;TCF12;BCL11B;NFKB1;CHD2;FOXJ3;HDAC5;SALL1;HOXA1;FOXP4;NFE2L3;XBP1;CALCOCO1;TFDP1;CREB3L4;CREB3;NR2F1;ZNF367;MAFG;ZIC1;BACH2;ZNF445;GLIS3;HEYL;ZNF182;RBPJ;PGBD1;HIVEP2;PRDM1;SMAD5;HIVEP1;CTCF;TCF3;TCF7L1;NEUROD6;STAT6;SMAD3;CLOCK;TGIF2;JUNB;NSD1;RELB;NFXL1;ZSCAN22;ELK4;THRAP3;NR2C2;YY1;SP7
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4701989548539817,1.2822892399572998,0.15011820330969267,0.7016068699303256,1.0,18/44,22.83%,KMT2A;CXXC1;KMT5A;EHMT1;KMT2B;RBBP5;NSD3;ASH1L;SETDB1;SETMAR;SETD7;NSD1;EZH2;KMT2D;SETDB2;KMT2E;SETD2;KMT5B
prerank,RNA polymerase II complex binding (GO:0000993),-0.37418847093932506,-1.2820787211948366,0.13157894736842105,0.5913977347964858,1.0,9/32,13.88%,ERCC5;WDR43;CTR9;URI1;HNRNPU;RPRD1A;WAC;UVSSA;SUPT4H1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3993909919836877,-1.2816369458723813,0.15384615384615385,0.5811352142878913,1.0,13/24,34.31%,KCNJ2;ABCC9;KCNJ3;KCNJ13;KCNJ12;KCNN3;KCNK6;KCNJ8;KCNN2;KCNH2;ABCC8;KCNJ16;KCNN1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6000205155233858,1.2812121856652854,0.21021021021021022,0.6990614875004658,1.0,2/11,3.16%,RASA3;ITPR1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.6033474682479317,1.2811170771454816,0.20454545454545456,0.6931774064626498,1.0,1/11,3.42%,SLC25A47
prerank,sequence-specific DNA binding (GO:0043565),0.3993153513632778,1.2790752634804938,0.003,0.6939080848133212,1.0,126/590,19.45%,RORA;NR1H4;RUNX2;ZEB2;KMT2A;SOHLH2;CREB3L1;RUNX3;POU5F1;CXXC1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;BCL6;MEIS2;GLI3;PKNOX2;TBX18;USF1;NR2F2;EGR3;IRF7;NFIX;GLIS1;RARB;SNAI2;ZIC4;GATA6;MAFB;PRRX2;BCL2;BATF;RXRG;ARNT;BHLHE22;SMG7;POU2F1;UBP1;TBX2;ZBTB38;E2F1;ARID5A;KMT2B;MMP12;NFKB2;TEAD1;CEBPD;PRDM2;ELF4;HSF2;PRDM5;CBFB;ZNF250;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;BHLHE40;NR1D2;FOXE1;MYRF;ZBTB12;MBD2;ETV5;TCF12;BCL11B;FOXJ3;AHR;MBD1;HOXA1;XBP1;SAFB2;CALCOCO1;CREB3L4;CREB3;NR2F1;MAFG;ZIC1;BACH2;TERT;RBPJ;PRDM1;SMAD5;HIVEP1;CTCF;SMG6;TCF7L1;SMAD3;CLOCK;TGIF2;JUNB;FOXN2;CXXC5;ELK4;NR2C2;YY1;PRMT5;ZNF276;NPAS2;ABL1;ZNF35;NKX2-8;KDM2A;KLF10;ATF2;TBX3;HOXB2;SKOR2;NFE2L2;EGR2;GABPA;TFAP2C;BBX;ZGPAT;SAFB;FOXO3;TFCP2;TELO2;TFCP2L1;ZNF23;ZNF32;ELK1
prerank,pentosyltransferase activity (GO:0016763),0.4785835818876107,1.2788349555921286,0.15636822194199243,0.6886380712432549,1.0,12/36,24.75%,PARP8;PARP3;LACC1;PARP11;SIRT2;PPAT;PARP14;TNKS2;PARP1;SIRT3;PARP4;QTRT2
prerank,DNA secondary structure binding (GO:0000217),0.497009421002719,1.2780004793954636,0.16876574307304787,0.6852736530807522,1.0,10/31,19.29%,RAD51B;KMT2A;XRCC3;HMGB2;YY1;ABL1;HMGB3;RBBP8;XRCC2;LIN54
prerank,protein phosphatase regulator activity (GO:0019888),0.4573269754625572,1.2775582956588913,0.14400921658986174,0.6809316108021268,1.0,15/53,17.09%,MGAT5;PPP1R9B;PTN;PPP4R1;RCAN3;PPP1R2;RCAN2;PPP2R5A;CALM3;PPP1R16A;PPP2R2A;EIF2AK2;CALM2;PPP2R5E;PPP4R2
prerank,exopeptidase activity (GO:0008238),0.46143814844026554,1.275463519706391,0.1566265060240964,0.6819489214783754,1.0,18/50,20.00%,FAP;XPNPEP2;ANPEP;XPNPEP3;XPNPEP1;DPP9;DPEP2;LAP3;CNDP2;GGH;METAP1;ENPEP;NPEPPS;DPP7;METAP1D;CTSA;CTSH;DPP8
prerank,phosphatase activator activity (GO:0019211),0.5632538699192966,1.275335638909076,0.19460227272727273,0.6765564052246147,1.0,8/14,21.59%,FRS2;PPP2R5A;CALM3;CALM2;PPP2R5E;GTF2F1;PPP2R5D;PPP2R5C
prerank,ligand-gated ion channel activity (GO:0015276),-0.37057862753915793,-1.2749423347256894,0.07407407407407407,0.5878023429316916,1.0,12/30,27.63%,GABRB1;GRID2;GRIK4;GRIN2D;GRIN3A;CHRNB1;GRIN2B;GRIA2;GRIA1;CHRNA4;GRIK2;GRIK3
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4926438879147804,-1.2744770693707796,0.19060773480662985,0.5784653926491571,1.0,3/11,8.79%,LEF1;SRRM2;GATA2
prerank,ligand-gated channel activity (GO:0022834),-0.37464708717476813,-1.2737182406130407,0.09216589861751152,0.5702011269584865,1.0,12/29,27.63%,GABRB1;GRID2;GRIK4;GRIN2D;GRIN3A;CHRNB1;GRIN2B;GRIA2;GRIA1;CHRNA4;GRIK2;GRIK3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5156284844810387,1.2700635016354127,0.17454068241469817,0.6882207660512728,1.0,10/23,21.66%,SH3PXD2B;WIPI1;SESTD1;MAPKAP1;PLEKHA5;GBF1;KIF16B;WDR45;PLA2G4E;SNX14
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6064069609192526,1.2695663206379888,0.21806853582554517,0.6842860393988102,1.0,3/10,6.92%,CDKN2B;CDKN2D;HEXIM1
prerank,zinc ion binding (GO:0008270),0.40064530634948314,1.2688367012413464,0.03510531594784353,0.6810705442377261,1.0,63/293,17.07%,MMP13;ENPP1;KMT2A;KNG1;ZEB1;CBLB;GLI2;SEC24D;MYCBP2;PAM;ANPEP;CSRP1;SEC23A;RASSF1;TIMP1;ZFPM2;GALT;SMPDL3B;ADH5;LITAF;SHH;TARS1;LIMS1;KMT2B;CDADC1;MMP12;PHF2;RNF2;PRDM2;GDA;SEC24A;RABIF;MMP16;TRIM8;KDM7A;PPARG;RNF11;PTPN1;RNF8;MBD1;SIRT2;EEA1;ARIH1;NQO2;ZMYM2;PAPPA2;CTCF;KPNB1;GRIN2A;SMAD3;NSD1;DHX58;ENPEP;CXXC5;MDM2;NPEPPS;ARIH2;TET2;KDM2A;TIMM13;TIMP2;LVRN;EPRS1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5859691933574243,1.2652767017006612,0.20967741935483872,0.6874417822550501,1.0,4/12,12.07%,DHRS4;AIFM2;NDUFS7;NQO2
prerank,retinoid X receptor binding (GO:0046965),0.5985594655286722,1.2650863420060545,0.2239884393063584,0.6824433832082945,1.0,5/11,14.01%,NRIP1;TACC1;ARID5A;PPARG;NSD1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.44125084061316555,-1.2639035177641706,0.14968152866242038,0.5741971246216224,1.0,8/16,30.11%,ANO4;ANO3;ANO1;ANO8;ANO2;ANO5;TTYH3;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.44125084061316555,-1.2639035177641706,0.14968152866242038,0.5741971246216224,1.0,8/16,30.11%,ANO4;ANO3;ANO1;ANO8;ANO2;ANO5;TTYH3;NMUR2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.4868311598680847,-1.2629769509860531,0.17270194986072424,0.5667556003061529,1.0,8/11,50.18%,HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,transcription coregulator binding (GO:0001221),0.45466357519247413,1.2612127786557323,0.14385150812064965,0.6899399718095484,1.0,11/50,13.71%,RORA;NEK6;EHMT1;PHF1;CDK9;AHR;HDAC3;TERT;CTCF;LCOR;SMAD3
prerank,phosphotyrosine residue binding (GO:0001784),0.4755633120315226,1.2609185061155035,0.18820577164366373,0.6855379704889809,1.0,13/37,16.97%,VAV2;SH3BP2;PTPN3;IRS1;PIK3R1;NCK2;PTPN6;GRB2;PTPN5;SHB;ABL1;YES1;VAV1
prerank,tRNA methyltransferase activity (GO:0008175),-0.4549208864572796,-1.260553049678856,0.18688524590163935,0.5631741688164525,1.0,8/16,24.50%,TRMT9B;ALKBH8;LCMT2;TRMT5;TRMT44;TYW3;TARBP1;TRMT12
prerank,peptidase inhibitor activity (GO:0030414),0.4804864594767819,1.2577327464121884,0.18998716302952504,0.6906367519088719,1.0,6/33,10.39%,KNG1;FETUB;PROS1;TIMP1;PZP;USP14
prerank,nuclease activity (GO:0004518),0.4548991463857105,1.2574786516682357,0.17803468208092485,0.6859612782665877,1.0,13/52,16.53%,ENPP1;ERN2;RNASE7;DNA2;REXO1;RNASE1;MAP1S;SND1;SETMAR;RNASEH2A;RNASEH1;DFFB;DNASE1L2
prerank,leak channel activity (GO:0022840),-0.4336288567686194,-1.2570983626533516,0.16785714285714284,0.5622250846509047,1.0,6/18,22.46%,KCNK5;TMEM175;KCNK10;KCNK6;KCNK13;KCNK12
prerank,carbohydrate kinase activity (GO:0019200),0.5892380312421759,1.2570434778661173,0.20150375939849624,0.6820645834444249,1.0,7/11,24.43%,GALK1;XYLB;HK2;GALK2;KHK;GNE;POMK
prerank,double-stranded RNA binding (GO:0003725),0.4358343136118657,1.2549679251466257,0.14831460674157304,0.6836065405326979,1.0,20/70,16.96%,ZBP1;CLTC;RFTN1;ILF3;EIF4A1;DHX15;TLR7;TARBP2;ZFR;EIF2AK2;DICER1;RC3H2;FMR1;DGCR8;OASL;MSN;HSPD1;DHX58;PRKRIP1;SIDT2
prerank,pseudouridine synthase activity (GO:0009982),0.5705051182528644,1.254843407767556,0.21842496285289748,0.6787706798925786,1.0,4/13,13.96%,RPUSD3;TRUB2;PUS7L;PUS3
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.27449731316222353,-1.2536245735979465,0.047619047619047616,0.5614637183297079,1.0,28/134,10.06%,ABCC4;ABCG2;SLC6A6;SLC26A7;SLC26A2;SLCO1C1;SLCO3A1;SLC6A9;SLC13A3;SLC22A6;SLC16A11;SLC39A8;SLC52A1;SLC16A1;SLCO2A1;SLC5A6;SLC1A1;SLC7A5;SLC25A42;GJA1;SLC6A1;SLC4A8;SLC4A3;SLC38A5;SLC25A17;SLC1A2;MPC2;MPC1
prerank,CARD domain binding (GO:0050700),0.5593813654533132,1.2529118571934674,0.20579710144927535,0.6796033503514586,1.0,3/14,9.05%,CASP4;CASP1;NOD1
prerank,sialyltransferase activity (GO:0008373),-0.41802410993785777,-1.2519313297074977,0.1678832116788321,0.5565907439234825,1.0,6/20,6.92%,ST3GAL6;ST6GALNAC3;ST8SIA4;ST3GAL4;ST8SIA6;ST8SIA2
prerank,actinin binding (GO:0042805),0.5175143568842349,1.250933293278544,0.20467032967032966,0.6808678721581604,1.0,7/21,12.92%,CSRP1;PKD2;CACNA1C;KCNA5;PPARG;NFKB1;PDLIM4
prerank,alpha-tubulin binding (GO:0043014),0.47496474237210407,1.2501904443506047,0.2093628088426528,0.678367311100342,1.0,4/31,5.53%,TAOK1;DLEC1;EML4;INO80
prerank,cell adhesion mediator activity (GO:0098631),-0.40210724891147315,-1.2484078633320195,0.17592592592592593,0.5562836406321576,1.0,8/24,9.79%,LRRC4C;BSG;ESAM;NTNG1;CNTN4;DSCAML1;CD47;ROBO4
prerank,lysine N-methyltransferase activity (GO:0016278),0.5192353701249536,1.2455536788357304,0.23140495867768596,0.6885734508386363,1.0,6/20,15.59%,KMT5A;EHMT1;ANTKMT;ETFBKMT;SETD7;VCPKMT
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5213914978084973,1.2437549042280327,0.21389645776566757,0.6891915660070573,1.0,1/20,0.16%,SLC39A14
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.385884313197946,1.2402886466375493,0.011,0.6951279770133278,1.0,121/597,17.90%,RUNX1;RUNX2;SOHLH2;CREB3L1;RUNX3;POU5F1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;YAP1;SOX5;BCL6;MEIS2;GLI3;PKNOX2;TBX18;USF1;CREB3L3;EGR3;ZBTB48;IRF7;NFIX;GLIS1;RARB;SNAI2;ZIC4;GATA6;PRRX2;BATF;RXRG;IRF1;ARNT;ARID5B;BHLHE22;UBP1;TBX2;E2F1;ARID5A;NFKB2;TEAD1;RBBP5;CEBPD;STAT3;ELF4;HSF2;CARM1;TAF7;MCM2;CREB3L2;PRDM5;NONO;ZNF250;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;BHLHE40;NR1D2;FOXE1;ZBTB12;MBD2;ETV5;TCF12;BCL11B;NFKB1;FOXJ3;AHR;DDX11;HDAC5;HOXA1;XBP1;AHRR;CALCOCO1;CREB3L4;CREB3;NR2F1;MAFG;ZIC1;BACH2;MCM7;GRWD1;MCM9;PRDM1;SMAD5;HIVEP1;CTCF;TCF7L1;SMAD3;CLOCK;TGIF2;JUNB;HSPD1;TBL1X;HMGB2;FOXN2;ELK4;NR2C2;YY1;ZNF276;GABPB1;TNF;NPAS2;ABL1;NKX2-8;KLF10;ATF2;ARID4B;TAF2;TBX3;HOXB2;SKOR2;NFE2L2;SPI1;KMT2D;EGR2;GABPA;TFAP2C
prerank,kinase inhibitor activity (GO:0019210),0.4703554766459692,1.2402630510160744,0.2022613065326633,0.6901220257488698,1.0,17/33,26.99%,GSKIP;HEXIM1;NCK1;PARVA;SH3BP5L;MAPK8IP1;SH3BP5;TAOK3;LRP6;PRKRIP1;SMCR8;TRIB1;GMFB;DNAJC3;CDKN1B;WARS1;SPRY4
prerank,phosphatase binding (GO:0019902),0.40282578394582236,1.2353893748730713,0.1518324607329843,0.7007569522392598,1.0,44/105,27.32%,JAK1;AP3B1;SMAD2;STX17;SPRED1;EIF2AK3;IKBKE;STAT3;EGFR;RCAN3;MVP;PIK3R1;CARHSP1;DLG4;CDC27;SIRPA;MAST2;PDLIM4;TRAF2;PTK2;ANK1;STAT6;SMAD3;TRPC4AP;ITGA1;KIF3A;CTSC;KIFAP3;SPTBN4;GTF2F1;TERF2IP;MAP2K7;TSC2;MAPK1;SH3YL1;MTMR9;VRK3;CDKN1B;TRAF3;IQGAP1;DLG3;VCP;JUP;PPME1
prerank,transition metal ion binding (GO:0046914),0.3865166447100641,1.2308695797227713,0.042,0.7106492801234092,1.0,79/397,17.07%,MMP13;HEPH;ENPP1;KMT2A;MGAT5;KNG1;ZEB1;CBLB;GLI2;SEC24D;LACC1;MYCBP2;PAM;ANPEP;CSRP1;SEC23A;SLC11A2;RASSF1;TIMP1;ZFPM2;GALT;XPNPEP3;SMPDL3B;ADH5;LITAF;ADCY2;GALNT3;SHH;TARS1;LIMS1;KMT2B;CDADC1;MMP12;PHF2;RNF2;PRDM2;ABCE1;XPNPEP1;GDA;SEC24A;RABIF;MMP16;TRIM8;KDM7A;PPARG;TDP2;RNF11;PTPN1;RNF8;MBD1;SIRT2;SCD5;EEA1;ARIH1;LOXL3;NQO2;FAM20C;NEK4;ZMYM2;PAPPA2;CTCF;KPNB1;GRIN2A;SMAD3;NSD1;DHX58;ENPEP;CXXC5;MDM2;NPEPPS;ABL1;ARIH2;TET2;KDM2A;ACO2;TIMM13;TIMP2;LVRN;EPRS1
prerank,R-SMAD binding (GO:0070412),0.51534212819601,1.2287288048430673,0.22759601706970128,0.7129036027428118,1.0,5/18,14.13%,PMEPA1;SMAD2;SMURF1;SMAD3;LDLRAD4
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5851009197175504,1.2284145770076675,0.2421875,0.7087788142009076,1.0,3/10,4.92%,CACNA1A;CACNB1;CACNA1C
prerank,dipeptidyl-peptidase activity (GO:0008239),0.585305083445259,1.2235496496558989,0.26506024096385544,0.7194352957383833,1.0,1/10,0.08%,FAP
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.41188730677601804,1.223412579402604,0.1711111111111111,0.7150620265598212,1.0,11/73,16.08%,MC5R;FSHR;S1PR2;EDNRA;RXFP2;ADCYAP1R1;GLP2R;LTB4R2;PTH1R;LGR4;MC1R
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3133390598072066,-1.2217085236664635,0.1377245508982036,0.6120491245379738,1.0,11/48,12.39%,TRPM3;SLC12A7;SLC12A2;TRPM6;TMEM165;ABCC9;SLC12A6;TRPC1;TRPV2;TRPM7;TRPV4
prerank,ephrin receptor binding (GO:0046875),0.5093984887472914,1.221326994937648,0.21793103448275863,0.7170355385341997,1.0,9/21,22.51%,EFNA4;ANKS1B;CBL;PTPN1;EFNA5;GRB2;ABL1;SRC;EFNB2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5616862299866066,1.219935859653259,0.27095808383233533,0.7166247648687901,1.0,3/12,9.05%,CASP8AP2;CASP1;NOD1
prerank,double-stranded DNA binding (GO:0003690),0.3805371866987291,1.2197995525444718,0.01701701701701702,0.7122904437672449,1.0,109/531,19.45%,RUNX2;RAD51B;ZBP1;SOHLH2;CREB3L1;RUNX3;POU5F1;RBMS1;PAX1;GLI2;TCF4;SNAI1;BCL6;MEIS2;GLI3;PKNOX2;TBX18;USF1;EGR3;ZBTB48;IRF7;NFIX;GLIS1;STAT1;RARB;SNAI2;SMAD2;ZIC4;GATA6;PRRX2;BATF;RXRG;ARNT;BHLHE22;UBP1;TBX2;FBH1;CGGBP1;E2F1;NFKB2;TEAD1;CEBPD;EGFR;ELF4;HSF2;ZNF250;ZBTB20;PPARG;E2F3;E2F8;TCF7;BHLHE40;NR1D2;FOXE1;ZBTB12;ETV5;TCF12;BCL11B;FOXJ3;AHR;MBD1;DDX11;HOXA1;XBP1;CAMTA2;CREB3L4;CREB3;NR2F1;MAFG;ZIC1;BACH2;ZNF445;PRDM1;SMAD5;HIVEP1;SETMAR;TCF7L1;CLOCK;TGIF2;JUNB;NUCKS1;HMGB2;FOXN2;ELK4;NR2C2;YY1;ZNF276;NPAS2;ABL1;HMGB3;NKX2-8;RBBP8;KLF10;ATF2;TBX3;HOXB2;SKOR2;EGR2;GABPA;TFAP2C;BBX;SAFB;NTHL1;FOXO3;TFCP2;TFCP2L1;ZNF23;ZNF32;ELK1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.39144097542753986,1.2139123506348086,0.11518858307849134,0.7259498704755645,1.0,55/181,22.24%,NR1H4;MDFIC;TCF7L2;NCOR2;TEAD3;PRRX1;NRIP1;MIER2;TACC1;RERE;STAT1;ZFPM2;DUSP26;ARNT;STAT3;HDAC1;TAF4;MTA2;CREBBP;SMARCD3;PPARG;PIAS2;BHLHE40;COMMD6;HDAC5;HDAC3;RBPJ;TCF3;SMAD3;COMMD7;GSK3B;BBS10;TADA3;PSMA6;RBBP8;ATF2;TCERG1;TBX3;NFE2L2;SPI1;EGR2;BBS7;MTA3;BAZ2A;ELK1;SMARCB1;SMARCA4;SPEN;IFI27;CDK5RAP3;BCAS3;PIAS1;DDRGK1;DTX3L;DACT1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4708083553089928,-1.211951541076809,0.2303206997084548,0.6281042213245603,1.0,8/11,52.18%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,neuropeptide hormone activity (GO:0005184),0.4900659031536346,1.2113533503008247,0.2389853137516689,0.7291052831719991,1.0,1/22,0.50%,QRFP
prerank,outward rectifier potassium channel activity (GO:0015271),0.5737316626343008,1.2102030859834867,0.2696296296296296,0.7279245204304754,1.0,3/11,7.35%,KCNT2;PKD2;KCNA5
prerank,semaphorin receptor activity (GO:0017154),0.5633637105447673,1.2086531466496035,0.2476489028213166,0.7279391040046316,1.0,4/11,11.38%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.47426562064230354,1.207168623275916,0.251604621309371,0.7277561401665191,1.0,10/28,19.89%,TNFSF11;STAT1;CASP8AP2;BABAM2;SIVA1;EDA;TRAF2;TNF;TRAP1;TRAF5
prerank,metal ion binding (GO:0046872),0.37913371570064214,1.2053938577877097,0.04604604604604605,0.7284945956337675,1.0,90/477,15.93%,MMP13;SCUBE1;ENPP1;POSTN;FBLN1;LRP1;SPARC;CDH11;NEK6;PDXP;THBS4;PCDHB6;PAM;SLIT3;SLIT1;MASP1;CRP;ERN2;LPL;LCP1;NUCB2;ITPR1;PLA2G5;CALR3;LRRK2;APOE;FBN1;RAP2A;IRAK3;PPA1;AIF1L;EPHX2;ANXA1;ADGRL3;PKD2;ADCY2;ATP2A2;CALML4;GALNT3;ASTN2;MARK1;SHH;CALU;PADI2;MMP12;ITSN1;SYT10;AIF1;TNNC1;RCN3;DCHS1;MVK;RCN2;MAN1C1;PLK1;CANX;FOXK2;SYT2;CEMIP2;THBS3;TDP2;CALM3;CLEC3B;MICU2;HSPE1;ADGRV1;MCTP2;CDH6;S100A6;PPP3CA;MAST2;SYT3;GNAI1;NDUFAB1;TPM4;CALM2;FKBP9;TKT;ANXA7;PAPOLG;IDH2;TPPP;PPA2;PGS1;CDH18;CDH24;BRSK2;RRAGC;ABL1;ENDOV
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.42314755602091025,-1.2042625254219583,0.22955974842767296,0.6390461320228186,1.0,4/14,9.98%,KCNJ2;KCNJ3;KCND3;KCNQ1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.3101809056636891,-1.2029574227273947,0.14285714285714285,0.633014541014226,1.0,30/57,30.14%,COX5A;COX8A;NDUFS1;COX4I1;NDUFV2;NDUFA13;COX6A1;NDUFA8;NDUFC2;NDUFB7;COX5B;NDUFA1;COX6B1;COX10;UQCRFS1;CYB561A3;UQCR10;CYBRD1;UQCR11;CYB5A;NDUFV1;NDUFA10;NDUFA3;NDUFC1;NDUFA12;COX15;NDUFS3;NDUFB10;UQCRH;NDUFA6
prerank,ribosomal large subunit binding (GO:0043023),0.5683393074718146,1.200595235113532,0.2857142857142857,0.7389742944018923,1.0,7/11,31.39%,NMD3;NEMF;RBM3;LTN1;MRRF;CPSF6;MALSU1
prerank,exoribonuclease activity (GO:0004532),0.5515887782723858,1.198933993151794,0.2694063926940639,0.7393158611364183,1.0,10/12,35.27%,EXOSC4;EXOSC2;EXOSC1;EXOSC3;EXOSC5;ZC3H12A;EXOSC7;EXOSC8;CNOT6;CNOT7
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5630340648727266,1.198871769782948,0.2859304084720121,0.7347924161001096,1.0,2/11,6.87%,RDH12;AKR1A1
prerank,cAMP binding (GO:0030552),-0.4755667902179244,-1.198701421040858,0.23850574712643677,0.6344100956248495,1.0,6/11,16.32%,PDE4B;RAPGEF2;PDE2A;PDE4D;HCN1;CNBD2
prerank,ATPase binding (GO:0051117),0.415316907420987,1.1983681170796248,0.2038073908174692,0.7318313157137593,1.0,24/71,18.13%,ABCA1;NKD2;SLC2A13;PTPN3;CHMP4A;DNAJB1;PKD2;TMTC4;BBC3;EGFR;SNX10;RALA;ATP6V1G1;PPP3CA;SELENOS;ANK1;TOR1AIP2;BRSK2;VCPKMT;TCIRG1;SYVN1;PSEN1;ATP6V0A2;PEX19
prerank,lipase activator activity (GO:0060229),0.5664867029368499,1.1970104916663842,0.2770897832817337,0.7313754930224906,1.0,5/10,25.10%,APOH;CCL5;ARHGAP6;SRC;PDPK1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4410590628712706,1.196951657737716,0.22853688029020555,0.7268644158993428,1.0,14/42,16.97%,VAV2;SH3BP2;PTPN3;IRS1;PIK3R1;NCK2;PTPN6;GRB2;PTPN5;SHB;FBXW7;ABL1;YES1;VAV1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.35557526803838707,-1.1964462304335353,0.19911504424778761,0.6311739036092293,1.0,11/29,26.04%,SLC26A7;SLC26A2;SLC13A3;SLC1A1;SLC26A6;SLC25A12;SLC25A14;SLC1A6;SLC26A8;SLC25A30;SLC25A13
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.4875863154841106,-1.1927067098856896,0.26373626373626374,0.631441419935094,1.0,5/10,22.44%,ANKRD13A;IDE;FAAP20;DNAJB2;ANKRD13D
prerank,iron ion binding (GO:0005506),0.42510519723667395,1.1891127735350444,0.2266355140186916,0.7470739718710927,1.0,11/48,17.66%,HEPH;FXN;PHF2;ABCE1;FTO;KDM7A;ALKBH1;SCD5;TET2;ACO2;CYP2R1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4103893966376353,1.1868120127620008,0.22334455667789002,0.7497966784868175,1.0,11/70,12.52%,CHSY3;B4GALNT2;EXT1;OGT;EXT2;GXYLT2;B4GALNT1;B3GALNT1;GCNT2;CHSY1;B3GLCT
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4288029196493348,1.185323027335213,0.2562874251497006,0.749882647006596,1.0,8/46,12.52%,MGAT5;EXT1;OGT;EXT2;B3GALNT1;GCNT2;MGAT3;B3GLCT
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3778641462187859,1.181322138465146,0.13144590495449948,0.7582914570737658,1.0,64/232,20.34%,TRIML2;SH3RF3;CBLB;DTX4;PDZRN3;RNF150;MYLIP;MYCBP2;BIRC3;UBR5;BRAP;RNF157;SMURF2;ANAPC11;UBR4;RNF111;RNF2;SIAH2;CBL;CDC42;TRIM21;RNF144A;NEURL2;DTX2;AREL1;TRIM56;PIAS2;RNF11;RNF19B;RNF145;KCMF1;RNF8;TRIM13;RNF138;TRIM11;ARIH1;SH3RF1;RC3H2;RNF149;TRIM62;SMURF1;TRIM35;PELI3;STUB1;PELI2;MDM2;TRAF3IP2;ARIH2;DTX3;SYVN1;RNF215;ITCH;EGR2;RNF121;FBXO2;TRIM44;TRIM17;TRIM27;RNF217;NSMCE2;ZNRF2;RNF181;NEDD4;UBE3B
prerank,nucleotide diphosphatase activity (GO:0004551),0.5237514538367669,1.1781379664929883,0.3068862275449102,0.7640718197953883,1.0,1/14,0.31%,ENPP1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4654706617401435,1.17609243485611,0.2857142857142857,0.7658578831156744,1.0,6/26,16.06%,CHSY3;B4GALNT2;B4GALNT1;B3GALNT1;CHSY1;CHPF2
prerank,glutathione transferase activity (GO:0004364),0.4829852473327623,1.175811880181374,0.26308724832214764,0.762000840718475,1.0,5/23,14.57%,PTGES;MGST1;ALOX5AP;GSTT1;GSTK1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4300731603933005,-1.1743402516483352,0.24853801169590642,0.6695636872376391,1.0,4/14,12.83%,CYB5R4;MICAL1;NCF2;NOX1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4381152083464257,-1.1735957429885333,0.26813880126182965,0.6625931651838071,1.0,3/12,12.47%,CNOT8;NOCT;CNOT6L
prerank,nuclear localization sequence binding (GO:0008139),0.50445803712789,1.1703854021560298,0.29305555555555557,0.7748632850018526,1.0,6/18,15.96%,KPNA3;BRAP;TNPO1;NUP153;KPNB1;NUP214
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.37149950552060507,1.164161290391547,0.15237134207870837,0.7900978150803434,1.0,53/254,17.90%,RUNX1;NR1H4;CREB3L1;TCF4;PRRX1;MEIS2;CREB3L3;SATB2;MITF;MLXIP;SMAD2;NPAS4;REL;IRF1;HOXB3;LITAF;UBP1;MEIS1;NFKB2;MYBL1;PRDM2;STAT3;ELF4;HSF2;SMARCD3;FOXK2;E2F3;ETV5;TCF12;NFKB1;FOXJ3;HOXA1;TFDP1;CREB3;ZNF445;RBPJ;TCF3;STAT6;SMAD3;CLOCK;ELK4;NR2C2;YY1;SP7;MDM2;NKX2-8;KLF10;ATF2;ZFP62;HOXB2;EGR2;GABPA;TFAP2C
prerank,ribosome binding (GO:0043022),0.42250000948708183,1.1640919995900725,0.2661955241460542,0.7856110385010082,1.0,9/46,12.19%,RPSA;CPEB1;SHFL;SEC61A2;SRP68;ERI1;YTHDF3;BAG6;FMR1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.44414091060507754,1.1615342495425236,0.2746566791510612,0.789062808131408,1.0,12/34,22.83%,KMT5A;EHMT1;ANTKMT;NSD3;ETFBKMT;SETDB1;SETD7;VCPKMT;EZH2;KMT2E;SETD2;KMT5B
prerank,ubiquitin protein ligase activity (GO:0061630),0.37076943208032703,1.1610699091518903,0.16700201207243462,0.7856757314460525,1.0,61/228,20.34%,TRIML2;SH3RF3;CBLB;DTX4;PDZRN3;RNF150;MYLIP;MYCBP2;BIRC3;UBR5;BRAP;RNF157;SMURF2;ANAPC11;UBR4;RNF111;RNF2;SIAH2;CBL;CDC42;TRIM21;RNF144A;NEURL2;DTX2;AREL1;TRIM56;RNF11;RNF19B;RNF145;KCMF1;RNF8;TRIM13;RNF138;TRIM11;ARIH1;SH3RF1;RC3H2;RNF149;TRIM62;SMURF1;TRIM35;PELI3;STUB1;PELI2;MDM2;TRAF3IP2;ARIH2;DTX3;SYVN1;RNF215;ITCH;RNF121;FBXO2;TRIM44;TRIM17;TRIM27;RNF217;ZNRF2;RNF181;NEDD4;UBE3B
prerank,TBP-class protein binding (GO:0017025),-0.3769123524270751,-1.1597789590243346,0.2490566037735849,0.6899680317779505,1.0,8/21,22.50%,ESR1;PSMC1;DR1;TAF13;HHEX;BRF2;PSMC2;TAF12
prerank,hexosaminidase activity (GO:0015929),0.5299321789535205,1.1596271054175595,0.29210134128166915,0.7859008433075253,1.0,2/12,8.92%,CEMIP;CEMIP2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5054191854953228,1.1586139166666594,0.28654970760233917,0.779926679735374,1.0,5/17,12.47%,EPHA7;EFNA4;EPHB3;EPHA1;EPHB2
prerank,ephrin receptor activity (GO:0005003),0.5054191854953228,1.1586139166666594,0.28654970760233917,0.779926679735374,1.0,5/17,12.47%,EPHA7;EFNA4;EPHB3;EPHA1;EPHB2
prerank,endopeptidase regulator activity (GO:0061135),0.4264344611165705,1.1573962067320083,0.29001203369434414,0.7790837704105448,1.0,6/40,10.39%,KNG1;FETUB;ABCA2;PROS1;PZP;USP14
prerank,ADP binding (GO:0043531),-0.3583194295539794,-1.155085274499711,0.2681818181818182,0.6935770025154504,1.0,7/25,12.78%,PRKAG2;ERN1;GLUD1;MSH2;MYO18A;ME1;ATP5F1D
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5112610906797674,1.1541008966677244,0.31851851851851853,0.7850513923546458,1.0,2/15,5.52%,CMKLR1;CCR1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4350613240638931,1.1536983734933626,0.2955367913148372,0.7819507321833818,1.0,7/34,10.86%,MYO1B;MYO10;GAB2;CYTH3;OGT;MAPKAP1;DAPP1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5412446414069862,1.146909762572471,0.32819722650231126,0.7988941598870098,1.0,2/12,2.26%,PDE3A;PDE7B
prerank,DNA-binding transcription factor binding (GO:0140297),0.36712727845235316,1.146658618080708,0.21202854230377166,0.7952640102361516,1.0,60/189,23.06%,NEK6;TCF7L2;YAP1;TEAD3;PRRX1;MIER2;USF1;RERE;STAT1;ZFPM2;FHL2;SMAD2;BCL2;DUSP26;TLE1;RUNX1T1;CGGBP1;STAT3;HDAC1;MTA2;CRTC3;CREBBP;PRDM5;PPARG;PIAS2;BHLHE40;TCF12;HDAC5;NOC2L;CRTC1;RBPJ;TCF3;SMAD3;CXXC5;GSK3B;BBS10;RBBP8;TLE5;ATF2;TCERG1;TBX3;NFE2L2;SPI1;EGR2;BBS7;GABPA;MTA3;CBX5;ELK1;SPEN;IFI27;PIAS1;DDRGK1;DACT1;PARK7;ZBTB7A;YWHAZ;TBP;DDIT3;TWIST1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.43037785944590295,1.1431746604962967,0.29301745635910226,0.8013772696900533,1.0,18/37,26.15%,YARS1;TARS1;IARS2;EARS2;CARS2;FARSB;CARS1;GARS1;NARS1;EPRS1;NARS2;FARS2;RARS1;TARS2;YARS2;TARS3;RARS2;WARS1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.45978103987114527,-1.142066429508811,0.30687830687830686,0.7216501091917779,1.0,6/10,24.05%,CD200;CXADR;CD47;DSG2;PKP2;DSP
prerank,growth factor activity (GO:0008083),0.3945597099135607,1.1418054173626637,0.2861878453038674,0.8012710788458658,1.0,8/74,6.13%,CXCL1;FGF20;PTN;FGF7;JAG1;EGF;FGF9;MDK
prerank,amino acid:sodium symporter activity (GO:0005283),0.5389648019399924,1.1414110481108577,0.3333333333333333,0.7979966720275443,1.0,1/11,0.58%,SLC1A3
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.41477621511785573,-1.141340764626111,0.27759197324414714,0.7145391797488141,1.0,4/16,16.97%,SLC25A42;SLC25A26;SLC25A17;SLC22A2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3501794238331294,-1.1402814061885689,0.2222222222222222,0.7082817910204172,1.0,9/27,11.83%,SLC12A2;MRS2;ITPR2;TMEM165;SLC9B2;ZDHHC13;SLC4A8;ATP2B4;ATP2A3
prerank,chemorepellent activity (GO:0045499),-0.3579959164645623,-1.1376102630955152,0.23715415019762845,0.706960514642399,1.0,16/25,22.27%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;DPP4;SEMA3D;SEMA4D;SEMA5A;NRG3;SEMA5B;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SEMA4A
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4429266626399062,1.1365331806690846,0.3124215809284818,0.8086044241498905,1.0,5/30,13.27%,SLC39A14;SLC11A2;SLC25A37;SLC39A6;SLC31A1
prerank,NAD+ binding (GO:0070403),-0.4413404576459262,-1.1349103826642635,0.29178470254957506,0.7055048581141355,1.0,8/12,28.11%,GLUD1;UXS1;HPGD;HADH;CRYL1;SIRT1;PARP9;SIRT5
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4008857528962391,1.1320688728545143,0.2991944764096663,0.8182769345774599,1.0,8/53,13.63%,SLC7A2;SLC1A3;SLC38A3;SLC7A7;SLC36A2;SLC7A11;SLC7A8;SLC1A5
prerank,mannose binding (GO:0005537),0.5184980136534003,1.1320486679244746,0.33185185185185184,0.8138955732477853,1.0,3/12,17.97%,LMAN2L;LMAN1;COLEC11
prerank,methylated histone binding (GO:0035064),0.3939699411339738,1.1307858521679826,0.31101021566401815,0.8133067749672078,1.0,12/62,13.98%,CXXC1;CBX8;PHF1;PHF2;RBBP5;TAF7;KDM7A;CHD8;MORC3;ATRX;FMR1;GLYR1
prerank,regulatory RNA binding (GO:0061980),0.42641225652285686,1.129020773304089,0.31417624521072796,0.8143264848457891,1.0,7/38,12.19%,POU5F1;PUM1;TLR7;RBM10;TARBP2;DICER1;FMR1
prerank,glutamate receptor binding (GO:0035254),-0.40132769354366016,-1.127114592722928,0.28214285714285714,0.7179891756162943,1.0,11/17,26.45%,SHANK3;SHISA6;SYNDIG1;HIP1;HOMER2;SHISA7;HOMER3;NSF;SHANK1;CAMK2A;AKAP5
prerank,cholesterol binding (GO:0015485),0.40138357944605074,1.12442174470623,0.3209580838323353,0.8248073034392832,1.0,7/47,9.82%,ABCA1;APOD;VDAC2;ABCG1;SOAT1;NPC2;GRAMD1A
prerank,telomerase RNA binding (GO:0070034),0.4562807146415796,1.1237393432683918,0.3220779220779221,0.8226392161308794,1.0,7/22,13.14%,SMG7;PINX1;NHP2;XRN1;TERT;DCP2;SMG6
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4815114620798568,1.1214478678981854,0.32238805970149254,0.8253967649387881,1.0,4/17,5.72%,ABCA1;ATP8B1;ABCG1;PLTP
prerank,methyltransferase activity (GO:0008168),0.4063507405745253,1.1213947939392135,0.2920673076923077,0.8212192189278511,1.0,14/46,24.61%,ASMT;EHMT1;COMTD1;MGMT;AMT;COMT;PRMT5;DNMT3B;MRM2;LCMT1;NTMT1;BUD23;COQ5;BCDIN3D
prerank,calcium channel inhibitor activity (GO:0019855),0.5396255331608899,1.120945957729261,0.36792452830188677,0.8183092263303408,1.0,4/11,13.46%,ITPR1;TNNI3;FKBP1B;CALM2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5130293582248413,1.1207785840618276,0.3412816691505216,0.8146098386092342,1.0,3/13,4.22%,PDGFRA;PDGFRB;IL1R1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.44266927014325363,1.1207082428038118,0.32349165596919127,0.8106399731224992,1.0,9/29,10.32%,CDKN2B;CDKN2D;SPRED1;SPRED2;PKIB;HEXIM1;PRKAR1B;RPTOR;SPRY2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.40873514517682874,1.1203490479466947,0.31235154394299286,0.8075174907003041,1.0,9/47,13.63%,SLC7A2;SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A11;PDPN;SLC7A8;SLC1A5
prerank,WW domain binding (GO:0050699),0.45283600762903564,1.1182652339884471,0.3288948069241012,0.8100241774481718,1.0,4/26,13.20%,PMEPA1;LITAF;PRRG4;TCEAL5
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.49995763280950806,1.114904677835166,0.36554621848739494,0.8161448229013941,1.0,4/15,21.63%,PLA2G5;PLA2G12A;PLA2G4A;PLA2G4E
prerank,SUMO binding (GO:0032183),0.5160724455833801,1.1119454405224398,0.347953216374269,0.8210546116143979,1.0,3/13,6.66%,CASP8AP2;USPL1;RNF111
prerank,peptidase activator activity (GO:0016504),-0.3555078466839979,-1.1095110703890014,0.3067226890756303,0.7569549271209374,1.0,8/22,12.78%,CAV1;MAL;APH1A;PCOLCE2;VSIR;APH1B;PINK1;EBAG9
prerank,voltage-gated calcium channel activity (GO:0005245),0.4172456849124294,1.1090525348431464,0.31003811944091486,0.8257313754426642,1.0,7/37,8.46%,CACNA1A;CACNB1;CACNA2D1;PKD2;CACNA1C;CACNA2D2;CATSPER3
prerank,protein phosphatase binding (GO:0019903),0.36046494564777454,1.108275602884816,0.3246346555323591,0.8238750370502196,1.0,22/117,13.50%,PPP1R9B;JAK1;SLC9A1;AP3B1;SMG7;STX17;EIF2AK3;IKBKE;STAT3;EGFR;MVP;PIK3R1;STRN;PPP1R16A;DLG4;CDC27;SIRPA;PDLIM4;TRAF2;PTK2;ANK1;STAT6
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.4305512860439411,-1.1081483879948697,0.34328358208955223,0.7511648929541732,1.0,6/12,24.43%,VEGFD;CDH5;CCDC88A;PGF;CADM4;DAB2IP
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5390395481731307,1.108079912465556,0.36930091185410335,0.8163212848784651,1.0,2/10,3.66%,DUSP2;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5390395481731307,1.108079912465556,0.36930091185410335,0.8163212848784651,1.0,2/10,3.66%,DUSP2;DUSP5
prerank,"DNA binding, bending (GO:0008301)",-0.4163928364535268,-1.1063718239935225,0.32515337423312884,0.7468607099517002,1.0,5/14,16.36%,LEF1;FOXD1;FOXL1;TFAM;HHEX
prerank,MAP kinase phosphatase activity (GO:0033549),0.5261081187659042,1.106270555942283,0.3849624060150376,0.8176740532333305,1.0,2/12,3.66%,DUSP2;DUSP5
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.493110815193801,1.1029744483864312,0.38074074074074077,0.8239450715631572,1.0,1/14,0.58%,SLC1A3
prerank,actin monomer binding (GO:0003785),-0.3505244621747814,-1.1023227078913382,0.3082706766917293,0.7493614462444813,1.0,8/22,13.03%,COBL;NOS3;TMSB4X;TWF2;TMSB10;PFN1;PRKCE;TWF1
prerank,lysine-acetylated histone binding (GO:0070577),0.449138216701497,1.0983736135403377,0.32083333333333336,0.8294394589714639,1.0,6/20,19.61%,KMT2A;CARM1;BRD4;BRD3;BAZ2A;SMARCA4
prerank,acetylation-dependent protein binding (GO:0140033),0.449138216701497,1.0983736135403377,0.32083333333333336,0.8294394589714639,1.0,6/20,19.61%,KMT2A;CARM1;BRD4;BRD3;BAZ2A;SMARCA4
prerank,methylation-dependent protein binding (GO:0140034),0.3881136934144423,1.0983024424152417,0.3670886075949367,0.8256029234710529,1.0,11/57,13.98%,CXXC1;CBX8;PHF1;PHF2;RBBP5;KDM7A;CHD8;MORC3;ATRX;FMR1;GLYR1
prerank,tau-protein kinase activity (GO:0050321),0.4540752594991173,1.097623083308425,0.37273991655076494,0.8238864311645263,1.0,8/20,22.02%,TAOK1;MARK1;GSK3B;BRSK2;ROCK2;CDK5;BRSK1;SIK3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.4183556174221602,1.0972930970180328,0.36239103362391034,0.8208522268478666,1.0,10/35,21.94%,TEC;PEAK1;BLK;STYK1;FRK;PTK2;ABL1;YES1;FES;SRC
prerank,DNA binding (GO:0003677),0.3423262863113829,1.0962632228170068,0.18,0.8199101004200421,1.0,160/694,20.74%,RORA;NR1H4;RAD51B;ZEB2;ZBP1;POU5F1;RBMS1;C1D;GLI2;TCF7L2;TCF4;MPG;BCL6;MEIS2;BRIP1;USF1;NR2F2;IRF7;STAT1;RARB;SNAI2;SMAD2;ZIC4;MAFB;DNA2;BCL2;AIFM2;BATF;SMC1A;IRF1;FUBP1;ARNT;ARID5B;POU2F1;KHDRBS1;ZNF496;RAD52;SOX21;ZNF292;INO80;ILF3;TBX2;FBH1;YAF2;MEIS1;CGGBP1;E2F1;ARID5A;MMP12;TEAD1;PHF1;SUB1;PRDM2;STAT3;MAP1S;EGFR;TAF4;TSHZ3;CREBBP;MCM2;PRDM5;CBFB;SNAPC3;FOXK2;PPARG;E2F3;TDP2;DCLRE1C;XRN1;RNF11;CDK9;FOXE1;DDB1;MYRF;ETV5;CHD2;FOXJ3;AHR;MBD1;DDX11;HOXA1;CHD8;XBP1;RNF138;SAFB2;CAMTA2;CALCOCO1;SETX;NR2F1;TERT;RC3H2;MCM7;RAD23A;RBPJ;OASL;HIVEP2;MCM9;CCNT1;CTCF;SETMAR;PDS5B;TCF3;TCF7L1;SMAD3;CLOCK;JUNB;NUCKS1;GLYR1;HSPD1;HMGB2;CXXC5;NUP35;ELK4;THRAP3;NR2C2;YY1;SP7;NPAS2;ABL1;ENDOV;HMGB3;ZNF35;NKX2-8;HMGN1;RBBP8;TIMELESS;HMCES;DNASE1L2;LIN9;TBX3;HOXB2;NFE2L2;KMT2D;EGR2;TFAP2C;COLEC11;SSBP2;SPTY2D1;ZGPAT;SAFB;NTHL1;POLG;RBM6;FOXO3;TFCP2;CARF;PATZ1;SMARCB1;SMARCA4;YBX1;SLTM;DRAP1;DDX3X;BCLAF1;HP1BP3;CALR;MAFK;POU6F1;ETS1;SAP30L
prerank,G protein-coupled receptor binding (GO:0001664),0.3562416627852508,1.0958284545952512,0.32574974146845914,0.8172164116002529,1.0,27/132,20.11%,WNT2;CXCL12;S1PR2;SFRP1;ADM;WNT5A;XCL1;WNT2B;WNT9A;DVL2;CCL5;FZD1;GNAS;GNAI1;LRP6;SDCBP;TUB;STUB1;TULP3;ARHGEF12;RTP4;PTCH1;PICK1;DVL1;NPY;ARRB1;GNAL
prerank,ATP binding (GO:0005524),0.34618438823868997,1.0954087621980935,0.27895266868076535,0.8145350146359367,1.0,34/266,9.63%,ABCA1;ENPP1;RUNX3;MYO1B;NEK6;TAOK1;MAP4K4;KIFC1;STK36;ERN2;PEAK1;ABCA2;IRAK3;ABCG1;MYH9;P2RX5;GALK1;MAP4K5;MARK1;MTHFD1L;TARS1;AKT3;PYGL;ABCE1;MVK;PLK1;TGFBR1;PXK;MLKL;ACVR1B;ACVR1;CARS2;CDK6;PIP4K2B
prerank,O-methyltransferase activity (GO:0008171),0.5340730162637285,1.0951641839499255,0.3630862329803328,0.8114747798373231,1.0,2/10,11.17%,ASMT;COMT
prerank,chemoattractant activity (GO:0042056),0.42698769459673663,1.0945832149912744,0.3577863577863578,0.8092871022574931,1.0,10/26,19.65%,FGF7;CCL5;CXCL10;FGF2;GPNMB;HMGB2;CX3CL1;GDNF;VEGFC;NTF3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.48329958372637905,1.0937220736664648,0.3798219584569733,0.808072894177654,1.0,1/15,0.58%,SLC1A3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.37142475858659835,1.0936285826834187,0.33511205976520814,0.8045266574769888,1.0,13/85,16.11%,CEL;LIPC;LPL;ASPG;LYPLAL1;PLA2G7;ABHD16A;GDPD3;PON3;DDHD2;PRDX6;PLA2G12A;H6PD
prerank,protein kinase C activity (GO:0004697),-0.4004618416757275,-1.0917502858182686,0.35873015873015873,0.7707325606626481,1.0,5/14,11.72%,PRKCH;PRKCZ;PRKCB;PRKD1;PRKCE
prerank,death domain binding (GO:0070513),0.5081419701168797,1.091074612679115,0.40381791483113066,0.80831679125859,1.0,3/11,8.27%,DAP;BCL2;BAX
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5068933749270651,1.0903077305129176,0.37445573294629897,0.80681914121277,1.0,4/13,13.85%,GPSM2;ARHGDIG;EIF5;ITGB1BP1
prerank,exonuclease activity (GO:0004527),0.39808556618178725,1.0902159063280406,0.3506024096385542,0.803395806847513,1.0,11/46,19.46%,ENPP1;REXO1;DCLRE1C;ERI1;EXOSC4;EXOSC2;EXOSC1;CPSF3;POLG;EXOSC3;DXO
prerank,cAMP response element binding (GO:0035497),0.5213085442496813,1.089877262934049,0.38961038961038963,0.8007223835217813,1.0,2/10,8.10%,CREB3L1;CREB3L2
prerank,amyloid-beta binding (GO:0001540),0.37351106204668794,1.087651949104504,0.348993288590604,0.803406874847213,1.0,15/79,14.25%,LRP1;HSPG2;CACNA1A;IAPP;TLR2;APOE;TREM2;GSAP;CD36;FCGR2B;PFDN1;EPHB2;PFDN4;GRIN2A;TM2D1
prerank,protein heterodimerization activity (GO:0046982),0.35030190836344394,1.08753963448147,0.32150101419878296,0.800087589908399,1.0,40/178,15.64%,SOHLH2;KRT25;TCF4;USF1;CREB3L3;TENM3;NPAS4;EXT1;BCL2;SMC1A;IRAK3;ABCG1;ARNT;EXT2;ZHX2;ADD2;FBXO7;TENM4;TAF7;BAX;BHLHE40;AHR;FZD9;MICU2;TOP2B;XBP1;SAE1;BCL2L2;RCC1;FMR1;TCF3;TPM4;MIGA2;TPM1;SDCBP;IRAK2;PRMT5;ITGA3;VAPA;RRAGC
prerank,hexosyltransferase activity (GO:0016758),0.3594877868751415,1.08669656375298,0.344644750795334,0.7990047200994996,1.0,27/101,23.38%,CHSY3;B4GALNT2;B4GALT5;ALG5;EXT1;OGT;EXT2;TMTC4;B4GALNT1;B3GALNT1;DPY19L3;GCNT2;CHSY1;B3GLCT;ALG6;A4GALT;POMT2;CHPF2;DPY19L4;GBA2;MGAT4A;B4GALT2;B4GALT7;B3GNT9;FUT4;POGLUT3;CHPF
prerank,phosphatidylinositol binding (GO:0035091),-0.25649481988483325,-1.0847150520817297,0.22988505747126436,0.7828796682498734,1.0,22/91,15.07%,PITPNC1;MCF2L;EPB41;DENND1A;PITPNA;PARD3;ITPR2;SCARB1;ESYT2;ITPR3;PLEKHF2;ESYT1;HIP1R;TNFAIP8L3;HIP1;PITPNM2;GPAA1;CCDC88A;ESYT3;MREG;RUBCN;SNX16
prerank,palmitoyltransferase activity (GO:0016409),-0.3229631401513481,-1.0840130534472803,0.3424124513618677,0.7760725002027411,1.0,17/28,36.80%,ZDHHC13;ZDHHC5;ZDHHC15;GLUL;GOLGA7;ZDHHC21;ZDHHC20;ZDHHC7;ZDHHC14;ZDHHC17;ZDHHC23;ZDHHC16;ZDHHC12;YKT6;GOLGA7B;ZDHHC2;ZDHHC22
prerank,voltage-gated ion channel activity (GO:0005244),0.4734877379189322,1.082474676422739,0.38516405135520687,0.8072985049231091,1.0,3/14,4.71%,HVCN1;VDAC2;PKD2
prerank,phospholipase inhibitor activity (GO:0004859),0.5192547652804367,1.0794144003780868,0.3925233644859813,0.8122837538809525,1.0,5/10,31.58%,ANXA1;ANXA2;ANXA4;ANXA9;ANXA5
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5132057767710365,1.0789440634310297,0.38664596273291924,0.8099649585215543,1.0,1/10,1.00%,EHHADH
prerank,disordered domain specific binding (GO:0097718),0.4448579923639025,1.0776169835815164,0.36114911080711354,0.8100690184995142,1.0,8/23,16.32%,CLTC;SMAD2;CALM3;BCL2L2;CALM2;GAPDH;MDM2;DFFB
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3946285224056334,1.0761227349309395,0.36829268292682926,0.8108203551726668,1.0,11/42,16.82%,CDKN2B;CDKN2D;CCNE2;HEXIM1;CCNL1;CKS1B;CCND3;CCNT1;CCNB2;CCNH;CCNC
prerank,translation initiation factor activity (GO:0003743),0.40545805902174326,1.0742374726505375,0.38404907975460123,0.8123656626387677,1.0,8/36,16.25%,EIF4G2;EIF4G3;EIF3H;EIF4A1;EIF5B;EIF1;EIF5;EIF2B3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.339608093810098,1.0716925425138957,0.30792377131394183,0.8161219375589063,1.0,88/346,20.05%,TRIML2;SH3RF3;CBLB;DTX4;PDZRN3;TNFAIP3;RNF150;MYLIP;MYCBP2;BIRC3;UBR5;BRAP;RNF157;SMURF2;ANAPC11;CNOT4;FBXO7;KLHL13;UBR4;RNF111;RNF2;SIAH2;CBL;CDC42;TRIM21;CUL1;UBE2L3;RNF144A;NEURL2;DTX2;UBE2J1;AREL1;TRIM56;RNF11;RNF19B;RNF145;KCMF1;RNF8;TRIM13;RNF138;TRIM11;UBE2E2;ARIH1;SH3RF1;PJA2;RC3H2;RNF149;TRAF2;TRIM62;MIB1;FBXW11;SMURF1;TRIM35;PELI3;UBE2Z;STUB1;PELI2;UBE2QL1;CHFR;MDM2;TRAF3IP2;ARIH2;UBE2W;DTX3;SYVN1;UBE2R2;RNF103-CHMP3;UBE2E1;RBCK1;RNF40;RNF215;ITCH;MAEA;RNF121;FBXO2;TRIM44;FBXO22;KCTD10;TRIM17;UBE2S;TRIM27;RNF217;RNF213;ZNRF2;TRAF5;RNF181;RNF168;NEDD4
prerank,protein homodimerization activity (GO:0042803),0.337826711663162,1.0714923763883402,0.239,0.8131485364552266,1.0,104/589,14.02%,FAP;ENPP1;KMT2A;ADIPOQ;SOHLH2;TRIML2;PDGFRA;MID1;GHR;ASMT;TBX18;USF1;MASP1;CREB3L3;JAML;NR2F2;TENM3;MAD2L1;LPL;STAT1;XCL1;LRRK2;APOE;EXT1;CAMK2D;XPNPEP3;BCL2;ST6GAL1;CRYM;CHMP4B;CHMP4A;IRAK3;EPHX2;PIP4K2A;ABCG1;MYH9;ARNT;PKD2;CLN6;CPQ;EXT2;FGFR1;ZHX2;MTHFD1L;ADD2;ZBTB38;PADI2;TENM4;CDADC1;STAT3;TNNC1;CCL5;XPNPEP1;TRPC6;TRIM21;BAX;GLDC;TRIM8;ACVR1;INHBB;ACOX1;NOD1;BHLHE40;ENO1;PIP4K2B;ZDHHC3;RNF8;AHR;PAXX;TARBP2;TMEM266;ERP29;FZD9;GNPTG;GBP3;DPYD;ALS2;KYAT1;EEA1;BCL2L2;PON3;HSD11B1;NQO2;TERT;FMR1;S100A6;SNX6;DGCR8;HM13;PDLIM4;ALDH3A2;SETMAR;TCF3;TPM4;MIGA2;CACYBP;TPM1;AIMP1;RAB11FIP4;SMAD3;LRP6;IRAK2;TKT;PTH1R
prerank,receptor tyrosine kinase binding (GO:0030971),0.37841345648920804,1.0714131213466829,0.3839080459770115,0.809817891157923,1.0,13/56,16.69%,CBLB;GAB2;IRS1;FRS2;CBL;PIK3R1;NCK1;SQSTM1;PTPN1;SH2B2;PTPN2;SOCS5;ANGPT1
prerank,cardiolipin binding (GO:1901612),0.5091417185696339,1.0675946850699007,0.39171974522292996,0.8169525530764132,1.0,2/10,9.83%,STOML2;PLEKHN1
prerank,phospholipase activator activity (GO:0016004),0.49977152088034804,1.0631117050286838,0.40062111801242234,0.8263801162136019,1.0,4/10,25.10%,CCL5;ARHGAP6;SRC;PDPK1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.36853412985677936,-1.0625338177619001,0.3614864864864865,0.8267659103339525,1.0,7/16,18.45%,INPP5F;MTMR10;MTMR11;MTMR14;SYNJ1;MTMR7;MTMR12
prerank,protein kinase binding (GO:0019901),0.3334368346192874,1.0613073568523488,0.3053053053053053,0.8278710426714967,1.0,105/479,17.36%,ROR2;TRIML2;CLTC;NEK6;TCF7L2;FAM83A;JTB;TNIP1;RND3;GHR;NELL1;USF1;PTN;DUSP2;ERRFI1;JAK2;SUFU;PDGFRB;GSKIP;RHOD;GATA6;DUSP5;PRKCSH;IRAK3;IRS1;SLC12A4;TIRAP;CDKN2B;NEK9;PRKD2;TREM2;KHDRBS1;CDKN2D;ADD2;SPRED1;SPRED2;RAC1;LIMS1;FBXO7;STAT3;CDC42;TNNI3;CACUL1;KCNA5;MVP;TRIM21;MAPKAP1;CKS1B;PLK1;DNM1;PTPN6;EPHA1;FOXM1;ACVR1;SQSTM1;PRKAR1B;LLGL1;CCND3;RPTOR;PTPN1;CALM3;RICTOR;FBXO5;SPRY2;NISCH;HDAC5;TOP2B;IBTK;SASH1;TOM1L1;RNF138;TBL2;GRB2;BORA;PJA2;SIRPA;TPX2;TRAF2;MSN;NEFH;PTK2;TCF3;CALM2;THY1;SMAD3;KIF13B;RELB;PPP1CB;FBXW5;CDC25A;GSK3B;PTPN2;IRAK4;IFNAR2;ABL1;MAPK8IP3;PRKRIP1;RHOBTB3;PDCD10;ATF2;FAM83H;PTPRJ;PTPN23;PICK1;RHOA
prerank,heme binding (GO:0020037),0.36999536063017757,1.0608016695634914,0.38047138047138046,0.8258540631015663,1.0,15/65,21.94%,CYP1B1;STEAP4;BACH1;JAK2;PXDN;CYP2A6;DGCR8;HEBP1;CYP2R1;PTGS2;PTGES2;TBXAS1;CYCS;NR1D1;SRC
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.45397025415000825,1.0606105380401842,0.42275280898876405,0.8228992349621509,1.0,4/18,13.01%,ALDH18A1;ALDH1A2;HSD17B12;ALDH3A2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5095181415488862,1.0590629826114115,0.4434250764525994,0.8236904742045444,1.0,1/11,5.99%,PADI2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.31028804533615945,-1.0589646569116524,0.3303964757709251,0.8283751637453689,1.0,12/32,23.74%,SLC6A6;SLC6A9;SLC43A2;SLC1A1;SLC7A5;SLC38A5;SLC6A7;SLC38A9;SLC38A2;SLC38A1;SFXN2;SLC7A10
prerank,androgen receptor binding (GO:0050681),0.42649030279777905,1.0581108729462039,0.39588688946015427,0.8228746965637779,1.0,11/25,24.26%,WIPI1;TGFB1I1;ARID5A;NSD1;SMARCA4;CALR;PKN1;PARK7;ZBTB7A;RNF14;KDM1A
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3797034297056041,1.0568903982858,0.38633686690223795,0.8228138750230405,1.0,10/53,12.07%,STEAP4;CYB5R2;ETFA;POR;AIFM2;MTHFR;ACOX1;ACOX3;DPYD;NQO2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4805004880100277,1.0500967661524827,0.44175491679273826,0.8381660023386378,1.0,4/13,16.53%,DNA2;DICER1;ENDOV;DNASE1L2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.5003973335747894,1.0499008112726789,0.4380664652567976,0.8351750207424627,1.0,8/11,31.10%,ALKBH1;HMCES;NTHL1;RPS3;NEIL1;HMGA2;APEX2;APLF
prerank,mRNA binding (GO:0003729),0.3330670574890862,1.04939266311079,0.3965863453815261,0.8330899967281609,1.0,53/249,20.49%,RBMS3;IGF2BP1;RBM46;RBMS1;ZFP36L1;IGF2BP2;CPEB1;RBFOX1;EIF4G2;SYNCRIP;EIF4G3;SHFL;FUBP1;GNL3;KHDRBS1;CELF1;PABPC4;KHSRP;RBM47;RBM4B;SAMD4A;EIF4A1;PTBP3;PUM1;CARHSP1;YTHDF3;SLBP;RBFOX2;RC3H2;FMR1;ACO1;RBMS2;MYEF2;NCBP2;CELF5;SNRNP35;SRSF1;HNRNPK;SLC4A1AP;RNF40;PUM3;MYH10;RSL1D1;IREB2;DXO;HNRNPA2B1;RBM15;LSM14B;CSTF2T;CPEB4;DDX3X;YTHDF2;CALR
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.47837131512247427,1.0482680989560218,0.42,0.8327428665528148,1.0,5/12,10.30%,BRD4;CDK6;CDK9;CDK13;CDK7
prerank,glucuronosyltransferase activity (GO:0015020),0.4411005210479706,1.0479015988355238,0.4195323246217332,0.830223084716583,1.0,3/19,12.45%,EXT1;EXT2;CHSY1
prerank,single-stranded DNA binding (GO:0003697),0.3525081157191838,1.0470887352433589,0.41252699784017277,0.8289820310594357,1.0,20/93,16.39%,RAD51B;RBMS1;FUBP1;RAD52;FBH1;SUB1;MCM2;TDP2;DDX11;RNF138;MCM7;RAD23A;MCM9;SETMAR;NUCKS1;HSPD1;HMGB2;NUP35;RBBP8;HMCES
prerank,kinase binding (GO:0019900),0.32883303473006603,1.0469637276669546,0.34534534534534533,0.8259566778820455,1.0,97/434,17.36%,TRIML2;CLTC;NEK6;TCF7L2;FAM83A;SNAI1;JTB;RND3;GHR;USF1;PTN;ERRFI1;JAK2;SUFU;PDGFRB;GSKIP;RHOD;GATA6;IRAK3;CASP1;SLC12A4;CDKN2B;NEK9;CDKN2D;ADD2;SPRED1;SPRED2;RAC1;LIMS1;FBXO7;UBQLN1;STAT3;EGFR;CDC42;TNNI3;CACUL1;KCNA5;MVP;TRIM21;MAPKAP1;CKS1B;PLK1;DNM1;PTPN6;EPHA1;FOXM1;SQSTM1;LLGL1;CCND3;RPTOR;PPP2R5A;PTPN1;CALM3;RICTOR;FBXO5;SPRY2;NISCH;DLG4;IBTK;SASH1;TOM1L1;RNF138;TBL2;GRB2;BORA;TPX2;RAD23A;TRAF2;MSN;NEFH;PTK2;ABI2;BTG1;CALM2;THY1;SMAD3;KIF13B;RELB;PPP1CB;FBXW5;CDC25A;GSK3B;STUB1;CDC37;PTPN2;IRAK4;IFNAR2;SP100;PRKRIP1;PIP5K1A;RHOBTB3;PDCD10;ATF2;FAM83H;PTPRJ;PTPN23;RHOA
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.38158355921076514,1.0453655883835322,0.43006993006993005,0.8269297231461055,1.0,10/49,12.68%,TNIP1;TNFAIP3;BABAM2;UBQLN1;IKBKE;PSMD4;SQSTM1;BAG6;RNF169;RAD23A
prerank,syntaxin binding (GO:0019905),0.36729687474562217,1.0445402982740093,0.425629290617849,0.8257132068162311,1.0,13/61,17.01%,ABCA1;CACNA1A;STX6;LRRK2;SYT10;STXBP1;SYT2;SCFD1;SYT3;PTPN2;UNC13A;ABL1;STXBP3
prerank,acid-thiol ligase activity (GO:0016878),-0.39463511238456395,-1.0429579096572759,0.4095238095238095,0.865204255926825,1.0,4/13,15.97%,ACSL1;ACSS1;ACSS2;AASDH
prerank,leucine zipper domain binding (GO:0043522),0.4944749414539299,1.0428084570768767,0.42260061919504643,0.8272030172750451,1.0,6/10,30.33%,MRTFA;PAWR;DDIT3;ATF4;PMF1;AATF
prerank,tropomyosin binding (GO:0005523),-0.35689412000154463,-1.0412083557348022,0.4020979020979021,0.861146460426994,1.0,3/16,11.08%,NEBL;TMOD3;LMOD1
prerank,nucleosomal DNA binding (GO:0031492),0.42801462527498335,1.0373797736160169,0.4368279569892473,0.8384480205373535,1.0,10/21,21.97%,SMARCC1;HDAC1;MTA2;MBD2;RCC1;GATAD2B;RBBP4;SMARCB1;SMARCA4;SMARCC2
prerank,beta-tubulin binding (GO:0048487),0.39731822906814396,1.0367913997724127,0.4183937823834197,0.8368217121079417,1.0,4/31,7.03%,TAOK1;DLEC1;EML4;MAP1S
prerank,G protein-coupled receptor activity (GO:0004930),0.32696180709991113,1.0343250869804874,0.4202020202020202,0.8402009280550564,1.0,35/239,18.29%,MC5R;P2RY10;FSHR;GPR176;S1PR2;GPR63;CMKLR1;PDGFRB;ADGRL3;RXFP2;GPR161;ADCYAP1R1;HRH1;GLP2R;S1PR3;MRGPRF;CXCR4;ADGRV1;PDGFRL;DRD3;GPR45;P2RY14;LTB4R2;PTH1R;TM2D1;OPN1MW;OPN1MW3;LPAR3;LGR4;MC1R;LPAR2;LPAR1;MRGPRE;CALCRL;GABBR1
prerank,rRNA binding (GO:0019843),-0.284005972370163,-1.0330760233657255,0.37790697674418605,0.8767613402012412,1.0,19/42,27.06%,RPL5;RPLP0;PTCD3;ERAL1;RPS13;RPF2;EMG1;NOP53;NGRN;MRPS7;MRPS18C;CIRBP;FASTKD2;RPS5;MRPL18;CAVIN1;FASTKD5;ANG;MRPL16
prerank,sulfotransferase activity (GO:0008146),-0.29239820849951004,-1.028928487341965,0.3939393939393939,0.8797260876189265,1.0,11/33,18.64%,HS3ST3A1;HS3ST1;CHST8;UST;TPST2;HS6ST1;CHST3;HS3ST2;CHST9;SULT1A1;GAL3ST1
prerank,chloride channel regulator activity (GO:0017081),-0.3818510322536891,-1.0286827191082524,0.39590443686006827,0.8711194409584005,1.0,3/14,21.03%,WNK4;WNK3;CFTR
prerank,GTPase binding (GO:0051020),0.33220773670213277,1.0283805626710727,0.4271151885830785,0.8531347896452943,1.0,61/195,21.10%,ABCA1;UNC13D;MYCBP2;MLPH;LCP1;LRRK2;STOML2;RAPGEF4;MYO5A;RABGAP1L;AMBRA1;FGD4;TRIP11;CDC42EP4;RAB34;RABGAP1;MAPKAP1;EXOC4;RAB3GAP2;TBC1D7;PDE6D;ENO1;AKAP13;GNB2;RTKN;ALS2;WHAMM;CDC42EP5;TBC1D20;ANKFY1;RCC1;CHML;ABI2;RANBP9;AIMP1;MTSS2;RAB11FIP4;PIH1D2;EXOC5;FGD6;SPTBN1;RAP1GAP;RRAGC;IFT20;ATG14;ANKRD27;RAB8A;RHOBTB3;EPRS1;GOLGA5;SPHK2;KIF3A;PEX5;BRK1;EVI5L;RAB3GAP1;SGSM3;YBX1;PKN1;PAK1;ATG16L1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.47538367274948556,1.0278446244803787,0.4418238993710692,0.8511362253369802,1.0,4/13,16.55%,PIP4K2A;PIP5K1B;PIP4K2B;PIP5K1A
prerank,insulin-like growth factor receptor binding (GO:0005159),0.46766086787191974,1.0275856399262064,0.4264036418816389,0.8484631040566113,1.0,6/12,22.82%,IRS1;PIK3R1;GNAS;ARRB1;IGF1;YWHAG
prerank,GTPase regulator activity (GO:0030695),0.32834088697142655,1.0271867123458394,0.43951612903225806,0.8462328461607679,1.0,49/212,15.23%,DLC1;RGS16;NRP1;ARHGAP24;SYDE1;ARHGAP42;SEC23A;ARHGAP15;ERRFI1;VAV3;LRRK2;ARHGAP32;SIPA1L3;ASAP1;RABGAP1L;ASAP3;ARFGAP3;GPSM2;OPHN1;NPRL2;RGS10;RABGAP1;TBC1D2B;NF1;DOCK1;RAB3GAP2;LLGL1;TBC1D16;TBC1D7;PDE6D;PREX1;RALGDS;TBC1D8B;RTKN;ALS2;TBC1D20;ARFGAP1;SIRPA;ELMOD1;ARHGAP20;THY1;MTSS2;EIF5;ITGB1BP1;ARHGAP35;FLCN;ACAP2;TBC1D13;RAP1GAP
prerank,protein serine/threonine kinase activity (GO:0004674),0.32315180287495604,1.0255874818471877,0.43043043043043044,0.8470275329331949,1.0,62/335,14.75%,MAP3K14;NEK6;TAOK1;MAP4K4;STK36;PRKCA;CASK;MAST4;NUAK1;ERN2;LRRK2;ALPK1;CAMK2D;IRAK3;PRKD2;CSNK2A2;MAP4K5;MARK1;CDK14;KALRN;ATM;EIF2AK3;AKT3;IKBKE;ATR;EGFR;CDK10;TRIO;PLK1;TGFBR1;FAM20A;ACVR1B;ACVR1;SQSTM1;BRD4;CDK6;MAP2K1;CDK9;CDK13;CDK7;CSNK1A1;HIPK4;NRK;MAPK11;TAOK3;ACVR2A;RPS6KB1;EIF2AK2;MYLK;MAST2;RPS6KC1;FAM20C;ARAF;HTATIP2;NEK4;CSNK1D;CAMK1G;IRAK2;PIK3R4;HIPK3;GSK3B;MAPK9
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.43154865993071256,1.0253346208313332,0.46372688477951635,0.844473610737361,1.0,5/18,11.28%,LTBP1;TGFBR1;ACVR1B;ACVR1;ACVR2A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.46692213444744723,1.0245647907905704,0.45481481481481484,0.8432805759179042,1.0,4/13,13.01%,ALDH1A2;ADH5;ALDH7A1;ALDH3A2
prerank,MAP kinase activity (GO:0004707),-0.3684431247706176,-1.0238253206127006,0.4057142857142857,0.8763894497753775,1.0,7/14,28.06%,MAPK4;MAPK12;MAPK10;MAPK7;MAPK8;MAPK14;MAPK3
prerank,translation elongation factor activity (GO:0003746),-0.3751719430772285,-1.0218571631561895,0.428125,0.8730782107783497,1.0,8/14,34.38%,TSFM;EEF2;EIF5A;EIF5AL1;EEF1B2;TUFM;EEF1A1;GTPBP1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3434578854238837,1.0202560476142508,0.4670981661272923,0.85143086281144,1.0,11/91,9.06%,SVIL;SH3PXD2B;MYO1B;WIPI1;SLC9A1;TIRAP;MARK1;SESTD1;MAPKAP1;SNX18;VILL
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.48045967191803685,1.0191681783396445,0.4799382716049383,0.8509267910665419,1.0,4/10,14.01%,NSD3;ASH1L;SETMAR;NSD1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4305706943963907,1.0185061736768193,0.46196403872752423,0.8494704206832414,1.0,2/21,2.26%,PDE3A;PDE7B
prerank,cGMP binding (GO:0030553),-0.405592521859184,-1.0175139585841433,0.4251497005988024,0.8760961939565228,1.0,6/11,34.95%,RAPGEF2;PDE2A;PDE11A;CNGB1;PDE10A;CNGB3
prerank,solute:sodium symporter activity (GO:0015370),0.401031822656593,1.0167650786492841,0.45454545454545453,0.8506170883138233,1.0,5/27,10.06%,SLC28A2;SLC4A4;SLC4A5;SLC20A1;SLC13A5
prerank,phosphate ion binding (GO:0042301),-0.4151701028730824,-1.0149296238641692,0.4339080459770115,0.8748471527240483,1.0,3/10,21.23%,PDE2A;MTHFD2;ADSS1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.31674259902098795,1.0147052081515637,0.45645645645645644,0.8524076603372708,1.0,65/431,13.47%,ABCA1;ENPP1;RUNX3;MYO1B;NEK6;TAOK1;MAP4K4;KIFC1;STK36;RND3;ERN2;PEAK1;ABCA2;RHOJ;RHOD;LRRK2;RAP2A;IRAK3;GNL3;ABCG1;MYH9;P2RX5;GALK1;MAP4K5;MARK1;RAB21;MTHFD1L;TARS1;GBP7;RAC1;AKT3;PYGL;TUBG1;ABCE1;CDC42;RAB42;MVK;RAB7A;ATL2;RAB2A;GNL1;PLK1;TGFBR1;PXK;MLKL;ACVR1B;ACVR1;RALA;RAB10;CARS2;CDK6;PIP4K2B;VPS4A;ATL1;GBP3;CHD8;ARL4C;MTREX;MAST2;RAB27B;CARS1;RERG;GNAI1;GUK1;RAB32
prerank,MAP kinase kinase activity (GO:0004708),0.4421516657491308,1.0123137254092254,0.4573529411764706,0.8552811518096595,1.0,3/15,9.54%,LRRK2;MAP2K4;MAP2K1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4330342674032989,1.0115776542530435,0.45685997171145687,0.8540018608411135,1.0,7/18,23.69%,SMAD2;TGFBR1;TGFB3;SMAD3;TGFBRAP1;TGFB2;TGFB1
prerank,histone acetyltransferase binding (GO:0035035),0.4163745553681135,1.0106296710957312,0.4755927475592748,0.8532413838319783,1.0,7/21,16.65%,GLI3;STAT1;TAF7;KANSL1;SIRT2;ECD;EID1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3185967147665449,1.0104605834315041,0.47076612903225806,0.8504815815644985,1.0,35/291,9.63%,ABCA1;ENPP1;RUNX3;MYO1B;NEK6;TAOK1;MAP4K4;KIFC1;STK36;ERN2;PEAK1;ABCA2;RAPGEF4;IRAK3;ABCG1;MYH9;P2RX5;GALK1;MAP4K5;MARK1;MTHFD1L;TARS1;AKT3;PYGL;ABCE1;MVK;PLK1;TGFBR1;PXK;MLKL;ACVR1B;ACVR1;CARS2;CDK6;PIP4K2B
prerank,histone deacetylase activity (GO:0004407),0.4204670777838396,1.0104127645583778,0.44291609353507566,0.847413412730478,1.0,5/19,11.57%,MIER2;HDAC1;HDAC5;SIRT2;HDAC3
prerank,chemokine receptor activity (GO:0004950),0.4069705912803431,1.008973521898014,0.46908602150537637,0.8481447695514944,1.0,3/24,10.70%,CMKLR1;CCR1;CXCR4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4140669563789443,1.0080512257957575,0.48053691275167787,0.8473655841241021,1.0,2/23,2.26%,PDE3A;PDE7B
prerank,nucleotidyltransferase activity (GO:0016779),0.42155589274696814,1.0079006436515352,0.4812760055478502,0.8446782406982126,1.0,8/19,23.37%,PAPSS2;TERT;TENT4A;CGAS;CRPPA;REV1;PAPSS1;TUT7
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.456409432888076,1.0036081633730807,0.4629080118694362,0.8525239909816327,1.0,3/12,8.70%,PHF2;KDM4D;KDM7A
prerank,protein phosphatase activator activity (GO:0072542),0.4548262821067166,1.0033936920017719,0.47707736389684813,0.8499427990401238,1.0,7/13,25.78%,PPP2R5A;CALM3;CALM2;PPP2R5E;PPP2R5D;PPP2R5C;PTPA
prerank,amino acid binding (GO:0016597),-0.2879742129505416,-1.0021112058150605,0.43842364532019706,0.9030510885551029,1.0,7/31,16.54%,GRM7;NOS3;GLRA3;GRIN3A;GLRA2;GRIN2B;GCLC
prerank,chloride channel inhibitor activity (GO:0019869),-0.4154589069870676,-1.0003441125811325,0.456973293768546,0.899667285483521,1.0,3/10,21.03%,WNK4;WNK3;CFTR
prerank,magnesium ion binding (GO:0000287),0.3262311021338088,0.9974989249266356,0.4896265560165975,0.8614509526642258,1.0,35/135,22.16%,NEK6;PDXP;ERN2;LRRK2;RAP2A;IRAK3;PPA1;EPHX2;ADCY2;MARK1;MVK;PLK1;FOXK2;TDP2;MAST2;GNAI1;TKT;IDH2;TPPP;PPA2;BRSK2;RRAGC;ABL1;ENDOV;MAP3K6;STK4;DXO;STK11;BRSK1;ADPRH;CDC42BPA;DIS3L2;SIK3;MAP3K20;MAP2K7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4149474489311855,0.9955290879944871,0.48202396804260983,0.862975958001894,1.0,3/22,7.28%,DUSP2;DUSP5;DUSP18
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.41407164049101197,0.99095231451012,0.4839609483960948,0.868418364726987,1.0,10/21,23.86%,CDK14;CDK10;CDK6;CDK9;CDK13;CDK7;CDK5;CDK11B;CDK12;CDKL1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.41407164049101197,0.99095231451012,0.4839609483960948,0.868418364726987,1.0,10/21,23.86%,CDK14;CDK10;CDK6;CDK9;CDK13;CDK7;CDK5;CDK11B;CDK12;CDKL1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3817816027537819,0.9890313310847751,0.49,0.8702357862286334,1.0,2/30,2.93%,KNG1;BIRC3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.37526639191259464,0.9869361936312494,0.5042630937880633,0.8722131754326589,1.0,11/35,18.37%,ENPP1;PLCXD3;PDIA3;SMPDL3B;TDP2;PLCL1;GDPD3;PLD4;SMPD4;SMPD3;PLCB3
prerank,histone deacetylase binding (GO:0042826),0.3293464122887012,0.9866462980319012,0.5043478260869565,0.8697687221758638,1.0,17/88,13.39%,NCOR2;GLI3;MIER2;USF1;SATB2;KCTD21;HDAC1;MTA2;NIPBL;HDAC5;SIRT2;TOP2B;CAMTA2;HDAC3;ZMYND15;PRDM1;LCOR
prerank,miRNA binding (GO:0035198),0.38136797807787115,0.9855960861351372,0.5044929396662388,0.8690654371246148,1.0,10/30,26.83%,POU5F1;PUM1;RBM10;FMR1;HNRNPA2B1;YBX1;TUT7;ZC3H7B;SOX2;ZNF346
prerank,Tat protein binding (GO:0030957),0.4721194361016457,0.9848036853231075,0.5,0.8680084370340461,1.0,1/10,0.90%,MDFIC
prerank,ribonuclease activity (GO:0004540),0.350001637604352,0.9847741254933875,0.4936268829663963,0.8650143722634573,1.0,17/56,22.27%,ERN2;RNASE7;RNASE1;SND1;DICER1;EXOSC4;SMG6;RNASEH2A;EXOSC2;RNASEH1;EXOSC1;CPSF3;RCL1;EXOSC3;DIS3L2;RNASE12;LACTB2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.30611999343599755,-0.9839119566621392,0.4774774774774775,0.9394770879395951,1.0,6/25,9.87%,NOS3;FMO5;MICAL3;FMO1;MICAL1;SQLE
prerank,RNA binding (GO:0003723),0.303879750616876,0.9834952131200184,0.599,0.8650769168470529,1.0,350/1321,22.91%,RBMS3;DCN;FNDC3B;IGF2BP1;ZBP1;BICC1;RBM46;POU5F1;CLTC;RBMS1;RRBP1;C1D;LRP1;RFTN1;RPSA;ZFP36L1;IGF2BP2;RPUSD3;AFF2;ALDH18A1;RBFOX1;APOBEC1;EIF4G2;CSRP1;MAK16;CCAR1;SYNCRIP;EIF4G3;YARS1;ZCCHC24;ATXN2;FASN;DDX17;PDIA3;SPATS2;RAE1;TRUB2;ARL6IP4;ZFP36L2;SREK1;DNA2;SMC1A;SHFL;RPL3L;FUBP1;GNL3;DNAJC21;MYH9;DYNC1H1;MRPS26;DNTTIP2;SMG7;MYO5A;KHDRBS1;ZC3H13;CELF1;TENT5A;CKAP4;SNRNP40;ARCN1;FSCN1;ILF3;PABPC4;LSM7;CDC42EP4;CNOT4;ASCC3;KHSRP;ZCCHC8;ANP32A;NOL11;SNTB2;SRSF12;PPRC1;SERPINH1;SUB1;HEXIM1;STAT3;SELENOH;RCAN3;PINX1;PES1;RBM47;SND1;RBM4B;SAMD4A;KIF1C;SRSF2;NHP2;EIF3H;EIF4A1;CSTF1;STXBP1;PSMD4;DHX15;UBE2L3;NONO;DNM1;DHX34;DHX8;CANX;PTBP3;SEC63;TRIM56;XRN1;CCDC86;TNPO1;TRMT2A;SRP68;ENO1;ALKBH1;PUM1;ERI1;PTPN1;TLR7;RBM39;ZC3H15;CHD2;RBM10;CDK13;NMD3;XPOT;TARBP2;DHX35;TNRC6B;YTHDF3;DDX11;ZFR;PDAP1;CCDC59;HSPE1;NOC2L;SAFB2;TBL2;GRB2;MRPL15;SETX;SLBP;EIF5B;GSPT1;EIF1AX;EIF1;EIF2AK2;RRP1B;RRP1;DICER1;METTL16;MTREX;RBFOX2;NOP56;TERT;RC3H2;DCP2;FMR1;POP1;DIDO1;GIGYF2;CCAR2;AGFG1;CARS1;BUD13;DGCR8;OASL;NOP9;GRWD1;DAP3;MSN;ALKBH5;DDX18;SMG6;ACO1;KPNB1;UBFD1;CAPRIN1;MTERF4;AIMP1;RPL14;EIF5;DDX28;NUCKS1;CCDC9B;HSPD1;MAP4;SUGP2;TBCA;NIP7;HMGB2;COL14A1;DDX31;RTRAF;DHX58;ANXA7;ANKHD1;SAP18;NOP2;ZCCHC17;DMGDH;DHX29;RAVER2;THRAP3;MOV10;RBMS2;MYEF2;BAG4;NOP14;YY1;NEMF;EXOSC2;RAMAC;SPTBN1;NCBP2;RNASEH1;DHX40;MSI1;POLR2B;MRM1;DHX57;UTP3;PSMA6;ELP1;PELP1;ENDOV;HMGB3;AKAP8L;CELF5;SNRNP35;SRSF1;HNRNPK;WDR36;ZC3H4;PRKRIP1;HNRNPUL1;SRP19;BMS1;CS;SON;HNRNPDL;SCAF4;WDR6;EXOSC1;SLC4A1AP;TCERG1;SIDT2;ZC3H14;NAT10;EPRS1;POP4;PUM3;USO1;ROCK2;CPSF3;TOP3B;ZCCHC7;PEF1;RPS25;RPL12;MTIF2;ESF1;FARS2;TLR3;CHERP;STAU1;SAFB;SRFBP1;HNRNPH2;PRRC2C;RBM6;EXOSC3;MYH10;CTNNA1;BAZ2A;RSL1D1;SRP72;GTF2F1;IREB2;NUDT4;DXO;MRPL1;ZRANB2;PARP1;HNRNPA2B1;RBM15;SPEN;ARF1;TRAP1;LSM14B;TBRG4;CSTF2T;LSM6;MRPS14;CPEB4;HADHB;YBX1;SLTM;DDX3X;YTHDF2;BCLAF1;UBA1;NOP16;CALR;FAM98A;CDK11B;LIN28B;NAP1L1;FIP1L1;EFTUD2;TOE1;NOLC1;EBNA1BP2;MBNL2;TRA2A;HELB;FBL;RPL22;ASS1;BCCIP;DDX10;FUS;ANXA2;KRI1;HDLBP;SF3B2;SF3B1;PRKDC;SEC23IP;BYSL;PPP1CC;YWHAE;MAP3K20;RBMX;WRAP53;BZW1;RPS27A;LACTB2;PARK7;U2AF1;DDX1;HEATR6;ACIN1;KYAT3;YWHAZ;NCOA5;POLRMT;UTP11;FAM50A;PRPF31;YWHAG;TPD52L2;RBM3;AKAP1
prerank,cyclic nucleotide binding (GO:0030551),-0.3158422784212889,-0.9822235187139774,0.4740740740740741,0.9355571025326704,1.0,6/21,16.32%,PDE4B;RAPGEF2;PDE2A;PDE4D;HCN1;CNBD2
prerank,channel activity (GO:0015267),0.3581787095139303,0.9809404203397032,0.511543134872418,0.8682226195566713,1.0,6/41,13.03%,BCL2;P2RX5;TMEM120B;BAX;TMEM266;PDPN
prerank,MHC protein binding (GO:0042287),-0.33154805644644514,-0.9802553100617862,0.5058365758754864,0.9324968796422854,1.0,8/20,34.36%,CD81;TUBB4B;ABCB9;LAG3;TAP2;ATP5F1B;LILRB1;DERL1
prerank,manganese ion binding (GO:0030145),0.34807718105663216,0.9796543543065737,0.5163934426229508,0.8682930186901247,1.0,8/48,12.90%,MGAT5;XPNPEP3;ADCY2;GALNT3;XPNPEP1;TDP2;FAM20C;NEK4
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3666188641966455,0.9793448023032776,0.4993726474278545,0.8659409922451684,1.0,10/38,13.60%,GAB2;LRRK2;IRS1;FRS2;PIK3R1;NCK2;NCK1;SH2B2;MMS19;DLG5
prerank,3'-5' DNA helicase activity (GO:0043138),0.4292437152181275,0.9788258774268647,0.515850144092219,0.8641917144221252,1.0,5/16,12.28%,FBH1;ASCC3;HELQ;MCM2;MCM7
prerank,general transcription initiation factor binding (GO:0140296),-0.3043596138523574,-0.9779479812571212,0.4708333333333333,0.9303646197490979,1.0,8/25,22.50%,ESR1;PSMC1;DR1;TAF13;HHEX;BRF2;PSMC2;TAF12
prerank,RNA cap binding (GO:0000339),-0.34129283228222196,-0.9776186265895859,0.47635135135135137,0.9226558160671907,1.0,6/16,20.79%,CYFIP2;DCPS;SNUPN;EIF3D;LSM1;NCBP3
prerank,calcium:sodium antiporter activity (GO:0005432),-0.39483624681607415,-0.9755726837801887,0.481994459833795,0.9196767986941979,1.0,3/10,7.62%,SLC24A2;SLC8A3;SLC8B1
prerank,Hsp70 protein binding (GO:0030544),0.3765893457297415,0.9730474133054815,0.49875311720698257,0.8747343585373676,1.0,4/31,6.04%,SPN;IQCG;DNAJB1;PPID
prerank,small GTPase binding (GO:0031267),0.3159870093522382,0.9710977555085502,0.5477903391572456,0.8764103272310219,1.0,47/170,20.01%,ABCA1;UNC13D;MYCBP2;MLPH;LRRK2;RAPGEF4;MYO5A;RABGAP1L;FGD4;TRIP11;CDC42EP4;RAB34;RABGAP1;MAPKAP1;EXOC4;RAB3GAP2;TBC1D7;PDE6D;AKAP13;RTKN;ALS2;WHAMM;CDC42EP5;TBC1D20;ANKFY1;RCC1;CHML;ABI2;RANBP9;MTSS2;RAB11FIP4;PIH1D2;EXOC5;FGD6;RAP1GAP;IFT20;ANKRD27;RAB8A;RHOBTB3;GOLGA5;SPHK2;KIF3A;PEX5;BRK1;EVI5L;RAB3GAP1;SGSM3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.37986750972590455,-0.9699017429094657,0.5050167224080268,0.9278461110530691,1.0,2/12,5.98%,CYFIP2;DCPS
prerank,sodium channel regulator activity (GO:0017080),-0.2689922446656842,-0.9690679639857377,0.5529411764705883,0.9216794850157919,1.0,9/37,15.22%,SNTA1;FGF12;FGF14;FXYD5;FXYD6;ATP2B4;FXYD1;NEDD4L;SCN4B
prerank,syntaxin-1 binding (GO:0017075),-0.31722693522464923,-0.9685621427484737,0.5111111111111111,0.9143963686336567,1.0,3/22,2.40%,UNC13C;SNAP25;UNC13B
prerank,endopeptidase activator activity (GO:0061133),-0.38644644259011335,-0.9668120963586437,0.5,0.911379735692005,1.0,5/10,21.79%,APH1A;VSIR;APH1B;PSME1;ADRM1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3332813238499531,-0.9629340832628458,0.5088967971530249,0.9133849784217758,1.0,8/17,27.63%,GRIK4;GRIN2D;GRIN3A;GRIN2B;GRIA2;GRIA1;GRIK2;GRIK3
prerank,potassium channel activity (GO:0005267),-0.2316697422771622,-0.9621729049933353,0.546875,0.9074784169753104,1.0,18/89,13.73%,KCNB2;KCNK5;GRIK4;KCNH7;KCNQ5;TMEM175;KCND2;ABCC9;KCND3;KCNC2;KCNK10;KCNQ3;KCNQ1;LRRC38;KCNT1;CCDC51;KCNH5;HCN1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.2912572595971724,-0.9600727232928109,0.4981949458483754,0.9054242279276319,1.0,4/23,6.35%,PLCE1;PLCB4;PLCB1;CHRM3
prerank,pyridoxal phosphate binding (GO:0030170),-0.3103063287781563,-0.9584593031616916,0.5164835164835165,0.9019129512322702,1.0,7/20,17.72%,PYGB;PLPBP;ACCS;PYGM;PDXK;CBS;ABAT
prerank,GTPase activator activity (GO:0005096),0.30244931544859294,0.9582563312127463,0.6024096385542169,0.90345498750956,1.0,67/313,15.23%,DLC1;RGS16;FARP2;VAV2;FARP1;NRP1;MYCBP2;ARHGAP24;SYDE1;ARHGAP42;SEC23A;ARHGAP15;ERRFI1;VAV3;NUCB2;LRRK2;CYTH3;RAPGEF4;ARHGAP32;EGF;SIPA1L3;ASAP1;RABGAP1L;ASAP3;ARFGAP3;FGD4;ARFGEF2;DENND4C;OPHN1;KALRN;NPRL2;ITSN1;RGS10;RABGAP1;TBC1D2B;NF1;RABIF;DENND5A;DOCK1;SH3BP5L;RASGEF1B;RAB3GAP2;LLGL1;TBC1D16;TBC1D7;GAPVD1;AKAP13;PREX1;SH3BP5;TBC1D8B;ALS2;TBC1D20;ARFGAP1;FNIP1;RCC1;DNMBP;LAMTOR5;ELMOD1;ARHGAP20;THY1;MTSS2;ARHGAP35;FLCN;ACAP2;TBC1D13;FGD6;RAP1GAP
prerank,Notch binding (GO:0005112),0.3925073056735281,0.9580027327483215,0.5203679369250985,0.9009182047708252,1.0,6/22,18.29%,NCOR2;JAG1;SNED1;GALNT11;TCIM;KCTD10
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.40054752756448647,0.957291513575751,0.5349462365591398,0.899516831025296,1.0,2/21,6.52%,P2RX5;GLRB
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4298977672223609,0.9566303979288822,0.5324675324675324,0.8979892143517191,1.0,3/14,9.05%,CASP8AP2;CASP1;NOD1
prerank,ubiquitin binding (GO:0043130),0.3322677248166245,0.9564543678168691,0.5591517857142857,0.8954462690296126,1.0,23/73,20.40%,TNFAIP3;OTULINL;RAE1;USPL1;FBXO7;UBXN2A;CKS1B;ILRUN;SQSTM1;RNF19B;CXCR4;SIRT2;TOM1L1;RAD23A;SMAD3;MVB12A;FBXW7;MDM2;RBCK1;UCHL1;RNF168;NEDD4;NBR1
prerank,voltage-gated potassium channel activity (GO:0005249),-0.22761132029276548,-0.9557908064038613,0.5913978494623656,0.9016530141757003,1.0,17/80,13.73%,KCNB2;KCNH7;KCNJ2;KCNQ5;KCND2;KCNJ3;KCND3;KCNC2;KCNQ3;KCNQ1;KCNJ13;LRRC38;KCNT1;KCNJ12;KCNH5;KCNN3;HCN1
prerank,sequence-specific mRNA binding (GO:1990825),0.4604251292675072,0.9554397630375939,0.5329153605015674,0.8948331478535709,1.0,2/10,12.19%,SHFL;FMR1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3057052399462862,-0.9548615552768273,0.5352112676056338,0.8965377578223251,1.0,4/20,9.82%,LPCAT2;LPGAT1;DGAT1;ABHD5
prerank,cation channel activity (GO:0005261),-0.2181906259187642,-0.9548399672642646,0.6301369863013698,0.8889812528323845,1.0,13/94,9.40%,TRPM3;SLC24A2;CACNB2;KCNK5;TRPM6;TMEM175;TMCO1;ABCC9;KCNK10;CACNA1D;ANO1;TRPC1;TRPV2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.35171099475646156,-0.9537408813786994,0.4852459016393443,0.8843040073034302,1.0,2/12,5.54%,ENTPD1;SLC25A42
prerank,ion channel activity (GO:0005216),-0.22868668317341578,-0.9529924536817463,0.6111111111111112,0.8788017053628114,1.0,16/80,13.88%,TRPM3;GABRB1;GRID2;TRPM6;GRIK4;ABCC9;MCUB;GRIN2D;GRIN3A;TRPC1;TRPV2;TMC6;TRPM7;TRPV4;CHRNB1;GRIN2B
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4466824452397121,0.9519683821370718,0.5348484848484848,0.8996992319965201,1.0,3/11,22.30%,CARM1;PRMT5;PRMT6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3384015892174514,0.9514979439489122,0.5528455284552846,0.897864408637345,1.0,7/55,13.05%,SLC7A2;SLC38A3;SLC16A12;SLC38A4;SLC36A2;PDPN;SLC7A8
prerank,ligand-gated calcium channel activity (GO:0099604),0.4010527289706672,0.9472058608748045,0.5428571428571428,0.9047801908998804,1.0,5/19,19.11%,RASA3;ITPR1;GRIN2A;TRPM4;GRIN1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.33865989097440136,-0.9470608726515345,0.5288135593220339,0.887014748988636,1.0,6/16,22.83%,MACROD2;CD38;SMUG1;ADPRS;SARM1;NEIL3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3881070276059597,-0.9469679953830004,0.5122615803814714,0.8799836528006634,1.0,4/10,13.84%,PRKAG2;PRKAR2A;PKIA;PRKAR1A
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.32840642117443974,-0.9458105852029373,0.4838709677419355,0.8754425755796484,1.0,10/16,33.01%,SLC13A3;SLC1A1;SLC25A12;SLC25A14;SLC1A6;SLC25A30;SLC25A13;SLC25A18;SLC1A4;SLC25A11
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3409981426592862,-0.9454728718783799,0.5032679738562091,0.8694822703915966,1.0,6/14,18.45%,MTMR10;MTMR11;MTMR14;SYNJ1;MTMR7;MTMR12
prerank,hydro-lyase activity (GO:0016836),0.3498204792055014,0.9452215498073743,0.5811138014527845,0.9063656315325526,1.0,17/41,26.31%,EHHADH;HACD2;GMDS;PCBD1;ENO1;ACO1;ACO2;ENO2;IREB2;HADHB;TBXAS1;FAHD2A;PARK7;ECHS1;PCBD2;CDYL;AUH
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2992250599487633,0.940327160045944,0.6519114688128773,0.9145056851090818,1.0,68/269,22.68%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;STAT1;CD40;SMAD2;UQCRC1;BCL2;AMBRA1;FBXO7;IKBKE;EGFR;CUL1;UBE2L3;ACVR1B;SQSTM1;RALA;UBE2J1;SLF2;RNF8;CXCR4;BAG6;SPOP;ARIH1;HM13;TANK;TRAF2;SMAD5;ABI2;SMAD3;AXIN2;HSPD1;PRDX6;PTPRN;FBXW7;CASP8;GSK3B;STUB1;BAG4;MDM2;SNX9;UBE2W;MC1R;RNF40;ITCH;HGS;EGR2;TRIB3;PATZ1;ARRB1;UCHL1;TRAF5;CALR;WASHC1;CDK5RAP3;TRIB1;CCDC50;AUP1;YWHAE;DDRGK1;WRAP53;DTX3L;RPS27A;HSPA5;YWHAZ
prerank,phospholipase activity (GO:0004620),0.3265771532832812,0.9397148564484362,0.5643564356435643,0.9128920963062919,1.0,20/67,23.39%,LIPC;LPL;PDIA3;ASPG;LYPLAL1;PLCL1;ABHD16A;GDPD3;DDHD2;PLD4;PRDX6;PLA2G12A;SMPD4;SMPD3;PLCB3;PLA2G4A;PLA2G4E;SEC23IP;LYPLA2;GPLD1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.31858405325885775,0.9392893073761236,0.5895439377085651,0.9108326806490452,1.0,18/74,16.27%,DCAKD;PAPSS2;GALK1;XYLB;HK2;MVK;FAM20A;TRPT1;GALK2;PANK2;FAM20C;ADPGK;PI4KA;PIK3C3;DGKH;COASY;KHK;GK
prerank,alanine transmembrane transporter activity (GO:0022858),0.4261121056879118,0.9390602024959125,0.5437037037037037,0.9084692231294238,1.0,3/12,13.05%,SLC38A3;SLC36A2;SLC7A8
prerank,mRNA methyltransferase activity (GO:0008174),0.43973890821406036,0.9385358872637783,0.5581395348837209,0.9067511866828043,1.0,2/12,11.76%,TRMT61B;METTL16
prerank,microtubule binding (GO:0008017),0.29741481577007334,0.9380186845408639,0.6189516129032258,0.9049654732754633,1.0,42/222,15.63%,KIF26B;MID1;CCDC170;MAP4K4;KIFC1;CFAP157;PSRC1;CEP295NL;EML4;RAE1;ALMS1;LRRK2;FSD1;NAV3;MAP1S;MACO1;CAMSAP2;HOOK2;KIF2A;KIF1C;REEP4;PLK1;EML3;DNM1;RMDN2;FAM161A;KIF5B;WHAMM;CLIP3;FGF13;FMR1;MAST2;TPX2;NEFH;FBXW11;MAPRE2;KIF13B;MAP4;TPPP;GAPDH;TPGS1;VAPA
prerank,symporter activity (GO:0015293),0.4517358893989585,0.9369677704068253,0.5615141955835962,0.9043312484214271,1.0,2/10,5.71%,SLC28A2;SLC4A4
prerank,filamin binding (GO:0031005),0.4473524979511111,0.9369674888347752,0.586924219910847,0.901404610077021,1.0,2/11,3.27%,DPYSL4;DPYSL3
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.3059928243955942,-0.9360798996336979,0.556390977443609,0.8733229250097625,1.0,5/22,6.77%,CHRM2;HTR1F;HTR2C;CHRM3;HTR7
prerank,serotonin receptor activity (GO:0099589),-0.3059928243955942,-0.9360798996336979,0.556390977443609,0.8733229250097625,1.0,5/22,6.77%,CHRM2;HTR1F;HTR2C;CHRM3;HTR7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.3059928243955942,-0.9360798996336979,0.556390977443609,0.8733229250097625,1.0,5/22,6.77%,CHRM2;HTR1F;HTR2C;CHRM3;HTR7
prerank,DNA replication origin binding (GO:0003688),0.37870272231689434,0.9352338847218825,0.5511596180081856,0.9023781270403491,1.0,6/23,13.99%,MCM2;DDX11;MCM7;GRWD1;MCM9;HSPD1
prerank,NF-kappaB binding (GO:0051059),0.3786608504647957,0.9351118925795806,0.5691275167785235,0.8997460876737987,1.0,6/24,15.80%,HDAC1;COMMD6;HDAC3;COMMD7;GSK3B;PSMA6
prerank,antiporter activity (GO:0015297),0.3928859627687102,0.9343907553093579,0.5661157024793388,0.8985696059708804,1.0,5/20,12.60%,SLC35D2;SLC25A16;TMEM241;CLCN4;SLC35C1
prerank,5'-3' exonuclease activity (GO:0008409),0.42435320672550114,0.9339385091423891,0.5776772247360482,0.8966835971345621,1.0,5/14,19.46%,DCLRE1C;XRN1;DCP2;CPSF3;DXO
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.34614708386210913,-0.9335842133380376,0.5773809523809523,0.87289218648287,1.0,4/13,14.21%,TRMT1L;TRMT10A;TRMT10B;TRMT5
prerank,kinase activator activity (GO:0019209),-0.27917771076450304,-0.9330423909164579,0.5864978902953587,0.8675790804392759,1.0,11/30,25.64%,PRKAG2;MADD;STRADA;MALT1;NCKAP1L;WNT11;GPRC5A;DUSP19;RPLP1;MOB1B;AGAP2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3488194647355779,-0.9298655465366732,0.5626911314984709,0.8682855743961899,1.0,5/13,13.84%,EZR;KCNQ1;PRKAR2A;PKIA;PRKAR1A
prerank,1-phosphatidylinositol binding (GO:0005545),0.4056032773928167,0.9294809754492199,0.5616835994194485,0.9036417931202934,1.0,5/15,15.85%,SESTD1;SNX10;EEA1;SNX9;ZFYVE16
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3222522975462098,0.9292184495366411,0.6043478260869565,0.9012934150677633,1.0,21/71,17.83%,PTPN7;PTPN3;DUSP26;PTEN;PTPN13;HACD2;DUSP18;PTPN6;PTPRZ1;PTPN1;PTPN18;CDC14B;PTPN5;ACP1;PTPRN;CDC25A;PTPN2;UBASH3B;PTPRJ;PTPN23;PTPN9
prerank,ubiquitin protein ligase binding (GO:0031625),0.29637639437587343,0.9289547538682578,0.6754032258064516,0.8989982117178356,1.0,44/254,16.08%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;CD40;SMAD2;UQCRC1;BCL2;AMBRA1;FBXO7;IKBKE;EGFR;CUL1;UBE2L3;ACVR1B;SQSTM1;RALA;UBE2J1;SLF2;RNF8;CXCR4;BAG6;SPOP;ARIH1;HM13;TANK;TRAF2;SMAD5;ABI2;SMAD3;AXIN2;HSPD1;PRDX6;FBXW7;CASP8;GSK3B;STUB1;BAG4;MDM2;SNX9;UBE2W;MC1R
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.30862052763494346,0.9285851498761324,0.6170212765957447,0.8969701352739966,1.0,26/100,22.38%,SH3PXD2B;MYO1B;WIPI1;MYO10;GAB2;CYTH3;OGT;SESTD1;MAPKAP1;PLEKHN1;DAPP1;ANKFY1;ZFYVE26;ZFYVE16;PLEKHF1;PLEKHA5;OSBPL5;GBF1;PLA2G4A;SAP30L;RUBCNL;KIF16B;WDR45;PLA2G4E;RPH3A;GSDMD
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.42595748659291877,0.9281523119323515,0.5774436090225564,0.8950426692522812,1.0,1/13,1.00%,EHHADH
prerank,nucleotidase activity (GO:0008252),-0.3363469568373039,-0.9275626251845319,0.5559322033898305,0.8677916225804901,1.0,8/15,30.04%,NT5E;NT5DC3;NT5C2;NT5C;BPNT1;ACP3;NT5C3B;BPNT2
prerank,retinoid binding (GO:0005501),0.38602569992005054,0.9267814754981215,0.5739247311827957,0.895284670461211,1.0,2/22,3.34%,NR2F2;ALDH1A2
prerank,alkali metal ion binding (GO:0031420),-0.3480964248324141,-0.9267283396372601,0.5627009646302251,0.8633481425631292,1.0,4/13,18.13%,ATP1A2;HDAC4;PDXK;ATP1A1
prerank,NADP binding (GO:0050661),-0.2673993818233568,-0.9254950524077812,0.6263157894736842,0.859694683583129,1.0,12/32,23.17%,ME3;LBR;NOS3;CAT;ME1;NOX1;DHFR;CBR4;NNT;CRYZ;CBR3;TM7SF2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3395542109035512,0.9233770956256303,0.5844907407407407,0.8996605594829096,1.0,9/49,11.45%,PDXP;PLCXD3;DUSP5;SMPDL3B;DUSP28;EPHX2;DUSP18;SACM1L;GDPD3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.409208936849511,0.9215837825929604,0.5507868383404864,0.9006322594755269,1.0,3/14,17.14%,TSEN2;POP1;POP4
prerank,thioesterase binding (GO:0031996),0.4315560919852385,0.9207623793024515,0.5843373493975904,0.8996226002962958,1.0,4/11,19.89%,RAC1;CDC42;TRAF2;TRAF5
prerank,single-stranded DNA helicase activity (GO:0017116),0.39150319502052366,0.920252075808326,0.5934065934065934,0.8980512074911879,1.0,4/19,12.28%,DNA2;HELQ;MCM2;MCM7
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3545305710125178,-0.9193241124289827,0.5570291777188329,0.8683983822719226,1.0,4/11,12.84%,SGMS2;SGMS1;AASDHPPT;PIGF
prerank,FAD binding (GO:0071949),0.3698199933273954,0.9179093154490904,0.5756756756756757,0.9002519417408618,1.0,3/24,6.42%,STEAP4;CYB5R2;MTHFR
prerank,adenylate cyclase binding (GO:0008179),-0.36967909800604426,-0.91670648007259,0.5618556701030928,0.8680805694186603,1.0,4/10,7.13%,AKAP6;ADCY5;CAP1;CALM1
prerank,CoA hydrolase activity (GO:0016289),0.4015346529806678,0.9151387364769036,0.5760709010339734,0.9031067786509499,1.0,3/16,10.66%,ACOT9;HIBCH;ACOT13
prerank,cation transmembrane transporter activity (GO:0008324),0.3294257494558317,0.9147680775729823,0.6045400238948626,0.9010792394475635,1.0,2/48,2.16%,SLC7A2;SLC38A3
prerank,phosphatidylglycerol binding (GO:1901611),-0.35273159998880604,-0.9146707959307132,0.5647058823529412,0.8665856980977409,1.0,2/13,1.73%,PITPNC1;PITPNA
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.31703389944765925,0.9143525079102119,0.5940023068050749,0.8991751694434393,1.0,21/60,25.30%,LRRK2;PTEN;CTDSPL2;LRRK1;CDC14B;PPP3CA;PPP4C;LRRC39;PPP1CB;PHLPP2;PPM1H;ILKAP;RPAP2;TIMM50;CTDSP2;PPP1CC;PPM1D;LRRC40;CDC14A;PPP2CB;PPM1M
prerank,GDP binding (GO:0019003),0.31826916504173236,0.9125624818268715,0.6063708759954494,0.8999913290456139,1.0,17/63,19.23%,RAP2A;RAB21;RAB8B;RAB42;RAB7A;RAB2A;RALA;RAB10;RAB27B;RERG;GNAI1;RRAGC;RAB9A;RAB8A;RAB12;RAB31;RIT1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.2633561168805442,-0.9123027148436098,0.6146341463414634,0.8659569308396932,1.0,5/32,9.98%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNQ1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4086805502050358,0.9120370941326758,0.56657223796034,0.8983795388514577,1.0,4/14,18.38%,CRYM;MTHFR;QDPR;AASS
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.261286093286173,-0.9097195525766196,0.5882352941176471,0.8657872374177692,1.0,15/35,24.57%,DTWD2;TRMT9B;DUS4L;ELAC1;QTRT1;QRSL1;LCMT2;TRMT5;MRPL58;GATC;MTFMT;TYW3;DUS3L;TRMT12;TRIT1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.36221404031224363,-0.9092571145855579,0.5698324022346368,0.8606709829474705,1.0,5/10,13.94%,STAMBP;ATXN3;CYLD;DESI2;OTUD4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3599429550071997,0.905236280557117,0.5900783289817232,0.9097079957590116,1.0,11/27,23.60%,SIAH2;RNF144A;RNF19B;DCUN1D1;ARIH1;ZMYM2;ARIH2;DCUN1D5;RNF217;AUP1;RNF14
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.28525396452858337,-0.9037452444153609,0.5916030534351145,0.8676727893944666,1.0,14/24,36.80%,ZDHHC15;GLUL;GOLGA7;ZDHHC21;ZDHHC20;ZDHHC7;ZDHHC14;ZDHHC17;ZDHHC23;ZDHHC12;YKT6;GOLGA7B;ZDHHC2;ZDHHC22
prerank,DNA polymerase binding (GO:0070182),-0.3050090372312191,-0.9037020350832294,0.5848375451263538,0.8616399723883544,1.0,4/18,11.59%,RTEL1;FANCI;HSP90AB1;PCNA
prerank,tubulin binding (GO:0015631),0.2846869985221046,0.9033976571517458,0.742713567839196,0.9106312384262836,1.0,74/295,22.41%,KIF26B;MID1;TAOK1;DLEC1;CCDC170;MAP4K4;KIFC1;CFAP157;PSRC1;CEP295NL;EML4;RAE1;ALMS1;LRRK2;FSD1;NAV3;INO80;MAP1S;MACO1;RABGAP1;HOOK2;KIF2A;KIF1C;REEP4;PLK1;EML3;DNM1;RMDN2;FAM161A;NCALD;B9D2;AGTPBP1;TTLL4;KIF5B;WHAMM;ARL4C;CLIP3;FGF13;FMR1;MAST2;TPX2;NEFH;MAPRE2;KIF13B;MAP4;TBCA;STMN4;TPPP;GAPDH;TPGS1;VAPA;IFT81;KIF3C;KIF5C;TUBGCP4;KIF3A;KIF5A;CAMSAP1;KIF27;TPPP3;CDK5;BRSK1;NDEL1;HOOK3;DDX3X;WASHC1;BCAS3;PAK1;KIF16B;CKAP5;KIF20A;DNAL1;SETD2;CCDC61
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.38002764829551755,0.902118827740962,0.5909712722298222,0.9104942332997022,1.0,3/20,8.20%,OTULINL;USP9X;EIF3H
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.31333038246840644,0.9012635547767375,0.6431014823261118,0.9094100060921114,1.0,9/72,9.06%,SVIL;MYO1B;SLC9A1;TIRAP;MARK1;SESTD1;MAPKAP1;SNX18;VILL
prerank,RNA stem-loop binding (GO:0035613),0.41167214210916236,0.8998998101169066,0.5838150289017341,0.9095033235350694,1.0,6/12,20.26%,METTL16;RC3H2;FMR1;EPRS1;MYH10;DDX3X
prerank,ligand-gated cation channel activity (GO:0099094),-0.2138353785984494,-0.8998520037617794,0.6907216494845361,0.8641034552664008,1.0,21/75,27.63%,GRIK4;KCNJ2;KCNJ3;GRIN2D;GRIN3A;KCNJ13;KCNJ12;CCDC51;KCNN3;CHRNB1;GRIN2B;KCNK6;GRIA2;MCOLN1;KCNJ8;KCNN2;GRIA1;CHRNA4;GRIK2;KCNH2;GRIK3
prerank,protein kinase activator activity (GO:0030295),0.31711492242290934,0.898936541183465,0.61795166858458,0.9088232725898439,1.0,14/60,13.72%,TAOK1;FAM20A;RPTOR;INCENP;MAP2K1;CALM3;RICTOR;SPRY2;ALS2;ABI1;FGF13;TPX2;CALM2;DBF4
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.30840488767262725,0.8988827263500346,0.645413870246085,0.9062043617390585,1.0,16/75,20.10%,EHHADH;RDH10;DHRS4;ADH5;RDH12;AKR1A1;PRXL2B;KCNAB2;HSD17B8;KCNAB1;GLYR1;UGDH;H6PD;HIBADH;DHRS3;HADHB
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.23348872357176514,-0.8979752681083514,0.6869565217391305,0.8620199146514937,1.0,13/55,12.39%,SLC24A2;CACNB2;ITPR2;TMEM165;TMCO1;ATP2B2;CACNA1D;TRPC1;TRPV2;ATP2B4;ATP2A3;TRPM7;TRPV4
prerank,NADPH binding (GO:0070402),-0.3318361519342057,-0.8957452463064681,0.6132075471698113,0.8609630203352326,1.0,6/13,26.58%,LBR;DHFR;CBR4;CRYZ;CBR3;GRHPR
prerank,GTPase activity (GO:0003924),0.2866400952176032,0.8951760217762081,0.717816683831102,0.9107250353596367,1.0,48/192,21.47%,RND3;RHOJ;RHOD;LRRK2;RAP2A;RAB21;GBP7;RAC1;RAB8B;NUGGC;ENTPD7;CDC42;RAB42;RAB7A;ATL2;RAB2A;GNL1;DNM1;RALA;GNAS;GNB2;ATL1;GBP3;GPN3;GSPT1;RAB27B;RERG;GNAI1;RAB32;GPN2;TPPP;RAP1GAP;RRAGC;RAB9A;RASD2;RAB8A;BMS1;RHOBTB3;DNAJC27;RHOA;RAB31;RIT1;GNAL;RAB24;DDX3X;EFTUD2;RHOF;RAP1B
prerank,GTP binding (GO:0005525),0.2853913879549599,0.8949410891798055,0.7107692307692308,0.9085568301877062,1.0,41/172,21.58%,RND3;RHOJ;RHOD;LRRK2;RAP2A;GNL3;RAB21;GBP7;RAC1;TUBG1;CDC42;RAB42;RAB7A;ATL2;RAB2A;GNL1;RALA;RAB10;PIP4K2B;ATL1;GBP3;ARL4C;RAB27B;RERG;GNAI1;RAB32;RRAGC;RAB9A;RAB8A;BMS1;RHOBTB3;TUBB2A;RHOA;TUBA1A;RAB31;RIT1;ARF1;TUBG2;RHOF;RAP1B;ARF4
prerank,SH3 domain binding (GO:0017124),0.3167242929237693,0.892725991793862,0.6447520184544406,0.9102528446932419,1.0,12/62,15.79%,CBLB;ADAM12;SH3BP2;DPYSL3;WIPF1;KHDRBS1;CBL;GRB2;ABI1;ABI2;RUFY1;ABL1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4072933323660932,0.8917505498798187,0.5963302752293578,0.909484724469572,1.0,2/14,3.27%,FETUB;TIMP1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.361589014605235,-0.8890784631370731,0.6215469613259669,0.8700640903600085,1.0,7/10,44.62%,NCF2;NOX1;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,CoA-ligase activity (GO:0016405),-0.3245604500492578,-0.8873206308064807,0.5807453416149069,0.868132643904643,1.0,3/14,15.45%,ACSL1;ACSS1;ACSS2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.27136089931166435,-0.8867861359511503,0.6380090497737556,0.8633534133088103,1.0,5/27,7.62%,SLC9A2;SLC9B2;SLC8A3;SLC4A8;SLC8B1
prerank,tau protein binding (GO:0048156),0.3272050425083171,0.8864161884495136,0.6373626373626373,0.9172226610287848,1.0,11/40,19.65%,TAOK1;SMAD2;APOE;MARK1;BIN1;GSK3B;STUB1;BRSK2;ROCK2;CDK5;BRSK1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.39188255025770985,0.8861713817488345,0.5982404692082112,0.9150417550889329,1.0,3/15,19.78%,P2RX5;P2RY14;P2RX7
prerank,clathrin adaptor activity (GO:0035615),0.3940182858504945,0.8860670864773397,0.5920471281296024,0.9125939146823728,1.0,1/15,0.83%,STON2
prerank,ATPase activator activity (GO:0001671),-0.2952248172902739,-0.8845558273127994,0.6,0.8622091272988156,1.0,4/20,7.65%,ATP1B3;ATP1B1;DNAJC19;DNAJC15
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2865343348190296,0.8834070525081376,0.7212435233160622,0.9151062996446779,1.0,29/147,12.43%,FARP2;VAV2;FARP1;MYCBP2;VAV3;NUCB2;CYTH3;RAPGEF4;EGF;FGD4;ARFGEF2;DENND4C;KALRN;ITSN1;RABIF;DENND5A;DOCK1;SH3BP5L;RASGEF1B;RAB3GAP2;GAPVD1;AKAP13;PREX1;SH3BP5;ALS2;FNIP1;RCC1;DNMBP;LAMTOR5
prerank,phospholipase C activity (GO:0004629),0.3510363791595754,0.8807505090099984,0.6361149110807114,0.9175366370580526,1.0,5/25,9.04%,PDIA3;EDNRA;CCR1;CCL5;PLCL1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3393962640214917,0.8798735285519764,0.6264294790343075,0.9163974304266154,1.0,14/33,23.64%,SIAH2;RNF144A;RNF19B;DCUN1D1;ARIH1;ZMYM2;ARIH2;TCERG1;DCUN1D5;RNF217;AUP1;PARK7;RNF14;RPS3
prerank,GABA receptor binding (GO:0050811),0.42024585925404556,0.8786346027617451,0.6332288401253918,0.9160913884919104,1.0,2/11,5.63%,TRAK1;ARFGEF2
prerank,5'-nucleotidase activity (GO:0008253),-0.3381704230903244,-0.875831190303038,0.6067796610169491,0.8755844793419107,1.0,4/13,15.05%,NT5E;NT5DC3;NT5C2;NT5C
prerank,dynactin binding (GO:0034452),0.4171203194228075,0.8757208063975614,0.61698956780924,0.9188297741978614,1.0,7/12,24.38%,SNX5;SPTBN5;SNX6;GSK3B;HOOK3;HTT;PAFAH1B1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.40352154599977336,0.8738877276384974,0.6094674556213018,0.919585869487802,1.0,4/12,27.77%,OPN1MW;OPN1MW3;GPR88;RRH
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.3511426004643061,-0.8737650339036301,0.596045197740113,0.8740735829495866,1.0,2/10,4.66%,MECOM;PRDM16
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2764333567637851,0.8728348908873103,0.7646464646464647,0.9189487284405128,1.0,58/248,20.26%,RND3;RHOJ;RHOD;LRRK2;DNA2;RAP2A;MYH9;RAB21;GBP7;RAC1;RAB8B;NUGGC;ENTPD7;CDC42;KIF2A;RAB42;RAB7A;ATP2B1;ATL2;RAB2A;KIF1C;MYO19;GNL1;DNM1;RALA;GNAS;GNB2;ATL1;GBP3;GPN3;GSPT1;RAB27B;RERG;GNAI1;DYNC2H1;RAB32;GPN2;DHX29;TPPP;RAP1GAP;RRAGC;RAB9A;RASD2;RAB8A;BMS1;RHOBTB3;RUVBL1;DNAJC27;RHOA;KIF3C;ABCG4;KIF5A;RAB31;RNF213;RIT1;GNAL;RAB24;DDX3X
prerank,phosphatase activity (GO:0016791),0.30342551525978384,0.8727843355641336,0.6893523600439078,0.9164155425820049,1.0,14/73,18.52%,PDXP;DUSP5;DUSP26;DUSP28;EPHX2;DUSP18;NT5M;ENOPH1;SACM1L;PTPMT1;PPP1CB;PLPPR2;PTPRJ;PLPP3
prerank,LRR domain binding (GO:0030275),0.3850553655873788,0.8726552827216597,0.6251830161054173,0.9140052210764106,1.0,6/14,28.04%,MRTFA;PAWR;ROBO1;DDIT3;ATF4;PMF1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.2563264281997143,-0.871609838100017,0.6776859504132231,0.8730664900534518,1.0,12/27,25.57%,POLR3B;POLR2G;POLR2F;POLR3H;POLR2E;PRIMPOL;POLR1H;POLR2A;POLR1C;POLR1F;PRIM1;POLR2J
prerank,ion gated channel activity (GO:0022839),0.3524053438317835,0.8713376027420289,0.6091503267973856,0.9137955784421665,1.0,1/24,0.61%,KCNT2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.35674489415640376,0.8691922985916606,0.6243654822335025,0.9152970707828826,1.0,4/22,11.26%,TNFAIP3;IKBKE;SQSTM1;RNF169
prerank,potassium channel regulator activity (GO:0015459),-0.229713400303909,-0.8687861731482308,0.7022900763358778,0.8733702920959365,1.0,9/49,14.50%,KCNIP4;ABCC9;DPP6;WNK4;WNK3;DPP10;LRRC38;ARPP19;NEDD4L
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3321078254072602,0.8678235280672181,0.6604477611940298,0.9153263122341646,1.0,10/34,18.37%,UBE2L3;UBE2J1;UBE2F;UBE2E2;UBE2Z;UBE2QL1;UBE2W;UBE2R2;UBE2E1;UBE2S
prerank,transferrin receptor binding (GO:1990459),-0.3406120501098049,-0.8665581863554781,0.6229050279329609,0.8724684962025572,1.0,3/10,16.00%,CD81;IKBKG;HFE
prerank,adrenergic receptor binding (GO:0031690),0.3782030219719747,0.8653168489137028,0.615819209039548,0.9172780861857743,1.0,6/16,20.05%,GNAS;ARRDC3;DLG4;APLP1;UCHL1;NEDD4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3175570514777352,0.8627848372461576,0.6491228070175439,0.9193076177703184,1.0,11/38,21.63%,SH3PXD2B;WIPI1;SESTD1;ZFYVE26;PLEKHF1;PLEKHA5;PLA2G4A;RUBCNL;KIF16B;WDR45;PLA2G4E
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3129161356220188,-0.8623558555911978,0.6454849498327759,0.8752863815308062,1.0,1/16,0.45%,PIR
prerank,kinesin binding (GO:0019894),0.34109854794797906,0.860490980255572,0.6493011435832274,0.9208445707008216,1.0,7/27,18.40%,NEK6;SPTBN5;IFT88;MAPK8IP1;NEFH;MAPK8IP3;KIFAP3
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4107074827547443,0.8590762524558881,0.6325878594249201,0.9207283309971286,1.0,1/10,1.85%,B4GALT5
prerank,calcium channel activity (GO:0005262),0.2902803703196067,0.8570475875900888,0.7211328976034859,0.9216862791028366,1.0,10/84,8.46%,CACNA1A;SLC24A5;CACNB1;CACNA2D1;PKD2;CACNA1C;CACNA2D2;PKD2L2;TRPC6;CATSPER3
prerank,cadherin binding (GO:0045296),0.26938584505157226,0.8569434285024251,0.8294884653961886,0.919329187384401,1.0,103/315,23.25%,MYO1B;CDH11;EIF4G2;FMNL2;FASN;STAT1;CCT8;BAIAP2;TNKS1BP1;GOLGA3;CHMP4B;DNAJB1;CALD1;MYH9;ANXA1;ASAP1;LIMA1;FSCN1;DBN1;SNX5;EGFR;CBL;DCHS1;CLINT1;SND1;DBNL;NCK1;PPFIBP1;PARVA;ACVR1;BAG3;CEMIP2;RAB10;LASP1;ENO1;GAPVD1;PTPN1;ZC3H15;KIF5B;ABI1;CDH6;NOP56;PCMT1;CAPZA1;GIGYF2;CSNK1D;UBFD1;RPL14;PI4KA;EIF5;PRDX6;CNN3;DHX29;CCNB2;SPTBN1;PHLDB2;CDH18;CDH24;VAPA;SNX9;EPS15L1;PLIN3;HNRNPK;PSEN1;CC2D1A;RUVBL1;PTPRJ;CTNND2;SH3GLB1;USO1;PLCB3;CTNNA1;RSL1D1;SH3GL1;UNC45A;EFHD2;MB21D2;EPS15;CGN;DDX3X;GIPC1;SNX2;RARS1;EHD1;CKAP5;ITGB1;ANXA2;HDLBP;SRC;NUMB;YWHAE;RAB1A;BZW1;PARK7;PTPRM;HSPA5;PDXDC1;STK24;YWHAZ;LYPLA2;CDH19;CDH7;CDH20
prerank,protein kinase regulator activity (GO:0019887),0.2792761007711612,0.856690864724692,0.7024442082890542,0.917196067888214,1.0,21/95,16.82%,GSKIP;CCNE2;HEXIM1;CCNL1;NCK1;CXCL10;PARVA;SH3BP5L;MAPK8IP1;PRKAR1B;CCND3;RPTOR;SH3BP5;TAOK3;FGF13;TPX2;CCNT1;CCNB2;PRKRIP1;CCNH;CCNC
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.33899994105249076,-0.8561580290400476,0.6564245810055865,0.8821132893706345,1.0,2/10,13.12%,DSEL;GALM
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3419381415385888,0.8560476545969475,0.6581632653061225,0.9158135562926619,1.0,3/29,3.66%,TNIP1;DUSP2;DUSP5
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3652195798562115,0.8560453099836195,0.6475644699140402,0.9132975849841656,1.0,3/17,10.66%,ACOT9;THEM4;ACOT13
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.32430669973114296,-0.852227441692162,0.6934523809523809,0.8841229893861472,1.0,3/12,4.92%,SLC9A2;SLC9B2;LETM1
prerank,endodeoxyribonuclease activity (GO:0004520),0.3633913605156487,0.8506489038597502,0.6914600550964187,0.9202024558462242,1.0,5/20,16.18%,DNA2;DCLRE1C;SETMAR;ENDOV;RBBP8
prerank,actin binding (GO:0003779),0.2722112480937487,0.8492699720629376,0.7758620689655172,0.920202149119099,1.0,31/170,13.51%,MRTFA;FHL3;SLC6A2;MLPH;LCP1;LRRK2;CALD1;SYNPO;MYH9;LIMA1;FSCN1;ADD2;DBN1;SSH1;PDLIM7;MAP1S;TNNI3;SPTBN5;DBNL;MYO19;PARVA;PLEKHH2;NCALD;CXCR4;PDLIM2;TMOD1;CAPZA1;PAWR;PDLIM4;PTK2;TPM1
prerank,fatty acid synthase activity (GO:0004312),-0.352069122107847,-0.8490807512802307,0.6807909604519774,0.8849438311985968,1.0,4/10,19.58%,ELOVL5;ELOVL7;CBR4;OXSM
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3880712546369104,0.847941525659843,0.6555386949924128,0.920001380943941,1.0,3/12,8.79%,LTBP1;TGFBR1;ACVR1
prerank,histone acetyltransferase activity (GO:0004402),0.328555770114365,0.8444675561303145,0.6857506361323156,0.9233369694801308,1.0,10/30,19.57%,BAZ1A;NAA50;CREBBP;EPC2;USP22;CLOCK;TADA3;ATF2;SRCAP;ARRB1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.29853999019552757,0.8436183024462568,0.6947976878612717,0.9222984788294784,1.0,15/54,21.10%,MIER2;ASPG;NTAN1;HDAC1;PIGL;HDAC5;SIRT2;HDAC3;NADSYN1;GLS2;ASRGL1;NGLY1;AMDHD2;HINT1;SIRT7
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2781573112990076,-0.8435269456756016,0.6729323308270677,0.8904549204179959,1.0,1/17,1.05%,SLC2A1
prerank,lysophospholipase activity (GO:0004622),0.3473472346708162,0.8432983653583802,0.6606896551724138,0.920362022531547,1.0,4/20,11.45%,ASPG;LYPLAL1;ABHD16A;GDPD3
prerank,pyrophosphatase activity (GO:0016462),0.3059932986746313,0.8428173496430899,0.6995359628770301,0.9185790838593747,1.0,11/50,21.89%,ENPP1;PPA1;ENTPD7;DCP2;DHX29;PPA2;NUDT14;NUDT4;DXO;DDX3X;ENTPD6
prerank,galactosyltransferase activity (GO:0008378),0.3972294755756715,0.8408150152678685,0.6501547987616099,0.9194643433298201,1.0,5/11,26.32%,B4GALT5;A4GALT;B4GALT2;B4GALT7;B4GALT4
prerank,O-acyltransferase activity (GO:0008374),0.328290868808902,0.840507996013999,0.6738305941845765,0.9175011261654769,1.0,8/30,21.17%,PIGW;SOAT1;MOGAT3;PRDX6;GPAM;GPAT3;PLA2G4A;LPCAT3
prerank,MHC class I protein binding (GO:0042288),-0.31447997296963504,-0.840076034907155,0.65527950310559,0.891164353723053,1.0,7/13,38.77%,TUBB4B;ABCB9;TAP2;ATP5F1B;LILRB1;DERL1;TAPBP
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3105559204634035,-0.8393219818719485,0.6886792452830188,0.8869262633507726,1.0,3/13,4.92%,SLC9A2;SLC9B2;LETM1
prerank,proton transmembrane transporter activity (GO:0015078),0.31033518587422826,0.8391613150813506,0.6981818181818182,0.9173686080006922,1.0,8/39,15.75%,SLC9A1;SLC11A2;UQCRC1;CLCN5;CLCN4;DMAC2L;COX7A2L;ATP6V1F
prerank,potassium ion antiporter activity (GO:0022821),0.3706296619594656,0.8383000376363169,0.6634078212290503,0.9163154647185636,1.0,2/15,2.75%,SLC9A1;SLC24A5
prerank,nuclear import signal receptor activity (GO:0061608),0.3748196301661739,0.8362827079878632,0.6744525547445256,0.9170264296947518,1.0,3/15,13.34%,KPNA3;TNPO1;KPNB1
prerank,carboxypeptidase activity (GO:0004180),-0.23228658474548036,-0.835780179291539,0.7589743589743589,0.8885789729756685,1.0,9/35,18.08%,CPD;FOLH1;MINDY1;CPE;CPM;NAALAD2;AGBL5;ACE2;VASH1
prerank,death receptor activity (GO:0005035),0.39526151558890277,0.8357059563224365,0.6515625,0.9155277344249549,1.0,3/11,17.04%,EDA2R;TNFRSF4;TNFRSF1A
prerank,protein kinase C binding (GO:0005080),0.3080527202380721,0.8354198532989949,0.7028985507246377,0.9136058273809373,1.0,15/43,22.82%,NELL1;PRKCSH;IRS1;TIRAP;PRKD2;SQSTM1;HDAC5;TOP2B;ABL1;PICK1;DACT2;HINT1;PKN1;DACT1;YWHAG
prerank,chemokine binding (GO:0019956),0.32706494418010773,0.8328850147354336,0.7054161162483488,0.9151267212538424,1.0,7/30,21.56%,CCR1;CXCR4;FGF2;PDPN;CCR9;ACKR2;ITGB1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3460234233777573,0.8309395911514943,0.6839080459770115,0.9158553869457262,1.0,11/20,28.93%,CASK;GUK1;DTYMK;AK8;AK2;MAGI3;CMPK1;AK3;AK6;AK4;DLG1
prerank,N-acetyltransferase activity (GO:0008080),0.349673970145953,0.8290512721148345,0.7011173184357542,0.916401796196674,1.0,2/19,4.88%,NAT1;NAA50
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.30019233544307317,-0.8290203752226514,0.6792452830188679,0.8963891783546853,1.0,8/15,29.18%,PIK3R3;SOCS7;PIK3R6;SOCS3;CCKBR;SOCS2;CISH;SOCS1
prerank,carboxy-lyase activity (GO:0016831),-0.26045722535930454,-0.8281477852419896,0.7322834645669292,0.8923837751161076,1.0,5/23,11.79%,PPCDC;UXS1;DDC;CSAD;GAD1
prerank,ATP hydrolysis activity (GO:0140603),-0.2222128549115055,-0.8277902197087956,0.7708333333333334,0.8875437577217347,1.0,9/41,13.14%,ABCA4;SMCHD1;CHD1L;VWA8;ABCB10;MYO18A;KIF26A;ABCA3;TOR1A
prerank,omega peptidase activity (GO:0008242),0.2808443800013176,0.8266994253639511,0.7585836909871244,0.9177937225500609,1.0,27/89,24.55%,TNFAIP3;USP9X;USP24;USP42;USP38;USP40;USP3;USP14;MINDY3;GGH;TANK;USP22;VCPIP1;OTUD3;USP47;MYSM1;MPND;PSMD14;ASRGL1;USP12;UCHL1;JOSD2;GGT7;USP34;USP4;USP37;JOSD1
prerank,phosphatidate phosphatase activity (GO:0008195),0.37883386742580993,0.825825104395752,0.6551204819277109,0.9167663300837656,1.0,8/13,33.10%,PLPPR2;PLPP3;LPIN3;LPIN2;PLPPR5;PLPP1;PLPPR3;PLPP4
prerank,kinase activity (GO:0016301),0.26984015488614993,0.8247443870138341,0.7705442902881536,0.9161153396690485,1.0,25/109,20.41%,TAOK1;MAP4K4;DCAKD;PAPSS2;LRRK2;COQ8B;MVK;ITPKC;FN3KRP;PANK2;ADPGK;PI4KA;PIK3C3;GSK3B;DGKH;COASY;ABL1;GK;SPHK2;TRIB3;CSNK2A1;CDK5;IP6K2;PANK4;PANK1
prerank,methyl-CpG binding (GO:0008327),0.3368682068138715,0.8245476462057484,0.6799468791500664,0.9140792990042265,1.0,6/22,19.85%,ZBTB38;MBD2;MBD1;CXXC5;PRMT5;LRWD1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.33141903797528943,0.8236548890513373,0.6910039113428944,0.9131539554736404,1.0,1/27,0.16%,SLC39A14
prerank,hexose transmembrane transporter activity (GO:0015149),-0.30943876272682497,-0.8205052532956185,0.646875,0.8950927896512196,1.0,1/12,1.05%,SLC2A1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2874617548488131,-0.8202596836176022,0.7121771217712177,0.890067394006433,1.0,2/17,3.33%,LBR;TECR
prerank,ion channel inhibitor activity (GO:0008200),0.3135988016536434,0.8195850855778725,0.7210144927536232,0.9171568280954473,1.0,11/35,26.82%,ITPR1;CAMK2D;TNNI3;FKBP1B;CALM2;KCNV1;NEDD4;VTI1B;COMMD1;SLC30A1;RASA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.23083648324194767,-0.8191075209225012,0.7864077669902912,0.8816237943691111,1.0,15/34,30.14%,NDUFS1;NDUFV2;NDUFA13;NDUFA8;NDUFC2;NDUFB7;NDUFA1;NDUFV1;NDUFA10;NDUFA3;NDUFC1;NDUFA12;NDUFS3;NDUFB10;NDUFA6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.23083648324194767,-0.8191075209225012,0.7864077669902912,0.8816237943691111,1.0,15/34,30.14%,NDUFS1;NDUFV2;NDUFA13;NDUFA8;NDUFC2;NDUFB7;NDUFA1;NDUFV1;NDUFA10;NDUFA3;NDUFC1;NDUFA12;NDUFS3;NDUFB10;NDUFA6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.318806539639363,-0.8180605341526815,0.7055555555555556,0.8782009791410739,1.0,5/12,19.90%,PIK3R3;PIK3R6;PIK3CD;PIK3CB;PIK3CA
prerank,tRNA binding (GO:0000049),-0.21764205366455538,-0.8177884550041187,0.8372093023255814,0.8735794040354046,1.0,9/43,14.28%,TRMT9B;ALKBH8;TYW5;ELP5;NSUN6;DARS2;TRMT10A;TRMT10B;RPUSD4
prerank,voltage-gated cation channel activity (GO:0022843),0.27061582429719483,0.8164248400111969,0.7693121693121693,0.9198285753518618,1.0,23/97,21.16%,CACNA1A;HVCN1;CACNB1;CACNA2D1;PKD2;CACNA1C;CACNA2D2;KCNF1;KCNG2;KCNA5;CATSPER3;KCNA4;GRIN2A;KCNMA1;CACNG3;KCNV1;GRIN1;KCNH8;KCNH4;KCNK1;TPCN2;KCNS3;KCNC1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2790605802506618,0.8160529751692798,0.7784946236559139,0.9180050211105618,1.0,19/83,19.58%,TNFAIP3;USP9X;USP24;USP42;USP38;USP40;USP3;USP14;MINDY3;TANK;USP22;VCPIP1;OTUD3;USP47;MYSM1;MPND;PSMD14;USP12;UCHL1
prerank,single-stranded RNA binding (GO:0003727),-0.22605094714083823,-0.8157391817052415,0.7712418300653595,0.872144739697207,1.0,11/43,18.86%,STRBP;ADARB2;AQR;HNRNPU;SNRPC;IFIH1;POLR2G;U2AF2;HNRNPA1;FXR1;ZFR2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.31555581809134653,0.8151244619134632,0.7083333333333334,0.9170838780486233,1.0,9/31,18.37%,UBE2L3;UBE2J1;UBE2E2;UBE2Z;UBE2QL1;UBE2W;UBE2R2;UBE2E1;UBE2S
prerank,deubiquitinase activity (GO:0101005),0.2766195261913624,0.8133794539933973,0.778372591006424,0.9174750290500792,1.0,20/88,19.58%,TNFAIP3;USP9X;USP24;USP42;USP38;USP40;USP3;EIF3H;USP14;MINDY3;TANK;USP22;VCPIP1;OTUD3;USP47;MYSM1;MPND;PSMD14;USP12;UCHL1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.34122234143754426,0.8074076871570623,0.7155425219941349,0.9243117717214026,1.0,4/19,11.45%,EGF;CCL5;EFNA5;ABI1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.37501699148312867,0.8035563572294739,0.6983154670750383,0.9278294118491951,1.0,2/11,7.65%,PABIR1;PPP1R2
prerank,phosphatidic acid binding (GO:0070300),0.34368337754883316,0.8023894139794004,0.7329545454545454,0.9272590462368481,1.0,5/19,9.83%,MARK1;PLTP;SESTD1;MAPKAP1;PLEKHN1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3822155394002157,0.8010670198711508,0.723404255319149,0.9268023773434954,1.0,2/10,14.68%,SLC10A6;SLC10A1
prerank,guanyl ribonucleotide binding (GO:0032561),0.25376893271345574,0.8002361644603647,0.86414708886619,0.9256777859879793,1.0,44/196,21.58%,RND3;RHOJ;RHOD;LRRK2;RAP2A;GNL3;RAB21;GBP7;RAC1;RAB8B;TUBG1;CDC42;RAB42;RAB7A;ATL2;RAB2A;GNL1;RALA;RAB10;PIP4K2B;ATL1;GBP3;ARL4C;RAB27B;RERG;GNAI1;RAB32;RRAGC;RAB9A;RAB8A;BMS1;RHOBTB3;TUBB2A;RHOA;RAB12;TUBA1A;RAB31;RIT1;ARF1;PDE5A;TUBG2;RHOF;RAP1B;ARF4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.38510679202501685,0.7998954578518687,0.7004538577912254,0.9214613532954665,1.0,3/11,14.96%,BAG3;HSPH1;BAG4
prerank,adenyl nucleotide binding (GO:0030554),0.38510679202501685,0.7998954578518687,0.7004538577912254,0.9214613532954665,1.0,3/11,14.96%,BAG3;HSPH1;BAG4
prerank,motor activity (GO:0003774),0.2781090644063728,0.7994160483820477,0.7798165137614679,0.9198474578804923,1.0,17/60,22.05%,KIF26B;KIFC1;MYH9;KIF2A;KIF1C;APPBP2;KIF5B;DYNC2H1;KIF13B;KIF3C;KIF5C;KIF3A;KIF5A;KIF27;KIF16B;GPR88;KIF20A
prerank,myosin binding (GO:0017022),0.28168518843149787,0.7953882752517606,0.771264367816092,0.9234474054070525,1.0,12/55,17.62%,NKD2;MLPH;TRAK1;CALD1;RALA;RAB10;LLGL1;CXCR4;RAB27B;RAB8A;RHOA;KIRREL1
prerank,C-C chemokine receptor activity (GO:0016493),0.3306968390765959,0.7937468826653283,0.7301808066759388,0.923483158101562,1.0,4/21,21.30%,CCR1;CXCR4;CCR9;ACKR2
prerank,phospholipase A2 activity (GO:0004623),0.31951026849511804,0.7928060851465247,0.7403100775193798,0.9225179701274239,1.0,6/26,21.63%,PLA2G5;PLA2G7;PRDX6;PLA2G12A;PLA2G4A;PLA2G4E
prerank,histone methyltransferase binding (GO:1990226),0.3784192898413865,0.7922082323134493,0.7197640117994101,0.9211069598882439,1.0,3/11,13.39%,PHF1;NOP56;LCOR
prerank,ATPase regulator activity (GO:0060590),0.2955428204896471,0.7912306055443712,0.7581620314389359,0.9202722975919051,1.0,9/38,15.46%,DNAJC1;DNAJB1;DNAJB6;BAG3;HSPH1;FNIP1;BAG4;TOR1AIP2;BRSK2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.33776610099473325,0.7897384290447751,0.7448840381991815,0.9201591763390459,1.0,3/18,17.07%,BIRC3;PRDX5;RPS6KA3
prerank,gamma-tubulin binding (GO:0043015),-0.24884514370318825,-0.789603918909682,0.8108108108108109,0.9109127305634784,1.0,9/21,29.11%,BRCA2;DIXDC1;TUBGCP3;TUBGCP5;RAD51D;RACGAP1;MARK4;CDK5RAP2;OFD1
prerank,neuropeptide binding (GO:0042923),-0.274177373100929,-0.7822466008561868,0.7827715355805244,0.9178438750301198,1.0,9/18,43.66%,OPRM1;SORL1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,potassium:proton antiporter activity (GO:0015386),0.37743211222513035,0.7805424334289445,0.746969696969697,0.9309511335362897,1.0,3/10,17.68%,SLC9A1;SLC9A8;SLC9A9
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.3425882987271557,0.7787271502566726,0.745125348189415,0.9311212266142068,1.0,3/15,13.01%,ALDH1A2;ALDH7A1;ALDH3A2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.34825719520213155,0.7775221026816488,0.7457886676875957,0.9305441040920112,1.0,4/15,13.94%,ATM;PI4K2B;PI4KA;PIK3C3
prerank,FMN binding (GO:0010181),-0.3055941454166744,-0.7767750072413699,0.727810650887574,0.9217144718621233,1.0,2/11,5.80%,NOS3;PPCDC
prerank,SUMO transferase activity (GO:0019789),0.3318150132080297,0.7751886203973807,0.7419354838709677,0.9316183027896269,1.0,5/16,21.64%,PIAS2;MDM2;EGR2;NSMCE2;PIAS1
prerank,3'-5' exonuclease activity (GO:0008408),-0.20618588028069967,-0.7710986876252732,0.89171974522293,0.9253390691570887,1.0,16/45,26.83%,CNOT8;NOCT;TATDN1;REXO4;CNOT6L;REV3L;RAD1;EXD1;ANGEL1;PDE12;DIS3L;MRE11;WRN;ERI2;TRIR;EXOSC10
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.26674470648656606,-0.7709078738798095,0.7800687285223368,0.9203235856893306,1.0,9/18,29.18%,PIK3R3;SOCS7;PIK3R6;SOCS3;CCKBR;AGAP2;SOCS2;CISH;SOCS1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2931989979799392,0.7681442029880697,0.799749687108886,0.938869955053637,1.0,10/33,23.16%,XRN1;ERI1;EXOSC4;DCP2;USB1;EXOSC2;EXOSC3;TOE1;DIS3L2;ERI3
prerank,endoribonuclease activity (GO:0004521),0.29616705644685165,0.7634163280990205,0.7938931297709924,0.943013823479581,1.0,7/32,17.81%,ERN2;SND1;DICER1;SMG6;ENDOV;CPSF3;RCL1
prerank,lipid phosphatase activity (GO:0042577),0.33657455073050424,0.7577784051808374,0.7593659942363112,0.9482632317635841,1.0,3/14,18.52%,EPHX2;PLPPR2;PLPP3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.3089256675646702,-0.754934528312384,0.8212121212121212,0.9380784721884526,1.0,3/10,14.89%,MGME1;TATDN1;DCLRE1B
prerank,RNA methyltransferase activity (GO:0008173),-0.24988505335390276,-0.7548120564668795,0.8113879003558719,0.9329109702873096,1.0,6/19,24.50%,TRMT9B;METTL4;LCMT2;TRMT5;TYW3;TRMT12
prerank,glycine binding (GO:0016594),-0.3000972814661251,-0.7543851109566928,0.7652173913043478,0.9283249530634398,1.0,4/11,13.88%,GLRA3;GRIN3A;GLRA2;GRIN2B
prerank,microtubule motor activity (GO:0003777),0.2667194200836379,0.7519291573492423,0.8249118683901293,0.9537397657274825,1.0,12/51,19.09%,KIF26B;KIFC1;KIF2A;KIF1C;APPBP2;KIF5B;KIF13B;KIF3C;KIF5C;KIF3A;KIF5A;KIF27
prerank,sodium channel activity (GO:0005272),-0.2104317932242342,-0.7509047274396425,0.90625,0.9280986383350345,1.0,7/37,15.40%,GRIK4;SCN2A;SCN8A;SCN3A;HCN1;SCN4B;SCN9A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3554848866958012,0.7495593338437357,0.7722929936305732,0.9543603097516548,1.0,2/11,5.17%,UBR5;ANAPC11
prerank,epidermal growth factor receptor binding (GO:0005154),0.2970147415261451,0.7491599220993886,0.7891332470892626,0.9525475971669085,1.0,7/25,21.58%,ATXN2;EGF;GRB2;SNX4;BTC;SNX2;ARF4
prerank,histone demethylase activity (GO:0032452),0.2953567158694237,0.747634933871664,0.7958387516254877,0.9522770533544598,1.0,6/27,20.24%,PHF2;KDM4D;KDM7A;KDM2A;KDM3B;JARID2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.29905550625446314,0.7472632378866729,0.8090909090909091,0.9504936634057194,1.0,6/24,19.80%,CAMK2D;PHKA2;CAMK1G;CAMK2B;DAPK1;CAMK1D
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.35018251932020217,0.7450047419190544,0.760670731707317,0.9511115791893857,1.0,2/11,7.68%,ITPR1;TRPC6
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3187029018416061,0.7439617581822422,0.7902995720399429,0.9501529514900601,1.0,4/18,14.63%,BAIAP2;ANXA1;RAB10;CNN3
prerank,ribosomal small subunit binding (GO:0043024),0.32111456556805623,0.7421055921315878,0.7796610169491526,0.9502343670932223,1.0,5/17,20.26%,ABCE1;EIF1;DHX29;MTIF2;DDX3X
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.27443915948250086,-0.738674138507971,0.7933130699088146,0.939431385589857,1.0,2/13,9.82%,LPCAT2;ABHD5
prerank,voltage-gated anion channel activity (GO:0008308),0.32121246885653165,0.7348103112973695,0.799405646359584,0.9572434794505325,1.0,4/15,16.87%,VDAC2;CLCN5;CLCN4;VDAC3
prerank,N-methyltransferase activity (GO:0008170),-0.24226001628219412,-0.7279306476086895,0.8631578947368421,0.9481576841077287,1.0,6/20,26.20%,TRMT1L;HNMT;TFB2M;ZCCHC4;TRMO;TFB1M
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2841920215315972,0.7278466837946559,0.8050065876152833,0.9637427066267565,1.0,4/25,10.86%,GAB2;SESTD1;MAPKAP1;DAPP1
prerank,titin binding (GO:0031432),0.32700965139906124,0.7235206981367979,0.7846607669616519,0.9666820830802875,1.0,3/13,13.46%,CAMK2D;CALM3;CALM2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.35313559156107843,0.7226605364656904,0.8253012048192772,0.9653554016913335,1.0,3/10,10.74%,SQSTM1;GNAS;DLG4
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2617765288667333,-0.7128247639423669,0.8639240506329114,0.9613327736709962,1.0,7/14,25.61%,NDUFS1;NUBPL;RSAD2;ISCU;CIAO3;ETFDH;NFU1
prerank,GTPase inhibitor activity (GO:0005095),-0.2672486396858047,-0.712709777731678,0.834375,0.9562603318130216,1.0,9/13,33.90%,SLIT2;CDC42SE1;RHOH;ARL2;IQGAP2;TNK2;GPS2;CPEB2;GPS1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.2899361337272952,-0.710755219449199,0.8257575757575758,0.9533684901238002,1.0,4/10,19.90%,PIK3R3;PIK3CD;PIK3CB;PIK3CA
prerank,telomeric DNA binding (GO:0042162),0.2734436081349859,0.7075588254939016,0.8405977584059776,0.981233791635841,1.0,8/32,21.23%,ZBTB48;SMG7;TERT;SMG6;TELO2;HNRNPA2B1;CTC1;TERF2IP
prerank,protein phosphatase 1 binding (GO:0008157),0.2938543117376241,0.7056288579537391,0.8615591397849462,0.9811777048217869,1.0,2/21,10.41%,PPP1R9B;PPP1R16A
prerank,acetylcholine receptor activity (GO:0015464),-0.22215490879699562,-0.7048204849109047,0.924187725631769,0.9545924013852994,1.0,3/22,13.59%,CHRM2;CHRM3;CHRNB1
prerank,gap junction channel activity (GO:0005243),0.28387312878121584,0.7039407787633006,0.8625850340136054,0.9807663859631708,1.0,3/22,14.44%,GJC2;GJD3;GJC1
prerank,pre-mRNA binding (GO:0036002),0.27479721379257877,0.7033358294137176,0.8489116517285531,0.9791406869439737,1.0,8/28,22.46%,CELF1;ERI1;TARBP2;SLBP;CELF5;RNPC3;U2AF1;RBM41
prerank,P-type ion transporter activity (GO:0015662),0.32668120038385096,0.7022175008030604,0.8288690476190477,0.9781824845985031,1.0,3/12,14.10%,ATP2A2;ATP2B1;ATP2C1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2499715932256606,0.7006397439361017,0.8783625730994152,0.9776965374306943,1.0,14/51,20.34%,SLC28A2;SLC4A4;SLC35D2;SLC25A16;SLC20A1;TMEM241;CLCN4;SLC35C1;SLC7A8;ANKH;SLCO1B1;SLC28A3;SLCO4C1;SLC25A10
prerank,myosin V binding (GO:0031489),-0.2482194276629134,-0.6999680456224514,0.8344827586206897,0.9546117241189916,1.0,5/15,20.25%,RAB14;RAB3C;RAB39B;RAB3D;RAB11B
prerank,snRNA binding (GO:0017069),0.2571197266665535,0.6984938179829784,0.8793532338308457,0.9778243257533321,1.0,17/42,27.42%,LSM7;HEXIM1;CDK9;COIL;CCNT1;NCBP2;SNRNP35;SNRPB2;RNPC3;EFTUD2;TOE1;RBM41;PRPF31;SART3;GEMIN5;PRPF8;RBM22
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2745947208384054,0.6978086033719975,0.8831168831168831,0.9763455208272497,1.0,4/28,11.30%,LRRK2;MAP2K4;MAP2K1;RPS6KB1
prerank,protein tyrosine kinase binding (GO:1990782),0.23963941973861935,0.693481324977974,0.893687707641196,0.9788674489664708,1.0,12/71,16.69%,CBLB;TREM2;KHDRBS1;CBL;NCK1;ACVR1;SQSTM1;PTPN1;SIRPA;PTPN2;SOCS5;ANGPT1
prerank,wide pore channel activity (GO:0022829),0.27759495455802075,0.6919302841716454,0.8709677419354839,0.9782792594502027,1.0,3/23,14.44%,GJC2;GJD3;GJC1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.26638809698351756,-0.6911114785866274,0.8365384615384616,0.9585425195917348,1.0,2/11,7.45%,MAP3K5;TAOK2
prerank,voltage-gated chloride channel activity (GO:0005247),0.32940983312246597,0.6910325694925002,0.8069620253164557,0.9769316352313434,1.0,2/10,12.56%,CLCN5;CLCN4
prerank,C-C chemokine binding (GO:0019957),0.2860567843059029,0.6907272641122808,0.8376891334250344,0.975028443246328,1.0,4/22,21.30%,CCR1;CXCR4;CCR9;ACKR2
prerank,metallocarboxypeptidase activity (GO:0004181),0.26987754442049755,0.6826004376422024,0.8656126482213439,0.9816496055759286,1.0,5/26,16.61%,CPXM1;AGTPBP1;CPA6;AGBL3;PEPD
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2706013895142177,0.6812994637567553,0.8703465982028241,0.9807840327315375,1.0,6/28,17.14%,DICER1;POP1;RNASEH2A;RNASEH1;ENDOV;POP4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.20311750029075526,-0.6810654363115646,0.9855072463768116,0.9632949503600707,1.0,15/29,33.43%,ACER2;HEXD;HPSE2;ADPRS;OVGP1;PARG;MOGS;HYAL2;CTBS;IDUA;ENGASE;PGGHG;ACER3;HYAL3;LCT
prerank,phospholipase binding (GO:0043274),-0.25926317109267705,-0.6795249883473796,0.8594249201277955,0.9598526386849784,1.0,3/13,15.49%,PRKN;DGKQ;SYK
prerank,snoRNA binding (GO:0030515),0.2639732955872692,0.679227637214081,0.8838383838383839,0.9806860833082431,1.0,10/30,27.93%,NHP2;NOP56;NOP14;BMS1;NUDT4;PRKDC;BYSL;NUDT7;UTP6;DHX37
prerank,fibroblast growth factor binding (GO:0017134),0.2816750739064769,0.6790370319539394,0.8500707213578501,0.9786223392541429,1.0,3/21,15.29%,FGFR1;GLG1;FGFRL1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.24945347650997826,0.6764150448945255,0.8891566265060241,0.9789394081431069,1.0,7/40,18.56%,ASMT;COMTD1;COMT;PCMT1;DNMT3B;THUMPD3;LCMT1
prerank,ankyrin binding (GO:0030506),0.281235326893501,0.6728549140745599,0.8811188811188811,0.980171559162759,1.0,1/19,2.07%,FLNC
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.27262110989390886,0.6721956060442137,0.8854447439353099,0.9786190665433686,1.0,8/24,22.38%,SESTD1;PLEKHF1;PLEKHA5;OSBPL5;PLA2G4A;RUBCNL;PLA2G4E;GSDMD
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3148556867860394,0.6685210180270084,0.8390625,0.9800959847242213,1.0,1/10,4.88%,NAA50
prerank,5'-3' RNA polymerase activity (GO:0034062),0.26605548541027624,0.6630274328391702,0.8886010362694301,0.9834183321711327,1.0,10/27,23.08%,TERT;CRCP;POLR2B;MED21;POLR3K;POLR1D;POLR3A;POLR1B;POLRMT;POLR2L
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.29888204928916007,0.6581621869512384,0.8701492537313433,0.9857047301452603,1.0,4/12,23.43%,FXN;SDHB;ISCA2;XDH
prerank,voltage-gated sodium channel activity (GO:0005248),0.2684031100259224,0.6579703194377738,0.8756684491978609,0.9836349930522881,1.0,3/22,11.40%,SCN7A;PKD2;SCN2B
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2597287444565022,-0.6571834151501758,0.911504424778761,0.9743652793379338,1.0,3/11,23.18%,STN1;HNRNPA1;RPA2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2697277069254581,0.650531145665823,0.8905608755129959,0.9883199336973331,1.0,5/21,15.99%,GSKIP;ARFGEF2;ACBD3;PJA2;AKAP8L
prerank,sodium:proton antiporter activity (GO:0015385),0.3100231083321911,0.6499526252549047,0.877488514548239,0.98661033450123,1.0,3/11,17.68%,SLC9A1;SLC9A8;SLC9A9
prerank,calcium-dependent phospholipid binding (GO:0005544),0.23351980055012309,0.6489757404486579,0.9211764705882353,0.9852870481109343,1.0,14/49,22.67%,CPNE7;ANXA1;CPNE2;SYT10;SYT2;MCTP2;SYT3;CPNE8;DOC2B;PLA2G4A;PLA2G4E;ANXA2;RPH3A;ANXA6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.28502451560182857,0.646709321577463,0.858433734939759,0.9850206589497154,1.0,5/15,23.71%,AGPAT5;GPAT3;ABHD8;AGPAT1;LCLAT1
prerank,store-operated calcium channel activity (GO:0015279),0.3085354392028489,0.6403726893359577,0.8854489164086687,0.9880725663312334,1.0,4/10,24.54%,TRPC6;ORAI1;STIM2;ORAI2
prerank,death receptor binding (GO:0005123),-0.2227209211797802,-0.632852002324625,0.9207920792079208,0.9868814091745627,1.0,4/15,14.19%,MADD;FEM1B;BDNF;BID
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2821696994536731,0.6319447690771047,0.8978102189781022,0.9928707415913948,1.0,2/14,10.91%,USP9X;MINDY3
prerank,calcium activated cation channel activity (GO:0005227),0.2716017764561221,0.6319365817942068,0.8951724137931034,0.990694057858575,1.0,8/17,30.99%,KCNMB4;KCNMA1;TRPM4;ANO10;TMEM63A;TMEM63C;ANO6;TMEM63B
prerank,BMP binding (GO:0036122),0.2937714800866257,0.6312194481804666,0.8894009216589862,0.9890324860288219,1.0,1/11,9.01%,GREM2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2394368592836632,0.6281601580412515,0.9284802043422733,0.9893530562263376,1.0,8/32,18.78%,FTO;TMLHE;KDM7A;ALKBH1;ALKBH5;TET2;KDM2A;HSPBAP1
prerank,mannosyltransferase activity (GO:0000030),0.25603740394999147,0.6256601863396385,0.9085948158253752,0.9892177985907098,1.0,5/21,18.08%,TMTC4;DPY19L3;POMT2;DPY19L4;ALG8
prerank,H4 histone acetyltransferase activity (GO:0010485),0.30362645452250614,0.6250129405287865,0.8772727272727273,0.987552033718059,1.0,3/10,16.77%,NAA50;USP22;ATF2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.27469118390281666,0.620004783222574,0.8967551622418879,0.9893041089992123,1.0,6/14,28.60%,DTYMK;AK8;CMPK1;AK5;NME2;AK4
prerank,U6 snRNA binding (GO:0017070),-0.22799747600408093,-0.6193455877261784,0.9146341463414634,0.9905242445997601,1.0,3/14,9.32%,PRPF4;LARP7;TUT1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.24611040766281722,-0.6191205805729817,0.9209809264305178,0.9855502453353232,1.0,6/10,34.12%,PHF8;RIOX2;KDM4C;KDM4A;KDM8;RIOX1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.25683471679432957,0.6171058607320233,0.924,0.9893763378607939,1.0,5/22,17.77%,ATP2A2;ATP6V1D;ATP2C1;TCIRG1;ATP6V0A2
prerank,acetyltransferase activity (GO:0016407),-0.18173955200463998,-0.6103031236195228,0.9818181818181818,0.9855473809086656,1.0,13/31,29.74%,EP300;KAT6A;ESCO1;KAT2B;SAT1;SPHK1;NAT8L;NAA80;SAT2;LCAT;NAT14;NAA10;KAT8
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.28290274242202823,0.6075189081149762,0.9142419601837672,0.9938480277551776,1.0,1/11,4.88%,NAA50
prerank,DNA polymerase activity (GO:0034061),0.24797109088326327,0.6064257734367624,0.932157394843962,0.992448707318673,1.0,5/22,22.21%,POLE3;TERT;POLI;POLG;REV1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.23961648442317157,-0.6053478107678063,0.9113149847094801,0.9831653687585891,1.0,7/11,34.31%,KCNN3;KCNN2;PKD2L1;KCNMB2;KCNN4;KCNU1;KCNN1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2059775492588657,0.6018315321660672,0.9709821428571429,0.9933584527546908,1.0,13/69,21.63%,CERS6;ASPG;CREBBP;SOAT1;ZDHHC3;CERS2;MOGAT3;ZDHHC9;ZDHHC6;PLA2G4A;LPCAT3;HHAT;PLA2G4E
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.2101025654061984,-0.5992199034394997,0.9391891891891891,0.9764073943378136,1.0,7/16,30.52%,ATP6V1A;ATP6V0D1;ATP6V0B;ATP6V0A1;ATP6V1B2;ATP6V0D2;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.2101025654061984,-0.5992199034394997,0.9391891891891891,0.9764073943378136,1.0,7/16,30.52%,ATP6V1A;ATP6V0D1;ATP6V0B;ATP6V0A1;ATP6V1B2;ATP6V0D2;ATP5F1B
prerank,transaminase activity (GO:0008483),-0.23030569330236644,-0.5982137460012712,0.9237536656891495,0.9720637083723703,1.0,11/11,76.99%,ABAT;GOT2;BCAT2;GOT1;GOT1L1;AADAT;AGXT2;OAT;BCAT1;AGXT;PSAT1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.23250529086061633,-0.5948042909666454,0.9566473988439307,0.9688592472936808,1.0,6/11,33.14%,DCPS;NUDT11;NUDT16;NUDT1;NUDT3;NUDT10
prerank,calcium channel regulator activity (GO:0005246),0.22421714017749494,0.5930839505408491,0.9476961394769614,0.9967128625670063,1.0,5/37,13.46%,ITPR1;STIMATE;TNNI3;FKBP1B;CALM2
prerank,aspartic-type peptidase activity (GO:0070001),0.28974086238238295,0.5904324088033992,0.9250398724082934,0.9961915982526443,1.0,2/10,16.37%,CTSD;PSEN1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.27628902181408976,0.5894381714005746,0.9283536585365854,0.9946853498862852,1.0,5/11,26.75%,LRRC8A;SLC35B2;SLC19A1;SLC25A24;SLC35B3
prerank,damaged DNA binding (GO:0003684),0.21621895389043333,0.5866434651941699,0.9660606060606061,0.9941586946705095,1.0,15/44,28.47%,MPG;CREBBP;DCLRE1C;DDB1;HMGB2;RBBP8;NTHL1;XRCC1;SDE2;RPS3;PNKP;APTX;CUL4B;ERCC2;XPA
prerank,N-acyltransferase activity (GO:0016410),0.22131039008689488,0.5829379771974146,0.9555555555555556,0.9941695687222185,1.0,6/32,21.63%,CERS6;NAA50;CERS2;NAT10;SIRT7;PLA2G4E
prerank,protein phosphatase 2A binding (GO:0051721),0.23629699783685743,0.5782341765255056,0.9457671957671958,0.9946807777999777,1.0,2/23,8.41%,SMG7;STRN
prerank,deoxyribonuclease activity (GO:0004536),0.25414061685456146,0.5706202482395479,0.9331352154531947,0.9964698060611384,1.0,3/14,16.53%,MAP1S;DFFB;DNASE1L2
prerank,Hsp90 protein binding (GO:0051879),0.21486474822014817,0.5687524613565264,0.9650436953807741,0.9953467177677714,1.0,10/33,23.64%,PPID;AHR;CYP1A1;STUB1;NPAS2;CSNK2A1;TELO2;UNC45A;TSC2;RPS3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.2621443157205906,0.568618481175298,0.9364599092284418,0.9932971229448475,1.0,5/12,26.75%,LRRC8A;SLC35B2;SLC19A1;SLC25A24;SLC35B3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.2575774273295882,0.5649590316557719,0.9416167664670658,0.992886401108907,1.0,3/12,21.06%,TENT5A;PAPOLG;TENT4A
prerank,adenylyltransferase activity (GO:0070566),0.23245505993106363,0.5559865905029209,0.9554317548746518,0.9951179622097809,1.0,7/21,21.06%,OASL;PAPOLG;COASY;ABL1;FLAD1;NMNAT2;TENT4A
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.20706346869842038,0.5442363139890793,0.967741935483871,0.9981165085055771,1.0,14/34,31.62%,ERI1;EXOSC4;USB1;EXOSC2;EXOSC3;TOE1;DIS3L2;ERI3;EXD2;EXOSC5;PARN;CNOT2;PNPT1;EXOSC7
prerank,nuclear export signal receptor activity (GO:0005049),0.2547273365742171,0.5414878404533651,0.946875,0.9971797939274283,1.0,2/11,15.96%,XPO7;NUP214
prerank,endonuclease activity (GO:0004519),0.19713727044307644,0.5374069850792498,0.9882903981264637,0.9967272821002388,1.0,8/49,18.79%,ERN2;SND1;DICER1;SMG6;SETMAR;CPSF3;RCL1;NTHL1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.21859940914874082,0.528810000860515,0.9780521262002744,0.9978411115332904,1.0,1/21,2.69%,POLE3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.20559614941381016,0.5165197753596054,0.9786381842456608,0.9997299091454966,1.0,9/24,28.60%,ITPKC;DTYMK;AK8;IP6K2;CMPK1;AK5;AK3;NME2;AK4
prerank,ribonuclease P RNA binding (GO:0033204),0.24686073292948013,0.5060957035091486,0.9661016949152542,1.0,1.0,2/10,17.14%,POP1;POP4
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.21540990006651725,0.5024700162555288,0.9742489270386266,0.9994762109839087,1.0,2/18,11.94%,HSD17B8;HSD11B1
prerank,RNA polymerase binding (GO:0070063),0.21250700393650923,0.5022046853521416,0.9688385269121813,0.9974605714618419,1.0,6/18,26.72%,BIN1;CCNT1;TCERG1;NEDD4;PHRF1;YTHDC2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2357292809552422,0.5008701258110106,0.9776119402985075,0.9957386349522519,1.0,3/12,18.94%,HM13;PSEN1;SPPL3
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.2092977483203491,0.49517994516025804,0.9617563739376771,0.9952148330339026,1.0,7/17,28.60%,DTYMK;AK8;CMPK1;AK5;AK3;NME2;AK4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.22432734030985596,0.48783338440084467,0.9734121122599705,0.9948179998854988,1.0,1/11,12.22%,SLC17A5
prerank,peptide hormone receptor binding (GO:0051428),-0.1862406628585776,-0.473814418630789,0.9815950920245399,0.9993841218960049,1.0,11/11,81.40%,ADCYAP1;CCK;UCN2;GPHB5;GHRH;GPHA2;UCN3;VIP;PSMC5;PTHLH;GNRH1
prerank,ribonuclease P activity (GO:0004526),0.2233689117573461,0.47098114741301134,0.9805680119581465,0.9962125155634102,1.0,2/11,17.14%,POP1;POP4
prerank,water transmembrane transporter activity (GO:0005372),-0.1844388212874245,-0.4633765388746798,0.9972375690607734,0.9957446295537286,1.0,1/11,8.32%,AQP11
prerank,microtubule minus-end binding (GO:0051011),0.21123975964188968,0.46289768561449374,0.9866071428571429,0.9954595851324836,1.0,3/13,18.91%,CAMSAP2;TUBGCP4;CAMSAP1
prerank,microtubule plus-end binding (GO:0051010),0.18664174930248387,0.4456422228093341,0.9904632152588556,0.9958242056068114,1.0,6/20,25.12%,CLIP3;FBXW11;MAPRE2;CLASP2;PAFAH1B1;NUMA1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.19122309720113617,0.414325593045902,0.9909365558912386,0.9968805466470637,1.0,3/12,25.99%,B3GALNT1;B3GNT9;B3GALT1
